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1. Introduction 
1.1 The epidemiological surveillance 
1.1.1 The definition of surveillance  
 
Epidemiological surveillance is the "continuous, systematic collection, analysis and 
interpretation of data for the improvement and evaluation of health systems, tightly 
integrated the timely dissemination of information collected, to all those who are devoted 
to interventions for prevention and control of diseases ". 
By this definition, Alexander D. Langmuir, a well-known American epidemiologist, 
explained the concept of epidemiological surveillance for the first time and it was the first 
step towards a progressive development of surveillance systems (1). 
In 1965, it was established the Division of Infectious Diseases of the World Health 
Organization (WHO) and the epidemiological study of disease was then considered to be 
in "a dynamic process". In 1968, the 21st World Health Assembly, led by Langmuir and 
Raska, focused its attention on global surveillance of infectious diseases and set out the 
key aspects of surveillance in public health matters: the systematic collection, analysis, 
and dissemination of data on health events. In addition, it was agreed that the surveillance 
had to be followed over time to verify that effective actions had been taken. From that 
moment, a wide variety of events related to public health, such as tumors, malformations, 
abortions, accidents, environmental, and behavioral risk factors were included in 
monitoring programs (2). 
 
1.1.2 The steps and functions of surveillance systems 
The surveillance system is undertaken to inform the disease prevention and control 
measures. This systematic and continuous system follows some steps and functions 
which enable to design procedures and methodologies in order to have effective systems 
that support the ongoing researches and public health actions. In Figure 1.1.1, there is a 
description of the flow of data and the lines of response in a surveillance system that can 
help assess the simplicity or complexity of the system. Meanwhile in Figure 1.1.2, there 
are described the steps of a surveillance system. 
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Figure 1.1.1.Public health surveillance: Detection and monitoring (3) 
(Centre for Infectious Disease Preparedness, UC Berkeley School of Public Health) 
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Figure 1.1.2 the steps of a surveillance system (3)  
MMWR (2001) Updated Guidelines for Evaluating Public Health Surveillance Systems 
 
Surveillance is the foundation of all efforts to understand and control and prevent disease. 
Once a health-related event occurs, such as infectious, chronic or zoonotic disease, injury, 
adverse exposure, risk factor or protective behavior, or other surveilled events associated 
with public health, identification and definition of cases will be in placed. The cases will 
be identified and analyzed by place, person, and time. At last, it is initiated the report 
generation and dissemination. This includes also the reporting sources as health care 
providers: physicians, veterinarians, laboratories, health-care organizations, schools, and 
vital records, hospitals, and data recipients at different levels as county and health 
departments. The management of the data is the key of the entire surveillance system. 
Following the collection, entry, editing, storage, analysis, and reporting of data, the 
dissemination and feedback of information is useful for public health action to control 
and prevent the disease. In this way, the generic surveillance system can measure the 
impact on community‘s health from any health-related event (1, 3). 
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It is important to recognize the functions that a surveillance system has to perform in 
order to be effective. These functions include: detection and notification of health events, 
collection and consolidation of pertinent data, investigation and confirmation 
(epidemiological, clinical and/or laboratory) of cases or outbreaks, routine analysis and 
creation of reports, feedback of information to those providing the data, feed-forward of 
data, and reporting data from Morbidity and Mortality Weekly Report (MMWR, May 
2004/53 [RRo05]). 
By achieving all the steps required for a successful generic surveillance system, the 
public health surveillance will provide the scientific and factual database essential to 
inform decision making and appropriate public health action. The key objective of this 
system is to provide information to guide interventions. 
 
1.1.3 The objectives and actions of surveillance system 
The key actions taken by the surveillance system can be summarized as: data collection, 
analysis, the processing of the information, and the return of the information to all those 
who need the data received. The latter include the local authorities responsible on 
prevention and control of diseases. These authorities plan and implement the 
interventions to the content. 
The main objectives of a surveillance system are to investigate and carefully assess the 
health of the population being studied. It also determines the priority actions in public 
health evaluation programs and provides incentives for scientific research. 
The ultimate goal of public health surveillance systems is the control and prevention of 
diseases, and pervasive and careful monitoring of lifestyles and risk factors related to the 
acquisition of the disease, in a continuous effort aimed at continually improving state of 
community health. 
Historically, a surveillance system has focused its attention primarily on the activities of 
infectious diseases controls and their causative agents, but in fact it carries out the 
surveillance in health interventions and for the prevention of disease and health 
protection. 
A well-organized surveillance system describes the risk factors, natural history, the 
space-time distribution for documenting the epidemiological characteristics of disease, 
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and also allows the evaluation of the successful chances of various intervention 
strategies. For the purposes of control and prevention, it is important that the data are of 
good quality and are analyzed in real time. This will enable the planning of intervention 
programs both locally and centrally, and will provide epidemiological information on 
understanding the transmission mode (3). 
The monitoring also allows the describtion and implementation of a careful monitoring of 
changes in the epidemiological scenario of diseases, with special attention to diseases 
emerging or "re-emerging, due to the form of new social arrangements and migration, 
and the problem of resistance of pathogens against antimicrobial drugs, as part of 
antibiotic resistance. At last,  allows to analyze changes associated with the introduction 
of new health practices, in diagnostic and therapeutic, and assess their impact on the 
population (the introduction of new vaccines, screening methods, ...) to facilitate the 
planning for the prevention and control health (4, 5). 
Before taking any action which aims the control of disease, it is necessary to define the 
program of surveillance, which consists of several stages (6): 
• identifying its importance; 
• defining the intervention objectives; 
• the case definition; 
• choosing the type and the way of the data collection; 
• defining the information flows; 
• identifying the tools for analysis, evaluation and feedback; 
• the cost planning. 
In the surveillance system, there should also be considered some fundamental 
assumptions (7): 
• the event under surveillance (specified by case definition); 
• the operators who report the event of interest; 
• the location where the event is recorded (such as an individual card for each  
 patient and a cumulative card with the total number of patients seen in a given  
 period of time. These cards are the source of information which is computerized 
later); 
• the frequency with which information is transferred by the notifier to the  
Dissertation 2011 
 
11 Elida MATA 
 
 collection center; 
• the way in which each event is observed from the Collection Center (actively  
or passively). There exists an active research for the cases and the information  
which has been gathered directly by health care providers or laboratories, or  
which has simply been asked from operators to report cases when they occur 
• the assessing of the procedures of data assurance which is considered sensitive; 
• the type of control and analysis which are performed on the data collected; 
• the information characteristics including the frequency with which they are  
 transmitted from the collection center. 
Each of the above points is crucial on the quality of implementation of the monitoring 
system.  
 
 
Fgure 1.1.3 the circle diagram of the main activities of the surveillance 
Overview of public health surveillance, CDC (1) 
 
In the passive surveillance, the collected data are used at different levels, from those who 
work in health sciences. These data include: the patterns of morbidity and mortality data 
(medical records and medical certificates, cancer registries, hospital discharge records, 
death certificates, and especially data related to epidemic events). Passive surveillance of 
infectious diseases is mainly based on mandatory notification system, organized 
according to a specific information flow, and on the data for the laboratory strains. The 
active surveillance is defined as acts through the initiation of epidemiological 
investigations, or ad hoc surveys planned on the basis of the needs, in order to monitor 
and investigate the outbreaks and other epidemiological anomalies, reducing the impact 
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in terms of morbidity and mortality of diseases (1). The planned ad hoc surveys consist of 
detection systems used on samples taken from the appropriate population. These methods 
are based on clinical, instrumental and laboratory techniques, properly conducted in 
accordance with the objectives of the investigations, and supplemented by information 
gathered from the direct competition of subjects studied by performing interviews and 
filling out questionnaires (1). 
 
1.1.4 The characteristics of surveillance system 
The evaluation of public health surveillance systems should involve an assessment of 
system attributes. Some of the latter are simplicity, flexibility, data quality, acceptability, 
sensitivity, predictive positive values, representativeness, timeline, and stability.  
 Simplicity - the simplicity of a public health surveillance system refers to both its  
structure and ease of operation. The surveillance systems should be as simple as possible 
while still meeting their objectives. Simplicity should cover the structure, the 
organization of the system and its operations. A simple designed system consists a case 
definition that is easy to apply (i.e., the case is easily ascertained) and in which the person 
identifying the case will also be the one analyzing and using the information. A more 
complex system presents additional issues. These special systems might require 
laboratory confirmation of cases, to perform detailed analysis on the cases of illness, use 
of multiple levels of reporting the information obtained, and finally to integrate data with 
other systems to better compare and interpret. Simplicity is closely related to acceptance 
and timeline. Simplicity also affects the amount of resources required to operate the 
system (4). 
• Sensitivity - the sensitivity of a surveillance system can be evaluated on two   
levels: the proportion of cases of disease (or other events relating to public health) 
detected by the system and the ability to detect outbreaks. The primary importance of the 
sensitivity of a system is to estimate the proportion of cases of a given disease detected 
by the system compared to the total number of cases in the population under surveillance. 
The sensitivity of a system can be increased by implementing an active surveillance 
through ad hoc surveys, using other monitoring indicators to monitor the quality of the 
reported cases, accurately identifying the cases of import and diagnostics and monitoring 
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movement of a specific causative agent (4, 8) see figure 1.14. The sensitivity of a system 
is a prerequisite if you intend to analyze the time course of a health problem, such as the 
trend of a disease and its epidemiological evolution. Sensitive systems are able to capture 
poorly the static phenomena. When examining the trend of a phenomenon we must 
always consider the possible changes in terms of sensitivity of a system (eg. the 
introduction of new diagnostic tests or changes in the conduct of surveillance) which 
could result in "artifacts, whose recognition is the first step in the study of epidemics; 
 
 
 
 
 
 
 
 
 
 
Figure1.1.4 Representation of the sensitivity of surveillance systems (4) 
• Acceptability - acceptability reflects the availability of people and organizations 
to participate in a surveillance system. Quantitative measurements of the acceptability of 
a system are: the rate of the participation of the organizations, the institutions or the 
individuals, the reporting, the timeline of the notifications, the proportion of questions 
that one answered or did not answer, and finally the rate of notifications carried out by 
doctors, laboratories, hospitals, and facilities for diagnosis and treatments. Some of these 
measurements can be obtained through a review of the reports that are received, while 
others require special studies and investigations; 
• Representativeness - a surveillance system can be defined as representative if it is 
able to describe the occurrence of an event within the study of the population in terms of 
space, time and people. The representativeness of a system is evaluated by comparing the 
characteristics of the events reported by the system with the actual events, examining 
some important elements, including the characteristics of the study of the population, the 
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natural history of disease or the evolution of specific events related to the health medical 
practices,the diagnostic techniques, and at last the other data sources (e.g. rates of 
morbidity and mortality which emerge from the comparison of the clinical and laboratory 
reports). Epidemiological investigations carried out in a heterogeneous population over or 
under a system that has resulted in the lack of representativeness can give misleading 
conclusions and considerations about the event under surveillance (8); 
• Flexibility - a flexible surveillance system can adapt to rapid changes in 
information and operating conditions, adding a small amount of time, personnel and 
funds. The flexible systems are capable to define new events in health, to establish major 
changes in the case of the definition and the technology, and changes in the way of 
researching and reporting sources. The systems that use the format of standard data, such 
as computers, can be easily integrated with other systems, making it possible to compare 
and cross-analysis of data. The flexibility of a system is better assessed in a retrospective 
analysis of how the system has responded to a new request. One can easily imagine that 
the monitoring systems of the dangerous factors associated with the development of a 
disease must be extremely flexible, reflecting the changes in the lifestyles of the 
population being studied. In general, simple systems are more flexible, and extremely 
complex systems often have limited flexibility; 
• Completeness - completeness consists essentially of two elements: the proportion 
of the total number of the cases having access to health services that are included in the 
surveillance system and the number of the cases diagnosed and reported in the system 
database. It is important to monitor the receipt of reports by all health services, 
monitoring possible delays. During the visits of the supervision it is necessary to estimate 
the proportion of the cases diagnosed by health services which are reported by 
surveillance systems; 
• Data Quality - the quality of the data reflects the completeness and the 
availability of the data collected by the national health surveillance system. The analysis 
of the percentage of "known‖ and "unknown" in the context of the quest within the 
modules to conduct the surveillance, is a simple and easy method for assessing the 
quality of the data system. However, a more rigorous assessment of the completeness and 
validity of the data system will requires further study. The calculation of the sensitivity 
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and the positive predicted value for each field of the data collection is an excellent 
method for assessing the quality of the information collected. A surveillance system that 
does not have high-quality data cannot meet the criteria of acceptability and 
representativeness (8); 
• Stability - stability refers to the reliability (i.e. the capability to collect, manage 
and provide data properly without losing any useful information) and the availability (i.e. 
to be operational if needed) of a system of the public health surveillance. A surveillance 
system is unstable, unreliable and difficult to implement appropriate measurements to 
prevent and control when it is necessary (5, 9); 
• Timeliness – This requirement reflects the rapidity of the subsequent operative 
steps while working with a system of the public health surveillance. The timeline is 
considered as very important for the evaluation of the time period between the onset of a 
disease case (index case) and the notification of the case by the responsible surveillance 
system for establishing appropriate measurements to control and prevent the infectious 
diseases see figure 1.1.5. Factors that may influence the length of this period of time 
include the recognition of symptoms and the validity of the case, the waiting for the 
outcome of laboratory tests for diagnostic confirmation, and then the forwarding of the 
notification of the cases by the members of the medical system in order to receive it. 
Another important aspect of the timeline of the system regards the time required to 
identify the trend of sickness and disease, and the effect of measurements taken for the 
prevention and control of communicable diseases. Factors that may affect this time 
include the severity, the contagiousness of the disease, and the timing of the 
communication between the health care facilities that are diagnosed and the units 
responsible for the implementation of the targeted interventions. The timeline of a 
surveillance system of public health can be assessed as a whole in terms of the 
availability of the information for monitoring the health of the event, including 
measurements of immediate control, and preventive and intervening plans. The need to 
obtain a quick response is directly linked to the nature of the event under surveillance and 
the objectives of the system. In general, for diseases characterized by a long incubation 
period, it is not essential to quickly identify the cases of the disease, but just early 
identification methods and sources of transmission, to try to interrupt the chain of 
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infection and the spread of the infection. The increasing widespread use of the 
computerized data and of the Internet, as well as the intersection of data from various 
electronic databases, is gradually promoting the timeline of surveillance systems (10, 11).   
 
 
 
 
Figure 1.1.5 Timeliness diagram of surveillance system (10) 
• Predictive positive value (PPV) - the positive predictive value expresses the true 
positive compared to the total positive value. In the area of disease surveillance, PPV 
expresses the probability for a subject with a positive test to be subject of the illness. The 
PPV depends on the specificity and the prevalence of the disease in the population that is 
applied to a test (10). In the field of epidemiology, the PPV is the percentage of cases 
reported by the system, actually presents the phenomenon (a disease for example) of 
surveillance. Thus the system represented by the ability to detect cases of disease in 
specific situations, such as outbreaks. The evaluation of sensitivity and PPV provides a 
valuable indication of how the system is working. Regarding the detection of outbreaks, a 
high rate of false positive reports may lead to overestimate the number of cases bof 
outbreaks, conducting prevention interventions in the wrong direction. Several sources of 
data can be useful in determining the PPV of a system of public health surveillance, 
including medical certificates, records of illness and death certificates. Investigating the 
PPV system is extremely important to prevent wasting time and resources by avoiding 
the investigation that these cases are neither false nor epidemics; 
 
1.1.5 The surveillance of infectious diseases 
An infectious disease crisis of global proportions is today threatening hard-won gains in 
health and life expectancy. Infectious diseases are now the world's biggest killer of 
children and young adults and the surveillance of infectious diseases, therefore, plays a 
crucial role in the control and prevention of diseases, in order to reduce the morbidity and 
mortality and promote health. They account for more than 13 million deaths a year - one 
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event
Recognition 
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in two deaths in developing countries (12). The poverty, old age and co morbidities are 
the main risk factors.  
WHO has set up several surveillance systems for communicable disease control, setting 
the priority measures for the control of some of them: intestinal parasites, leishmaniasis, 
schistosomiasis, TBC, malaria, HIV/AIDS, trachoma and trypanosomiasis. Diseases such 
as leprosy, lymphatic filariasisel'oncocercosi have become the main target of elimination 
as they often cause permanent disability and serious economic and social problems, but 
there are effective interventions for most of them (13). 
In fact, the whole scenario of European surveillance of infectious diseases is mainly 
related to ECDC (European Centre for Disease Prevention and Control), in addition to 
individual active systems within the different nations of the European Union. The 
consideration of the ECDC is the U.S. CDC (Centre for Disease Prevention and Control) 
and is operated currently from United States of America (10, 11). 
Other systems and active surveillance programs for the control of infectious diseases 
include:  
 Euvac-Net (A Surveillance Community Network for Vaccine preventable 
Infectious Diseases) responsible on the prevention of infectious diseases within 
the European Union,  
 Episouth (Network for Communicable Disease Control in Southern Europe and 
Mediterranean Countries) responsible on the control of infectious diseases in 
Southern Europe and Mediterranean countries (involved  Albania 2010-2013),  
 Epinorth (Cooperation Project for Communicable Diseases Control Nothern in 
Europe) for North Europe,  
 EARSS (European Antimicrobial Resistance Surveillance System) for 
surveillance of antimicrobial resistance,  
 EWGLI (European Working Group for Legionella Infections) for the control of 
Legionella infections,  
 EPR (Epidemic and Pandemic Alert and Response) of WHO for epidemic and 
pandemic alert (13). 
The health surveillance on the diffusive and infectious diseases takes a strategic 
importance in the health system. The detection and notification of events from the 
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national surveillance system will be based on the confirmation of the phases presented in 
the following scheme (see Figure 1.1.6.Decision-making tool for the notification of 
infectious diseases). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.6 Decision – making tool for the notification of infectious diseases (13) 
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1.1.6 The european surveillance system (TESS-y) 
TESS-y (The European Surveillance System) is a highly flexible system for the 
collection, the validation, the analysis and the dissemination of the data. Its goal is to 
analyze the data in order to begin interventions for the public health. All EU Member 
States must report their data about the infectious diseases, as described in the Resolution 
n.2119/98/EC. In addition to the routine surveillance, TESSy has replaced the data 
collection systems in place for the Dedicated Surveillance Networks (DSNs) to provide 
experts with a one-stop-shop for EU surveillance data. The ECDC and the competent 
bodies for the surveillance have developed the objectives for the future surveillance at the 
EU level. The objectives are formulated with respect to general surveillance, as well as 
disease specific surveillance and have been agreed by all the Member States. These 
objectives serve to guide the discussion on the future plans and the development of each 
of the disease specific surveillance networks in the EU.  
The overall goal is to contribute in reducing the incidence and the prevalence of 
communicable diseases in Europe by providing relevant and accurate public health data, 
information and timely reports for the decision makers, professionals and health care 
workers to trigger and inform actions that will result in the prevention and the control of 
communicable diseases in Europe (14). To achieve this, they need to achieve an excellent 
level of quality and comparability of data between Member States and therefore they 
have introduced the standardized criteria for the analysis of diseases, including a case 
definition. Developing the case definition has gone through many stages, including 
discussions of the Commission 2002/253/EC, 2003/534/EC and the subsequent review of 
the decision 2008/426/EC. 
According to this definition, the distinction includes: 
• possible case – presence of compatible clinical signs; 
• probable case – compatible clinical signs linked epidemiologically;  
• confirmed case – clinical signs compatible with laboratory tests (15); 
The case definition is intended to create greater unity in the European surveillance, 
overcoming the differences between individual nations. 
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For all diseases there is an obligation to report confirmed cases; probable; or possible 
cases are only shown for some diseases and meeting certain criteria of the European 
Union (15). 
The main goals for European surveillance system (TESS-y) are as follows, to:  
• Monitor trends in communicable diseases over time in order to assess the present  
 situation and to compare Communicable Disease (CD) trends across Member  
 States (including health care associated infections and antimicrobial resistance) in  
 the EU to respond and to rise above warning thresholds and to facilitate  
 appropriate evidence-based actions.  
• Detect and monitor any multi-national infectious disease outbreaks with 
respect to source, time, and population and place in order to provide a rationale 
for public health action.  
• Contribute to the evaluation and monitoring of the prevention and control  
 programs targeted at infectious disease surveillance in order to provide the  
 evidence for the recommendations and to strengthen and improve these programs  
 at the national and European level.  
• Identify population groups in danger and in need for targeted preventive 
measurements.  
• Contribute to the assessment of the burden of communicable diseases on the  
 population using such data as disease prevalence, complications, hospitalization,  
 and mortality.  
• Generate hypotheses on (new) sources, modes of transmission and groups mostly 
at risk and identify needs for research and development and for pilot projects (14, 
16).  
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1.1.7 The vaccination system in Europe 
All nations that are part of the European Union share the same goal for the control and 
eradication of vaccine-preventable diseases. However, there are differences in child 
immunization strategies and schedules among nations, depending upon health care 
systems, immunization habits and epidemiology of infectious diseases. All nations 
immunize the children against diphtheria, tetanus, poliomyelitis, measles, rubella and 
mumps. Immunization against pertussis, haemophilus influenza, hepatitis B and 
tuberculosis are not systematically applied. 
Immunization programs can be divided into different groups such as: 
 Mandatory vaccinations for all  
 Mandatory vaccinations for those at risk  
 Recommended routine vaccinations for all  
 Recommended vaccinations for those at risk.  
The mandatory vaccines are governed by the legislation that the recommended 
vaccinations are voluntary. The ten most common diseases, against which vaccinations 
are provided, are diphtheria, tetanus, pertussis, polio, measles, and mumps rubella, 
Haemophilus influenzae b, Hepatitis B and BCG. Other childhood vaccines include 
meningococcal C, pneumococcal, varicella and influenza see table 1.1.7 which shows the 
Childhood Vaccination Schedule in European Countries.  These vaccines are less 
commonly administered according to national vaccination schedules (18). 
Inactivated polio is administered for all doses in the childhood schedule in 24 countries. 
Measles mumps rubella (MMR) vaccine is included in the routine childhood 
immunization schedule of all twenty eight participating countries. 
Hemophilus influenza B vaccine is routinely administrated in 25/28 participating 
countries. Hepatitis B vaccine is currently routinely given in 20 participating countries. 
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The table 1.1.7 Childhood Vaccination Schedule in European Countries 
First dose is given at birth in eight countries (BG, EE, ES, LT, LV, PL, PT, RO) while 
the remaining countries commence the vaccination at 2-3 months of age. If a mother is 
HBs Ag positive, the first dose is given within 12 hours of birth. In Latvia and Italy, 
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where the mother is known to be HBs Ag positive, four doses of Hepatitis B vaccine are 
recommended for the child. 
In addition, Belgium, Czech Republic, Denmark, Finland, Ireland, Netherlands, Norway, 
Portugal, Sweden and the United Kingdom administer Hepatitis B vaccine to groups in 
danger. 
In total, nineteen countries are administered BCG. BCG is given at different ages ranging 
from within 24 hours of birth to 13-15 years of age. In France if BCG is not given at 
birth, it must be given before age of 6 years, prior to commencing the school. BCG is 
only given to those who are categorized as high risk groups either due to family member 
with tuberculosis or else if native of a country with high endemicity.  
In Cyprus, BCG is given only to children when there is continuous contact with a case of 
contagious form of TB. Norway normally administers BCG at 13-15 years of age; 
however, children of immigrants from countries outside low endemic countries receive 
BCG at birth. In the UK, BCG is recommended for high risk group infants, previously 
unvaccinated new immigrants from high prevalence countries for TB and children who 
after screening for TB risk factors and tested Mantoux negative. In Bulgaria, the Czech 
Republic and Slovakia BCG is recommended only if tuberculin negative at 7, 11 and 10 
years respectively. Other vaccines that are applied in EU countries are Meningococcal 
(the Men C) which is given routinely in eleven countries;   
Pneumococcal - The vaccine used in childhood vaccinations is the pneumococcal 
conjugate PnV7, which is given routinely in nine of the participating countries; 
Varicella.  Varicella is listed as a routine childhood vaccination in four countries; 
Influenza vaccine - Influenza vaccination is recommended for children in at risk groups 
i.e. children with underlying medical conditions which place them at increased risk of 
developing potentially fatal complications in 27 of the participating countries. 
 
 
 
 
 
 
Dissertation 2011 
 
24 Elida MATA 
 
Challenges of vaccination schedules in EU countries are: 
1. Despite availability of vaccines, children in the EU continue to suffer from vaccine 
preventable disease 
2. Harmonization of schedules would be important, but will be hard to achieve in the near 
future 
3. Lack of comprehensive and adequately funded vaccination programs is the real 
problem 
4. New vaccines and vaccination strategies should be recommended and funded  
a. according to each countries resources 
b. with cross-border outbreaks / public health in mind 
WHO/Europe‘s goal is to reach and maintain high levels of child immunization, 
particularly in vulnerable groups, at the appropriate ages and recommended doses. To 
achieve this goal, WHO/Europe works with Member States, international organizations 
and bilateral agencies to help countries strengthen their programs for the control of 
infectious diseases (19). 
Current major initiatives include: 
• promoting safe immunization practices; 
• introducing new and underused antigens; 
• eliminating measles, linked to accelerated prevention of congenital rubella  
 infection and 
Vaccination is one of the most cost-effective health interventions available, saving 
millions of people from illness, disability and death each year. Effective and safe 
vaccines, which protect against more than 20 serious diseases, are available and many 
new promising vaccines are being developed (20). 
Immunization is a shared responsibility of governments, legislators, health care 
providers, parents/caregivers, the pharmaceutical industry and other stakeholders. 
One country‘s routine immunization system starts when vaccine is supplied by the 
manufacturer and ends when it reaches children. This process involves a supply system 
and careful quality control to ensure that only vaccines of demonstrated quality, safety 
and efficacy are used. 
 
Dissertation 2011 
 
25 Elida MATA 
 
2. The geography and population in Albania 
The Republic of Albania is a small country located on the Balkan Peninsula in south-
eastern Europe. It has a surface area of 28,748 square kilometers. It shares a 172 km 
border with Montenegro to the north-west, a 115 km border with Kosovo to the north-
east, a 151 km border with Macedonia to the north and east, and a 282 km border with 
Greece to the south and south-east. Its coastline is 487 km long. The lowlands of the west 
face the Adriatic Sea and the strategically important Strait of Otranto, which puts less 
than 100 km of water between Albania and the heel of the Italian ‗boot‘ and links the 
Adriatic Sea to the Ionian and the Mediterranean Sea. 
Albania has a coastline on the Adriatic Sea and the Ionian Sea. The country is 
characterized by three geographic areas—mountainous areas, mostly to the north and 
east, a central area, and a coastal area of lower lying land. Mount Korab is the highest 
point in Albania at 2,753 meters, located in the district of Dibra in the northeast of the 
country.  The capital of Albania is Tirana with 700.000 habitants. 
The climate is considered a continental climate characterized by cold winters and hot 
summers. Albania has 12 prefectures (or counties), 36 districts. Sharing the third level 
administrative features municipalities in urban and rural municipalities. The 
municipalities are called bashkiin Albanian. 
Albania‘s official population count registered in the 2001 Population and Housing 
Census was 3,069,275 (INSTAT, 2002). In 2008, the population of Albania was 
estimated at 3,170,048 and the density was about 110 people per square kilometer. 
Compared with the population count in the 2001 Population and Housing Census, 
Albania‘s population has increased by approximately 106,748 people. The average life 
expectancy at birth for the period 2005-2008 was 72.1 years for males and 78.6 years for 
females. Life expectancy is higher in urban areas than rural areas—both women and men 
in urban areas live approximately 3 years longer than those in rural areas (INSTAT, 
2008). 
More than 98 percent of the populations are ethnic Albanians with small groups of 
Greeks, Macedonians, Vlachs, Roma, Bulgarians and Serbs. Although religion was 
banned during the communist period and a majority of Albanians do not practice any 
religion, the populations are nominally of three main religions—Muslims are found 
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throughout the country, while Catholics are mostly in the north and Orthodox Christians 
are concentrated in the south. 
The majority of people (58%) still live in rural areas, although the cities have grown 
rapidly since the early 1990s, particularly the capital Tirana. Migration within the country 
is one directional: from the mountainous rural areas to the central-coastal urban and 
periurban areas (21). 
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Map of Albania 
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2.1 The characteristics of the health system in Albania 
 
2.1.1 The health care system 
The health system in Albania is mainly public. The state is the major provider of health 
services, health promotion, and the disease prevention, diagnosis and treatment. The 
private sector, which is still developing, covers most of the pharmaceutical and dental 
services, as well as some clinics for highly specialized diagnosis, mostly in Tirana and in 
a couple of other big cities. The Ministry of Health (MoH) is the leader of the health 
policy development and planning and of the implementation of health strategies (22). 
The diagnostic and curative health service in Albania is organized in three levels: primary 
health care, secondary hospital service and tertiary hospital service (Figure 2.1.1). The 
public health services are provided within the framework of primary health care and are 
coordinated and supervised by the Institute of Public Health. Other national health 
institutions that report to the MoH and that provide specific services are: the National 
Centre for Blood Transfusion, the Centre for Child Development and Growth, the 
National Centre for the Quality, Safety and Accreditation of Health Institutions, the 
National Centre for Drug Control, the Centre the Continuing Education, and the National 
Centre of Biomedical Engineering. 
 
Figure.2.1.1Organization of Diagnostic and Curative Health Services in Albania (23) 
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2.1.2 The primary health care 
The main mission of the Primary Health Care (PHC) system in Albania is to ensure the 
best possible health conditions for the population to confirm  the main goal of the MoH, 
‗Health for All‘. PHC services at the community level represent the first level of access 
of health care. The PHC system puts high priority on the hygiene and epidemiological 
situation of the population and population‘s need for health services. The integrated PHC 
services are especially cost effective and efficient in responding to urgent health 
situations. In December 2006, the MoH introduced the Reform of Primary Health Care 
with the main goal of redirecting the PHC system into a single-source setting. The reform 
was based on the Decision of the Council of Ministers (No. 857), 20 December, 2006 
‗Financing of the Primary Health Care Services‘.  
The implementation of the Reform of Primary Health Care started in January 2007and 
consisted of the following elements: 
•  Pooling all PHC funds at the Health Insurance Institute; 
•  Payment for PHC services based on facility's performance (i.e., quality of PHC  
services provided) 
•  Autonomy of health centers to set their own objectives and to manage their own 
resources according to the services provided; 
•  Health services provided in accordance with the package of services approved by 
MoH; 
•  Combining of public and private funding by expanding services to include those 
financed through the PHC insurance scheme; 
•  Improved planning of PHC services at the regional level to better meet population  
needs. 
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2.1.3 The hospital services 
In Albania, the second level of health care is provided by hospitals. There are over forty 
public hospitals in the country, including 22 District Hospitals, 11 Regional Hospitals, 
four University Hospitals Centre, University Trauma Centre, Psychiatric Hospitals, and 
National Centre for Child Development and Growth. 
With a continuous support from both the Albanian government and donors, the hospital 
infrastructure and medical equipment and supplies have been improved substantially in 
recent years. It is imperative that hospitals to use the standardized treatment protocols 
that ensure not only the quality of services, but also the efficient use of financial 
resources. The MoH is under the process of approving of the decree on ‗Financing of 
Hospital-Based Health Care Provided in Public Hospitals from the Obligatory Scheme of 
Health Insurance‘. Considering hospitals as a priority, the MoH will continue to finance 
the Psychiatric Hospitals, the National Service of Blood Transfusion, the Electro-medical 
Repair Services Centre, and the Helicopter Emergency Transport Unit from the 
government budget (Albanian Ministry of Health, 2009; Albanian Ministry of Health, 
2002; Albanian Ministry of Health, 2004) (22, 23). 
 
2.1.4 The public health structure 
Public health is a function of government and is organized into central, regional and 
district levels. At the central level, the public health directorate in Ministry of Health is 
organized in three sectors which conduct their activity according to the respective 
legislation (see Legislation on public health) (23). 
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Figure.2.1.2 The structure of Health Ministry in Albania (22) 
The organization and structure of public health at the country level is based on the 
administrative division in 12 prefectures, 62 municipalities, 36 districts and 302 
communes in total (see figure 2.1.3. the map of Demographic and health survey) (24). 
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Figure 2.1.3 the map of demographic and health survey in Albania (24) 
At the national level, the Institute of Public Health operates as the leading, referring, and 
coordinating institution of public health problems. Institute of Public Health supports the 
MoH in the field of expertise, research and training (23, 24). 
 
Dissertation 2011 
 
33 Elida MATA 
 
This department (see figure.2.1.4) consists of the sector of Hygiene and Epidemiology, 
reproductive health, family medicine and oral health. It supports their activities on six 
jurisdictions, (Health Insurance Law as amended, the Law on infectious diseases, the law 
on HIV/AIDS, the Law on dental services, and the law on tobacco and on alcohol law). 
 
Figure 2.1.4 Structure of Public Health at the regional level (24) 
At the regional level, (12regions) the public health is organized into regional health 
departments which have the respective sectors (see organization chart of the regional 
public health). At the district level, (24districts), the public health is organized into public 
health departments of the respective sectors (see figure 2.1.5). 
The organization and the dependency of the public health services is vertical where the 
orders and instructions are coming from the Ministry of Health to regional or district 
Public Health Directorates. 
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Figure.2.1.5 Structure of Public Health at the district level (24) 
 
At the national level, the Public Health Service is led by the Chief Health Inspector and 
in region or district level is led by the chief who is also director of the respective 
Department. The public heal that the country level is financed by the state budget, but it 
might accept funding from other lawful sources too (24). 
 
2.2 The Legislation of Public Health, Infectious Diseases and Immunization in 
Albania 
The infectious diseases have represented and still represent the major burden of the total 
morbidity in Albania. As result of their great harmful impact on public health, infectious 
diseases have always been subject of an ongoing intense legislative activity. 
The various problems concerning the relationship (of a cause – effect nature) between 
infectious diseases and environment hazards (pollution of water, air, and soil and food 
safety as well) are regulated by numerous Laws such as: (23) 
• Law ―On Public health and the State Sanitary Inspectorate‖ (No.7643 of 
02/12/1992) amended in 1995 and 2006 expresses the organization of inspectorate 
structure, the problems and fields covered by this organism. Sanitary State Inspectorate is 
vertical structure organized into regional and district level nears the Public Health 
Directories.  
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This structure has the function and mission of the ―monitoring and controlling‖ of all of 
the activities that take place in the country by public and private entities that may affect 
human health by air, land and waters. 
• Law ―On fighting and prevention of infectious diseases‖ (No. 7761 of 
19/10/1993) amended 1999 expresses widely all of the problems of infectious diseases in 
the field of fighting and prevention of them by causes. In the first chapter, articles 1-8 are 
described their group, organs and structures that cover the areas of fighting and 
prevention of infectious diseases, also the employees must be specialized persons.  
In the second chapter of articles 9-22 are described the fighting measures of the infectious 
diseases, financing and modalities of their announcement.  
In the third chapter, there are presented the set of measures for immunization of the 
population, types of vaccine, vaccination calendar and determining of type of vaccine and 
their import, which are the obligation of Ministry of Health and National Immunization 
Committee.   
 In Republic of Albania,   Law ―On Health Care‖ (No.10107 of 30/03/2009)  
expresses the essential principles, legal framework and regulations that should apply the 
public and private entities which operate in the health care system. 
• Law ―On Public Health‖ (No.10138 of 05/11/2009) aims the health protection and 
promotion of healthy living through organized activities by public health structures.  
In this law ―Umbrella‖ is summarized in detailed manner of legal documents in the public 
health field. In the first chapter, the articles 1-4 present the purpose, scope, the key 
definitions and the basic principles of the public health.  
Chapter II, Sections 5-8, presents  the main public health activities and determine the 
package of services also reflects the main directions of public health services and the 
attention is "a professional of the public health‖ as a person specialized in public health 
(23, 25). 
In the third chapter, is presented the main public health systems with a combination of all 
health and non-health structures dealing with problems of this field.  
The main responsibility of public health is given to the Ministry of Health and the 
National Council on Public Health.  
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In fourth and fifth chapter, are presented tasks, functions, organization, financing and 
dependencies of IPH and regional public health structures. 
The sixth chapter is focused mainly on the new module of Inspection Health.  
From seventh chapter to seventeenth chapter, are   presented the problems and key fields 
of public health respectively the infection diseases and immunization, public health 
laboratories, non-infectious diseases, environmental health, radiation, food and nutrition, 
health education, smoking, alcohol and drugs. 
In eighteenth chapter are presented the health information and way of organization and 
reporting by public and private entities.  
• Law ―On Hospital Service‖ (No.9106 of 17/07/2003) has as purpose to arrange all 
the activities in the hospital service at the country level.  
In the first chapter, the sections 1-10, describe in detail the definitions belonging to the 
hospital structures, rules that apply both to public and private hospitals, modalities of the 
hospital service and the ambulatory, hospital and emergency services and the agreements 
linking a hospital with public and private health insurance.  
In Chapter Two, the articles 11-22 present in detail the management structures of health 
authority for public hospitals.  
The third chapter, the articles 23-30 describes the rules, functions and duties of public 
hospitals and the role of the Ministry of Health in organizing and implementing the health 
policy and the involvement of the health insurance.  
In chapter four, the Articles 31-38 determine that the Ministry of Health, in the context of 
health policy, is charged on the recognition, opening, classification and licensing of 
hospitals.  
In the fifth chapter, the  articles 39-42,  present  in detail the issues of hospital planning, 
the establishment of the National Committee for hospital planning at central and regional 
level. 
In chapter six, in article 43 detail the description of non-public hospitals, the rules 
required to apply for their opening, specific conditions, the type and way of medical 
management (23, 25). 
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• Law "On the Blood Transfusion Service (No. 9739 of 21.05.2007), sets the exact 
rules of transfusion activity, object, key definitions and its application areas that are part 
of sections 1-4. 
In chapter II, the articles 5-10 define the age allowed to donate blood (18-60 years), the 
required documentation and the responsibilities and duties of the National Transfusion 
Center. 
In chapter three, sections 11-12 represent basic transfusion services structures, 
organization, levels and national standards for products manufactured and offered by 
these services.  
In chapter four, the section 13 presents the role and functions the Albanian Red Cross and 
non-profit organizations in the field of blood transfusion, the registration of their 
members and the coordination of work within the transfusion public service.  
The fifth chapter, articles 14-17 introduces the role and tasks of the Ministry of Health, 
on national services of blood transfusion. 
In chapter six, the articles 18-22 present in detail the essential measurements to the self-
sufficiency of blood and its derivatives and the Ministry of Health annual programs.  
In the seventh chapter, articles 23-24 provide for PHI, the inspection structure and which 
should not exceed up 2 years. 
• Law ―On Prevention and Control of HIV/AIDS‖ (No.9952 of 14/07/2008) 
substitutes the law of year 2000 and is focused on the setting of measures for the 
prevention and control of this entity in our country.  
In the first chapter, there are presented all the necessary definitions in the field of HIV 
prevention, the management of the situation and its preventive principles, the modalities 
of the policies composition. 
The second chapter is divided into two sections which present the problems of 
information, education and communication about the purpose, content, institutions and 
groups who should follow this process: in the second section there are presented the 
measurements to prevent HIV / AIDS, which clearly state the duties of the public and the 
private health institutions, local governments and the role of the MOH in the coordination 
of this activity. 
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The third chapter presents extensively the epidemiological research modalities, sentinel, 
and the modalities of voluntary and mandatory testing for HIV / AIDS.  
In the fourth chapter, there are described the other medical measurements for the control 
and the prevention of HIV / AIDS, blood donor institutions, prevention of the sexually 
transmitted infections, and the prevention of the transmission from mother to child. 
The fifth chapter represents all considerations regarding the HIV / AIDS as a positive 
case that is required to be performed by health institutions, rules and defined the tasks by 
the MOH and the reimbursement in case of infection by health institutions (25). 
 
2.3 The infrastructure and operation of public health 
One of the main priorities of the MoH is the building capacity of human resources in the 
public health sector. In Albania, there are included: hygienist (specialized and not 
specialized) epidemiologist (specialized and not specialized) microbiologist (specialized 
and not specialized) chemist (specialized and not specialized) and secondary staff (see 
table 2.3.1). Training and specializations of the public health staff are carried out at the 
Faculty of Medicine in the respective departments. Specializations in the field of public 
health even though with the same purpose, they are separated into these categories: 
hygiene, epidemiology and microbiology. We have not standards regarding the number 
of specialized staff versus number of population and the problems in public health field 
(see table 2.3.1) Also, the public health structures do not operate within a region but 
within an administrative district. Actual experts are specialized after graduating from the 
Medicine and Chemical School;   after 2007 it was created the public health school at the 
Faculty of Medicine (based in educational system of Bologna, Italy) attended after 
student graduate from the secondary school. The assistants of the public health are trained 
after completing secondary school by training courses (about 1 to 2 years). We have a 
lack of specialized epidemiologist in 15 districts (41.7% of their total) and of specializes 
microbiologists in 13 districts (36.1% of total districts). In the state and the health 
policies the prevention of the infectious diseases is the main goal, the reforms carried out 
did not belong to a health strategy or long-term approved policy.  Reforms in the health 
services are mainly based on financing the health system through health insurance funds. 
Public Health is led and is funded from the Ministry of Health.
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Table.2.3.1The actual number of public health staff in Albania by districts 
 
The government‘s mission is to improve the quality of life in Albania by (26): 
• prevention of the infectious diseases (reducing of the infectious diseases 
incidence) 
• improvement of water and sanitation 
• improvement of food safety 
• prevention of chronic diseases 
• promotion of a healthy lifestyle. 
• the major disease-based surveillance, which is mainly hospital-based and  
mandatory.   
The structure of the system for the detection of cases and outbreaks of communicable 
disease is carried out by infectious disease surveillance (21, 27). 
Infectious diseases are reported each month through a particular form called 14Sh (ICD-
9). This form is divided into three groups: notification within 24 hours (with emphasis on 
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outbreaks and cases within 24-48 hours), weekly reporting, and mandatory monthly 
reporting as follows;  
• ‗ALERT‘, a syndrome-based surveillance system, which is based on  GP and 
emergency units and involves a mandatory weekly notification of nine specific 
infectious syndromes; 
• case-based AFP (Acute Flaccid Paralysis) surveillance for polio; 
• case-based measles/rubella surveillance; 
• case-based, hospital-based surveillance system of congenital rubella syndrome 
(CRS); 
• case-based, hospital-based HiB (Hemophilus influenza type b) (severe 
pediatric diseases: meningitis, sepsis and severe pneumonia) surveillance; 
• case-based, hospital-based surveillance of viral hepatitis (A, B and C); 
• hospital-based surveillance of pediatric gastroenteritis for rotavirus-associated 
diarrhea, with laboratory confirmation; 
• case-based surveillance of aseptic meningitis and encephalitis; 
• case-based surveillance of hemorrhagic fevers. Yearly biological surveillance of  
 infectious   agents that are transmitted through blood transfusion for patients 
receiving multiple transfusions; 
• case-based surveillance of HIV and AIDS; 
• syndromes surveillance of STI; 
• case-based surveillance of syphilis; 
• Sentinel Seasonal influenza surveillance; 
• case-based surveillance of severe respiratory syndrome and unexpected deaths,  
which is hospital-based (related with case definition of pandemic influenza and 
avian influenza in humans); 
• second-generation surveillance for HIV/AIDS. 
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2.4. The epidemiological surveillance system of infectious diseases in Albania 
The Albanian system of epidemiological surveillance for infectious diseases has 
continuously been mandatory:  the infectious diseases included in this system should be 
reported by law. The statutory notification system dates from the years ‘50. In spite of 
small improvements over the time, the essential features of the system remained as before 
until 1998.Before the years ‘98,  the surveillance system have had registered as shortage  
and deficiency on the  information flow on infectious diseases   due to the  non applicable 
active and sentinel epidemiological surveillance, which is related directly to the 
quantitative and the qualitative shortage of the existing form of mandatory reporting of 
infectious diseases (28).Today in Albania, the information flow on infectious diseases has 
been released and continues to be released through the monthly reporting form (named-
14/Sh).The monthly reporting form of infectious diseases (14/Sh) is compiled by the 
epidemiological service in the district level  and sent to the Department of Epidemiology 
and Biostatistics at the Public Health Institute (under the direction of the Minister of 
Health nr.189, dt.08.08.1995, and the approval of the Statistical Institute, 134 letters, 
dated, 08.25.1995). 
The flow chart of collected data by mandatory notification systems in Albania (28) 
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It should be emphasized, that the content of the monthly reporting form (14/Sh- see 
annex.1) which has hardly changed in the performance of time implicitly reflects the fact 
that the mandatory report of infectious diseases from the epidemiological services of the 
district, has continuously been based on passive epidemiological surveillance. 
The deficiencies of monthly reporting form of infectious disease before 98 years are as 
follows: 
• In the monthly reporting form (14/Sh) before years‘ 98, the number of infectious 
diseases has been limited. Specifically, in the reporting form up to the year of 94 
"cholera" did not exist, so as a consequence of the Cholera epidemic in 1994 this entity 
was included in the reporting form. But the possibility and reality of an eventual 
importation of cholera is a very meaningful fact. This means that eventual importation is 
not excluded in Albania and for other infectious diseases with tropical nature as cholera. 
Just for illustration, the Ebola cases imported to Germany in 1995, or plague epidemic in 
some European countries in 1995.  These cases were   a proof that it is important to 
include in the monthly reporting form (14/Sh) other infectious diseases, taking into 
account always the features of the Albanian ecosystem (physical, chemical, biological, 
and social). 
• In the existingform14/Sh, the label of some infectious diseases is general, which 
did not allow the determination of specific diseases entities included under the same 
label. Thus, "TB" is a general label which includes diseases as: pulmonary tuberculosis 
and extra-pulmonary, tuberculosis meningitis, etc., who are with tubercular nature, but 
within the theoretical and practical importance of the epidemiological surveillance, the 
data are necessary to be reported as separate diseases. 
• In the previous monthly reporting form there did not exist a division of infectious 
diseases in three groups (according to the respective Ministry of Health guidelines based 
on the degree of importance and urgency of report). In addition, the previous form did not 
contain the terms "suspected case" and "confirmed case‖.  
• The data through the monthly form of these diseases have been reported as a case 
number. These data have not had a scientific value because they are not associated with 
the data at the individual level. 
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• The previous monthly reporting form also did not contain the fatality rate data. 
The presentation of morbidity data without mortality data creates a gap in the flow of 
information on the infectious diseases. 
• The quantitative and qualitative improvement of information flow on the 
infectious diseases in Albania was an immediate necessity. This mainly related to the 
restructuring of the monthly reporting form (14/Sh) and the individual epidemiologic 
forms of infectious diseases which implicitly dictate the application of the active 
epidemiological surveillance in addition to the passive routine. This will also require the 
application of sentinel epidemiological surveillance. 
In 1990, WHO started the Intensified Programme of Action for strengthening 
epidemiological capacity (Intensified Action Program for strengthening epidemiological 
capacity) for each of its members (29). 
 
Monthly reporting form (14/Sh) of infectious diseases of the restructured - (Annex 1) 
1. In the monthly reporting form there are included 73 infectious diseases (from 41 
infectious diseases before 98 years) for the following reasons: 
In this form, there are added those infectious diseases which, although not present in 
Albania, they contain in themselves the potential of their survival and proliferation in 
case of an eventual importation. 
On the other hand, there are included the sub-divisions of special diseases (according to 
ICD-9) infectious diseases already existing in the monthly reporting form (14/Sh) 
specifically for diarrhea diseases, tuberculosis, syphilis, leprosies, common cold (flulike 
syndrome) and  pediculosis etc. 
2. The infectious diseases are sub-grouped into three groups confirmed by the Ministry of 
Health Guidelines on reporting of the infectious diseases. (A sub-division does not exist 
in previous form). 
• Group A - contains 20 infectious diseases, which are subject to International  
Health Regulations represent particular importance to the public health. Any suspected 
case from the clinical medical service immediately is declared near epidemiological 
service at district level, and from there immediately is reported to the shortest path 
(telephone, telegram, fax, radio transmitters, etc.) to the Ministry of Health and IPH.  The 
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reporting to the central level is urgent, within 24 hours of clinical suspicion of the case. 
The regional epidemiological service in cooperation with regional clinical service fills 
out the individual form which is sent to the IPH after appropriate laboratory confirmation. 
The individual form is a subject of a mandatory urgent (within 24 hours) notification.  
• Group B contains 48 diseases that are reported by the clinical service to the 
epidemiological service of the district (same as of Group A). The latter fills the 
epidemiological individual form. In general, the reporting time for this group is within 1-
3 days. In case of eventual outbreaks, the reporting timeline is the same as for the group 
A, diseases (urgent, within 24 hours) from data sources to IPH. 
• This is not the feature for the last 5 infectious diseases of the group C, where the 
monthly notification is not based on specific case definition (see table 2.4.1). 
Table 2.4.1 Classes of notification of infectious diseases, and the time of reporting (30) 
The aggregated data in the 14/Sh monthly form are presented for each infectious diseases 
according to place (urban and rural), specific case definition (suspected and confirmed 
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case), age groups (16 ones in total, that is by a narrow division). The next column 
belongs to the hospitalization admission number, and the last column to the number of 
deaths. 
The 14/Sh monthly form of the actual reporting system is obligatory by law to be 
accompanied by the individual forms 14-1/Sh (for each of group A diseases) see annex 2, 
14-2/Sh (for most of the group B diseases) see annex 3, 14-3/Sh (for TBC entities 
included in group B) see annex 4, and 14-4/Sh (for the sexually transmitted infectious 
included also in the group B). 
The individual forms contain a highly detailed epidemiological information about the 
case-patient (protocol field investigation) thus increasing first of all the specificity of the 
surveillance system and quantitatively and qualitatively enriching the system 
epidemiological evidence. Therefore, they serve as a necessary complement to the 14/Sh 
form‘s aggregated data. The individual forms are constructed in such a form to simplify 
and standardize data entry on computer, control, and statistical analysis required for 
tabulation. 
 Infectious diseases of group A (14-1/Sh individual form) 
The individual file (14-1/Sh) is divided into:  
1. Part I – general information on the case 
2. Part II – history of the case 
3. Part III – the data of microbiological diagnosis (signed by  
  microbiologist‘s doctor) 
4. Part IV – epidemiological survey conducted by epidemiologist of the  
  respective districts. 
Finally, based on clinical, laboratory and epidemiological data are presented the 
conclusions on the case definition according to criteria 1, 2, 3, 4, which are explained in 
the following section on infectious diseases of group B/1 (14-2/Sh individual form). 
Specifically, not only for infectious diseases in group A, but also for those of group B / 1, 
Group B / 2, and group B / 3, (which are individual forms), we used only two case 
definitions: the probable case - when are not realized all the required criteria for 
infectious diseases and the confirmed case - when are realized all the required criteria for 
these diseases. 
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 Infectious diseases of group B/1 (14-2/Sh individual form) 
In group B / 1 are included the infectious diseases of a high frequency (incidence) and for 
which the intervention and control is possible. 
Individual form of group B / 1 of infectious diseases (14-2/Sh) is the same (Part - I, II, 
III, and IV), with individual form of group A (14-1/Sh) (see annex.3). 
Also, the 14-2/Sh gives the conclusions on the case definition (probable and confirmed 
case) according to criteria 1, 2, 3, 4 which are explained as follow: 
1. Clinic: the presence of the symptoms (clinical manifestations perceived by the  
doctor) and the symptoms (clinical manifestations perceived by patients) of 
pathology in the review. 
2. Direct examinations: Identification of the etiological agent by microscopic 
examination.  
3. Culture: Isolation and cultivation of the etiological agent in proper conditions 
and its identification through serotype. Positivity in culture is sufficient criterion 
of laboratory confirmation in the absence of direct examination or serology 
4. Serology: Identification of specific antibodies against etiological agents in 
significant titre when a single sample of blood serum of the patient or 
identification of sero- positive between the two serums samples of blood (growth 
4 times the titre of specific antibodies between acute and convalescent phase of 
the disease.   
 Infectious diseases of group B/2 (individual form 14-3/Sh ) 
In the group B/2 is included tuberculosis in all its forms, pulmonary and extra pulmonary. 
Why tuberculosis is reported on separated form, because it has own epidemiological 
specifics as disease compared with group B/1. The 14-3/Sh individual file is divided into 
three parts:  
1. Part I - contains the vital information on the case and the onset of the 
disease, signed by family physician; 
2. Part II - Clinical and epidemiological investigation detailing all 
requirements related to clinical aspects of qualified clinical diagnostics and 
epidemiological aspects on concomitant risk factors; 
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3. Part III - Data on the microbiological diagnosis, (signed by 
microbiologists), aims to confirm the definitive case, i.e. full confirmation of 
tuberculosis infection nozologic entity (see annex.4). 
 
In Albania, as an European global level, the surveillance of infectious diseases is one of 
the most important aspects of prevention and control of diseases, according to the 
principles set out in Law ―On fighting and prevention of infectious diseases‖ (No. 7761 
of 19/10/1993) amended 1999 which expresses widely all of the problems of infectious 
diseases in the field of fighting and prevention of them by different causes.  
In Albania, at the 2010 has started the new action plan for prevention and elimination of 
infectious diseases rely mostly on the development of specific programs and strategies for 
chronic and infectious diseases as well as the formulation of policies and strategies for 
immunization, HIV / AIDS and sexually transmitted diseases. 
The monitoring of infectious disease is crucial to identify the eventual outbreaks and 
assess the impact, study the risk factors, evaluate the possible strategies for prevention 
and control. 
Under this perspective, at the end of 2010, the Region of Puglia has invested on an 
electronic quality system of Infectious Diseases Information, which will provide useful 
epidemiological data for the planning of the service and monitoring of the performance. 
This computerized information system is based on the individual notification forms of the 
respective diseases (see Annex 5, 6, 7) which will allow us to statistical analysis of data, 
offering the opportunity to study and monitor the progress of the disease in different 
territories of the districts and regions of the our country. 
The project of implementation of the surveillance system and notification of infectious 
diseases undertaken by the Region of Puglia is under the INTERREG IIIA Project 
(Albania e Puglia: oltre la Sanita). This project has identified four types of tabs called:  
 group A of infectious diseases;  
 individual tabs of the group B / 1;  
 individual tabs 14-2/Sh antropozoonotic diseases and  
 individual tabs B / 3 of sexually transmitted diseases. 
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2.5 The “Alert” syndrome - based surveillance system 
Another system of reporting infectious diseases ALERT system is implemented by WHO 
in January, 2000 [ALERT meaning ―alarm‖ representing in meantime the acronyms 
Albanian Epidemiological Reporting Tool]. 
This system is funded by ECHO, and jointly implemented by the Institute of Public 
Health and WHO, has created an effective early warning system for infectious diseases in 
Albania.  
The "ALERT" system is based on infectious syndromes, which is based on GP and 
emergency services include weekly compulsory notification of nine specific infectious 
syndromes, namely: diarrhea without blood, diarrhea with blood, upper respiratory 
infection, lower respiratory infection, rash with fever, jaundice, hemorrhage with fever, 
suspected meningitis, and unexplained fever. 
The data flow structure of the ALERT system implies the weekly mandatory notification 
from the basic level (data sources) to the national one (DE of IPH) of the surveillance 
system through the local level (district epidemiological service).  
The report (according to person characteristics and place for each of 9 above – mentioned 
syndromes) is presented in the Alert weekly Form (see annex. 8).   
 
2.6. The  immunization program in Albania 
The immunization of population has started at the end of the 1950 with diphtheria toxoid 
and later with DT and DTP in the early 1970s, tuberculosis vaccine (BCG), measles and 
polio vaccine. After 1993, in the immunization calendar are included other vaccines such 
as viral hepatitis B, trivalent vaccine (measles, rubella and mumps) and at the end 
homophiles‘ influenza type B which is introduced in 2009.  
The Expanded Program Immunization is a World Health Organization program with the 
goal to make vaccine to all children throughout the word and has started in Albania in 
1993. The national health system before 1993 has produced the vaccines for Bacillus 
Chalmette Guerin (BCG), Diphtheria Tetanus Pertussis (DTP) and measles, except the 
oral polio virus (OPV) which was imported from abroad, covering, in this way, all the 
country‘s needs for the compulsory national immunization calendar (31). 
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Since 1993, UNICEF started to provide the whole vaccines according to the WHO 
recommendation for immunization. In 1995, Ministry of Health in Albania introduced 
also the immunization against hepatitis B for all newborns. However, from 1997 the 
provision and distribution of this vaccine has met some difficulties causing shortage and 
delay in the national immunization schedule see table 2.6.1. 
Every month, the district epidemiologists organize the distribution of the vaccines to the 
600 health centers based on commune levels. The vaccines from the health centers are 
distributed to the village nurses who are equipped with cold box. The distribution from 
the district to the communes is organized on fixed dates of every month. In the main 
towns, the immunization is performed every day by Mother and Child Consultancies in 
each district. In each health centre, at urban as well as at rural level, the nurse in charge 
with the immunization activity register all data in a specific notification book and in the 
child immunization card which is given to the mother (32). 
This information is transferred every month at district level to the district epidemiologist 
and every three months from the districts to the IPH by the reporting schedule (see 
annex. 9). 
Institute of Public Health (IPH) is responsible for planning, monitoring and management 
of the immunization programme at the national level. The epidemiology units in PHC 
Directorates provide guidance, monitoring, supervision and assessment of the 
immunization services delivered by the primary health care facilities and maternity 
hospitals. They are also responsible for the distribution of vaccines and safe injection 
equipment, disease surveillance, response during the outbreak, and organization of 
supplementary immunization activities. 
The urban population receives the vaccinations in maternity hospitals (birth doses of 
BCG and HepB) and near Mother and Child Consultancies situated at the town 
polyclinics.  
In Albania from April to September1 996, there was a polio epidemic which affects for 
the entire region. A national campaign for the immunization of the population between 0-
50 years of age was initiated. In the second stage of the campaign, people above 50 years 
of age were also included. In the following years, there were three additional national 
campaigns of immunization against polio, during which children from 0-5 years were 
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covered. During the political turbulence of 1997, many of the refrigerators, which were 
part of the EPI cold chain, were damaged. The Ministry of Health, jointly with UNICEF 
and WHO, have since replaced the refrigerators and rehabilitated the cold chain. 
Table 2.6.1 Immunization calendar in Albania since 1993 
Source: Ministry of Health, UNICEF, WHO 
After the year 1993 in the immunization calendar have been introduced the following 
vaccines:  
1995 - Viral hepatitis B,  
2000 – bivalent vaccine of measles & rubella (MR) 
2005 – trivalent vaccine measles, mumps and rubella (MMR) 
2009 – penta-vaccine DTP + Hep.B + HiB (influenza hemophilus B). 
The ratio of immunization coverage for every antigen is calculated based on the routine 
reporting collected from each district starting from the health centers in the villages every 
three months. According to the data possessed by the Public Health Institute, the ratio of 
immunization coverage is high for all antigens (table 2.6.2). 
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Table 2.6.2 Immunization coverage rate, 1990 – 1999 
 
Source: IPH 
In 1999, based on these data, the Ministry of Health, jointly with UNICEF and WHO 
carried out a national study to estimate the percentage of immunization coverage for 
every antigen from collected routine data by the Institute of Public Health.  The study 
was conducted nationally in the country‘s 12 prefectures. This study created an 
opportunity to evaluate the routine information system. Data supplied from the various 
health centers were proven to be valuable and overwhelmingly correct. The study showed 
that the level of immunization coverage was high for each anti gene compared to most 
European countries. Nevertheless, the high incidence of measles in Albania (measles 
incidence in children of 5 years is among the highest in Europe (247/100 000 in 1997) as 
well as the outbreak of polio in 1996 call for increased attention and caution (33). 
Actually, Albania is experiencing serious electricity shortages which cause long 
disruptions in energy supply especially during winter. This situation may affect the 
appropriate functioning of the cold chain. 
Polio eradication 
In Albania, poliomyelitis was endemic until the end of 1970. The average incidence rate 
was 43 in 1950, 15 in 1960, and 14 in 1970. In 1980, poliomyelitis reached the sporadic 
levels. The epidemic outbreak of polio in 1996 (138 cases, 16 fatal) was preceded by a 
decade of 0 incidence. In 1996, a massive immunization drive (0-50 years) and National 
Immunization Day in 1997 and 1998 in addition to the routine coverage of immunization 
of OPV, led to a spread of polioviruses. After 1997 there is no record of polio incidence. 
979799.9  99.6989797978280Polio
9394979688NANANANANAHep B
91909592918176878085Measles
9796.698.698979699947890Pertussis
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9796.698.698979699947890Diphtheria
83879494978782818094BCG
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Year
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Diphtheria 
At the 1950 the average incidence rate of diphtheria in Albania was 364/100.000.  
The introduction of the toxoid diphtheria vaccine was made possible only after the 50‘s, 
while DT and DTP were introduced at a later stage in the 1970‘s. This led to a quick 
reduction of the incidence of diphtheria.  
In the years 1990-1996, 126 cases were recorded. The most affected age group were 
children between 5-14 years (7%), followed by the age group 15-24 years (16%) the 
greatest part of who were supposed to be immunized, as per the available immunization 
data. The greater incidence of diphtheria was among inhabitants coming from the rural 
areas. Serological surveys in the years 1990-1991 confirmed doubts about inflated reports 
of DTP revaccination in some of the rural areas. 
The swift measures taken by the Health Ministry, aided by UNICEF, consisted in the 
closure of gaps in immunization and in the regular supply of diphtheria vaccines. 
In the National EPI Study covering 12 prefectures of the country, the DTP3 
immunization coverage was estimated to be high in children of 18-30 months (99%). 
Elimination of neonatal tetanus from 1995 
The high coverage of tetanus immunization in children from 2 to 15 years before 1995 
led to a low neonatal tetanus incidence. The average number of neonatal tetanus cases has 
declined in each decade as follows: 
In the year 2000, in the first six months there has been no record of neonatal tetanus 
incidence. For over five years there has been no record of neonatal tetanus incidence. 
Pertussis 
Pertussis was epidemic in Albania in the period before immunization. According to the 
vaccination scheme introduced in 1974, the first DTP dosages were administered to 
children 3, 4, and 5 months of age; later, another two dosages were delivered at 6-9 
months, while at 2 years of age, children were given DTP3. 
In 1950-1960, the annual incidence rate was 3.1/100.000 and 3.7/100.000 population. 
During the years 1970‘s, when the DTP vaccine was introduced, over 7,000 cases of 
pertussis were reported yearly. In 1980‘s, the average rate of incidence was 1.5/100.000 
population, representing an improvement of 79% compared to the period before 1970‘s. 
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In 1980‘s, about 20% of the cases were of children in the age group between 5-14 years. 
This led to an adjustment in the immunization scheme and to the administration of a re-
immunization, a DTP dosage at the age of two years old. 
The average incidence of pertussis cases in the years 1990‘s was 0.3 cases/100.000 
population lower than in 1980‘s.  
The spread of pertussis cases by age groups shows more affected are infants of 0-12 
month‘s age and children between 0-14 years. 
Measles 
Reduction by 95 per cent of deaths and reduction by 90 per cent of measles cases 
compared to pre-immunization levels by 1995 was a major step to the global eradication 
of measles in the longer run. Before 1955, measles was endemic in Albania. The 
Epidemics had taken place in 1948-1949 (40,106 cases) and in 1954-1955 (190,020 
cases) and in the years 1970 (37,761 cases). 
Until 1980, there was no record of measles incidence. During the period March 1989 to 
March 1990, another epidemic broke out that covered the entire country, the number of 
cases was 168,636 with an incidence rate 5.4/100 000 population. The highest incidence 
was in 1-year-old children (10,122/100,000 population); infants from 01-12 months 
(76,706 cases/100,000 population) and adolescents between 14-18 years (from 6.735 to 
8.134/100,000). The high intensity of the epidemic in 1989-1990, has highlight on a 
number of issues related to immunization from the diseases resulting from (i) 
inefficiencies in the cold chain system and (ii) adverse effects from vaccine. In 1991-
1992, the measles incidence rate was 0 (28). In these years, country production of the 
measles vaccine was interrupted. As the result, half of the birth group in 1989 and the 
birth group of 1990 were not immunized. The groups in 1991-1993 were only partially 
immunized. 
In 1993, 1994, and 1995, respectively, the incidence of measles was 7, 29 and 15, 
whereas in the period 1996-1999 the measles incidence rose. 
In November 2000, were conducted national immunization campaigns for measles and 
rubella (the year which marks the introduction of the vaccine bivalent MR), vaccination 
that covered children 0-15 years old. This campaign was sponsored by UNICEF in 
Albania (33). 
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Tuberculosis 
A substantial decline in the annual incidence rate of new pulmonary tuberculosis cases 
was recorded in the second half of 1980. In the year 1887, TB incidence was 26.7 per 
100,000 inhabitants. This declining tendency continued until 1992, when the incidence 
hit 15.4 per 100,000. The year 1993 marked an increase of TB incidence by recording 
22.6 per 100 000 inhabitants. The reliability of data after the 1990‘s is a question if one is 
to take account of the massive internal and foreign migration. 
During the period 1990-1997, the total number of cases affected by TB was 721 (23 per 
100,000 inhabitants), in which 75% were affected by pulmonary TB, where the children 
0-14 years old represent 9.3% of the new cases (see table 2.6.3). 
 
Table 2.6.3 Percentage distributions of all forms of TB, 1990 – 1997 
Source: Ministry of Health 
 
In 1995, the National Program for the fight against TB sponsored by ECHO/WHO, 
MERILIN and IMC started in Albania.  During the implementation of this program found 
that only 69 percent of newborns received a BCG injection within 48 hours after birth in 
some districts. 
Viral hepatitis B (VHB) 
The acute viral unspecified hepatitis level is decreased over the period 1990-1997.  The 
annual number of incident cases varies in range 11291 to 1990 with an annual incidence 
rate from 352.2/ 100.000 populations to 60.5/100.000. 
The Routine immunization of newborns was introduced in May 1995. 
In order to bring its immunization system to the next level, and address these challenges, 
the Albanian Institute of Public Health (IPH) is collaborating with WHO to (34): 
Age - groups
______________________________________________________________________
0-1 1-4 5-14 15-24 25-44 > 45
Percentage 
of cases 0,6 2.0 6.7 16.0 47.0 33.6
______________________________________________________________________
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• Validate new approaches that address challenges in quality and use of  
 immunization and vaccine logistics data in Albania. 
• Study the cost-benefit of rationalizing vaccine distribution and storage in the  
 country (modeling). 
• Demonstrate the management benefits of remote alarm systems in monitoring  
 refrigerator temperatures.  
• Establish policies to promote the adoption and scale-up of successful  
interventions in the country and region, and contribute to the development a 
national long-term vision for immunization supply systems.  
 
The cold chain of vaccine in Albania 
The annual supply interval in the National Central Cold Store, Institute of Public Health, 
in Tirana is twice per year. The distribution is organized four times a year from the 
primary Cold Store to the Districts Cold Store. Vaccines are distributed each month by 
the Institute of Public Health to the immunization centers in each district and 
municipality (35). The cold chain equipments available in the Expanded Program of 
Immunization in Albania are divided within two types: 
1. The active cold chain equipment used for the storage of the vaccines.  
This group is composed of:  
a. At the central cold store (IPH), 3 walk – in cold rooms and 1 walk – in freezer  
 room. 
b. At the district store (Albania has 36 districts), two or more ice-lined refrigerators 
and one or more freezer and  
c. At the commune health centre (Albania has 508 health centers) one refrigerator  
 which can be ice-lined or of Liebher type.  
The well being baby consultancies (vaccination centers in urban areas) are generally 
equipped with ice-lined refrigerators due to their high working load.  
 
2. The passive cold chain equipment serves for the transportation of the vaccines  
through the consecutive levels. This group is composed by huge vaccine carriers 
which are used for the transportation of the vaccines from the Primary Cold Store to 
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Districts Cold Store, and vaccine carriers that are used by health staff for small 
quantities of vaccines. The complete set of vaccine carriers includes: thermometer, a 
plastic container (inside vaccine carrier) surrounded by ice-packs to avoid the direct 
contact of vaccines with ice packs and so on prevent the vaccines from getting wet 
and having the label on the vial damaged.  
Our immunization policy is that in rural vaccinations centres, the vaccines which are 
needed for the immunization schedule of the current month are picked-up in Commune 
Health Centre and administered within 48 hours to all target population. The population 
has to be previously informed and gathered in advance for the immunization session.  
During these 48 hours, the vaccine is kept in vaccine carriers with regular exchange of 
the cold ice packs until the immunization session is finished. 
 
2.7. The country epidemiological profile (over the period 1990-1997) 
In Albania, the infant mortality rate (IMR) and under-five mortality rate (U5MR) are 
relatively high compared with the other European countries, even though the two kind of 
rates have been decreased consistently over the recent years. 
During the recent five-year period, the level of the under-five mortality rate has been 22 
deaths per 1,000 births, implying that about 1 in every 45 children born in Albania during 
this period has died before reaching their fifth birthday. However, the infant mortality 
rate has been 18 deaths per 1,000 births against infant mortality, which in European 
countries is an average of 7 deaths per 1000 live births. Looking at the pattern of 
mortality during the first year of life, almost two-thirds of infant deaths takes place in the 
first month of life; the neonatal and post-neonatal mortality rates are 11 and 7 per 1,000 
births, respectively (24). 
Albania presents some peculiarities concerning its epidemiological profile. While the 
mortality patterns are similar to those observed in other developed European countries, 
the morbidity patterns are more similar to those of developing countries. There is a high 
prevalence of infectious diseases such as diarrhea diseases that are related to poor 
environmental conditions, but at the same time, vaccine preventable diseases such as 
diphtheria, measles, rubella, and neonatal tetanus are well on their way to being 
eliminated from the population or have already been eliminated such as polio (28).  
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The epidemiological transversal studies (survey), carried out by the Institute of Public 
Health, provide a further detailed account of the epidemiological picture on some 
diseases groups namely: 
 diarrhoeal  diseases  
 viral hepatitis 
 airborne infectious diseases 
 infectious diseases of National Programme on Immunization (EPI -  Expanded 
Programme on Immunization), (most of them being of an airborne nature of 
transmission) 
 tuberculosis (TB) 
 zoonoses 
It is important to note that the availability of epidemiological surveillance data is from 
1990 for all the infectious diseases which are included in the existing mandatory 
reporting system of Albania that defines the period 1990 – 1997. 
 
Diarrheal Diseases 
The table 2.7.1 presents the annual frequency (number of cases) and incidence rate 
(cases/100,000 population) of the diarrheal diseases during the period from 1990 until 
1997 (period before our study).  
During the period 1990-1997, the annual incidence (cases/100, 000) of diarrheal disease 
has been much lower than those of the previous period 1970-1990, in which the annual 
incidence of cases varies from 3.049 to 4.571 cases/100, 000; an incidence which does 
not show any descending trend annually during 1990-1997 with about 1500-1600 cases 
per 100,000 inhabitants (see table 2.7.1). 
 
 
 
 
 
 
 
Dissertation 2011 
 
58 Elida MATA 
 
Table.2.7.1 Annual frequency (number of case) and Incidence rate (case/10
5
) over the period 1990-1997 
 
Typhoid and paratyphoid fever and non-typhoid salmonellosis have been represented as 
the most important water-borne diarrheal diseases from public health impact point of 
view. The annual frequency (number of case) and incidence rates (cases/10
5
) of typhoid 
and paratyphoid fever occurrence during the period 1990-1997 is low. The non typhoid 
salmonellosis shows a similar decreasing trend. 
The cholera epidemic in year 1994 in Albania represents the most conspicuous and at the 
same time, a terrible example of the potential risk posed by the water infrastructure. 
The epidemic, a consequence of cholera importation, was concentrated in 14 out of 36 
districts, namely: Kucove, Berat, Librazhd, Lushnje, Fier, Mallakaster, Kavaje, Durres, 
Tirane, Elbasan, Peqin Pogradec, Korce and Devoll. The districts of Kucove, Berat and 
Librazhd (where the first cases were appeared) indicated the highest incidence rate (28). 
A total of 1748 cases were reported; 74.2% (1297/1748) of them belonged to rural areas. 
Shigellosis – During the period 1990-1997, the epidemiological surveillance data on 
shigellosis (bacillary dysentery), concerning their annual frequency (number of case) and 
incidence rate (case/10
5
), demonstrated a steadily decreasing trend. 
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Regarding to amoebasis (amoebic dysentery), there are no data till 1994, a year which 
denotes the beginning of mandatory laboratory diagnosis at the district level on 
Entamoeba histolytica (causative agent) as well as (along with that routine on Shigellae) 
in each reported case with diarrhea with blood infectious syndrome. The epidemiological 
surveillance data during this period indicated a low annual number of reported cases (an 
average 0f 14-15 cases per year). 
The epidemiological surveillance data on the poising, concerning their annual frequency 
and incidence rate, demonstrated a consistently decreasing trend during the period 1990-
1997. It is important to emphasize that most of the tests carried out by the district 
microbiological agents laboratories have failed to provide a reliable and efficient 
monitoring system in each of the reported outbreaks of food borne intoxications 
regarding the etiological agents.  
Measles, Rubella, Mumps, Diphtheria, Pertussis and Tetanus  
In the air borne infectious diseases are included measles, rubella, mumps, pertussis and 
diphtheria except influenza, streptococcal infectious. Some of the diseases mentioned 
above represent in themselves, the infectious diseases which are preventable by 
vaccination.  
Measles  
• From 1945 till 1955 measles has had its usual continuous epidemic circulation  
 among the country population with two epidemic peaks. 
• In 1956, immediately after epidemic years of the 1954-1955, a strategy of a total  
and rigorous quarantine toward each eventual imported measles case was 
established throughout Albania.  
• In 1971,  the routine of the mandatory vaccination against measles was introduced  
 in the national immunization calendar for all new birth. 
The period 1990-1997 was characterized by measles at sporadic level with small and 
limited outbreaks, with an annual average of 700-800 reported cases but always zeros 
deaths (see table 2.7.2). 
In 1998 Albania passed the measles epidemic with over 140,000 cases spread throughout 
the country. The Ministry of Health supported by the government undertook some 
measurements that resulted in the reduction and also the distinction of the epidemic (the 
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importation of measles vaccine). Measles vaccine till the onset of the epidemic was 
produced within the country. The year 2000 denoted the beginning of the implementation 
of the ―National Strategy on Measles Eradication by 2007 in Albania ―, set up a 
confirmation on the WHO respective target for the European Region. Under this strategy, 
starting from January 2001, the 2
nd
 dose (booster dose) of measles at 5 years of age (with 
measles-rubella bi-vaccine) was introduced in the routine of the mandatory vaccination.  
Rubella 
For rubella (no congenital rubella) three epidemic peaks were recorded over the period 
from 1964 to 1994. 
• the epidemic of 1969 with 3676 reported cases (or an incidence 0f 180 cases/105); 
• the epidemic of 1985,which is the largest one, with 78594 reported cases (or an  
 incidence of 3080 cases/10
5
); 
• and the epidemic of 1994 with 3432 reported cases (or an incidence of 110  
 cases/10
5
). 
The annual number of reported rubella cases over the period 1990-1997 except 1994 
presents a declined trend. 
Table 2.7.2 Annual frequency (number of case) and Incidence rate (case/10
5
) over the period 1990-1997 
Year Measles  Rubella  Mumps  
no. of 
cases 
Inc. 
cases/10
5
 
no. of 
cases 
Inc. 
cases/10
5
 
no. of 
cases 
Inc. 
cases/10
5
 
1990   15 0.5 2598 81 
1991 0 0 9 0.3 3102 96.1 
1992 0 0 12 0.4 999 30.4 
1993 7 0.2 111 3.4 4128 125.5 
1994 29 0.9 3432 104.4 2863 87.1 
1995 15 0.4 10 0.3 243 7.5 
1996 1204 36.6 180 5.5 1324 40.2 
1997 2386 72.6 66 2 2969 90.3 
 
Diphtheria, Tetanus and Pertussis 
The epidemiological surveillance data of annual frequency (number of reported cases) 
and incidence rates (cases/10
5
) of diphtheria, pertussis and tetanus present a steady 
decline of their occurrence, during the period 1990-1997 see table 2.7.3 
During the period 1990-1997 the number of diphtheria cases is decreased until 0 (zero) 
cases and they are reported as suspected (not laboratory confirmed) cases. The annual 
reported cases of Pertussis during the period 1990-1997 show the decreased trend. 
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Also, the Tetanus, over this period presents very low level of disease occurrence; the 
annual frequency is only 2-4 reported cases (see table 2.7.3). 
Table 2.7.3 Annual frequency (cases) and incidence rate (case/10
5
) over the period 1990-1997 
Year  Diphtheria  Pertussis  Tetanus  
  no. of cases Inc. 
cases/10
5
 
no. of cases Inc. 
cases/10
5
 
no. of 
cases 
Inc. 
cases/10
5
 
1990 17 0.5 329 10.3 14 0.4 
1991 23 0.7 275 8.5 8 0.2 
1992 48 1.4 51 1.5 7 0.2 
1993 18 0.5 124 3.8 18 0.5 
1994 14 0.4 244 7.4 14 0.4 
1995 4 0.1 136 4.1 14 0.4 
1996 4 0.1 228 6.9 2 0.06 
1997 0 0 78 2.4 3 0.09 
 
Pulmonary Tuberculosis (TB) 
The occurrence levels of tuberculosis in Albania have remained nearly constant over the 
period of 1990-1997. The annual numbers of incident cases vary in a range from 530 to 
765 with an annual average 0f 660 cases or 20.1 new cases/10
5
 as incidence rate (see 
table 2.7.4). Despite of the measurements taken by the Ministry of Health, TB prevention 
system was weak. There was a lack of proper methods for diagnosis, lack of information 
about the patient treatment and poor communication between the responsible medical 
centers namely TB dispensaries and the epidemiological services at the district level. 
 
Table 2.7.4 Annual frequency (cases) and incidence (case/10
5
) over the period 1990-1997 
 
Years 
Tuberculosis (TBC) 
no. of cases Incidence rate - cases/10
5
 
1990 653 20.4 
1991 628 19.5 
1992 530 16.1 
1993 636 19.3 
1994 547 16.6 
1995 664 20.2 
1996 707 21.5 
1997 655 19.9 
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Viral Hepatitis 
The 14/Sh form of the statutory contains along with “Unspecified viral hepatitis”, the 
three basic types of viral hepatitis (Viral hepatitis A, Viral Hepatitis B and Viral hepatitis 
C) as well. Nevertheless, the following data belong to “Unspecified viral hepatitis” only, 
due to the impossibility (the lack of diagnostic test kits) of routine virus type 
identification by the district microbiological laboratories. The data on the viral hepatitis 
over the period 1990-1997 are characterized by a decreasing trend with huge  oscillations 
of the annual incidence rates around an average level of 100 cases per 100,000 population 
(see table 2.7.5). 
Table 2.7.5 Annual frequency (cases) and incidence (case/10
5
) over the period 1990 – 1997 
 
Year  
Hepatitis, acute, viral, unspecified  
no. of cases Incidence rate - cases/10
5  
1990 11291 352.2 
1991 6814 208.4 
1992 4576 139.2 
1993 5255 159.9 
1994 7624 222.1 
1995 3973 120.9 
1996 2035 61.9 
1997 1990 60.5 
 
Zoonoses (Anthrax, Brucellosis, Leishmaniasis and Leptospirosis)   
The term of ―zoonoses‖ includes a very large number of infectious diseases.  
The zoonoses diseases are subject of the veterinary medicine control and prevention and 
a public health importance, namely anthrax, brucellosis, leishmaniasis and leptospirosis.  
The occurrence of all zoonoses shows a common increasing trend, mainly because of a 
conspicuous increase of brucellosis frequency during the period 1990-1997 
The epidemiological surveillance data on leishmaniasis in Albania, during the period 
from 1990-1997 regarding the annual frequency and incidence rate shows a fluctuated 
trend with an increase in the disease occurrence every 3-5 years (see table 2.7.6). 
The frequency and incidence rate of leptospirosis in Albania shows a declined trend 
during the period 1990-1997 (36, 37). 
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Table 2.7.6 Annual frequency (cases) and incidence (case/10
5
) over the period 1990 – 1997 
Year  Anthrax  Brucellosis  Leishmaniasis 
visceralis 
Leishmaniasis cutis  Leptospirosis  
no. of 
cases 
Inc. rate 
cases/10
5
 
no. of 
cases 
Inc. rate 
cases/10
5
 
no. of 
cases 
Inc. rate 
cases/10
5
 
no. of 
cases 
Inc. rate 
cases/10
5
 
no. of 
cases 
Inc. rate 
cases/10
5
 
     
1990 98 3 42 1.3 120 3.7 7 0.2 148 4.6 
1991 63 1.9 17 0.5 77 2.4 0 0 75 2.3 
1992 111 3.4 62 1.9 58 1.8 1 0.03 46 1.4 
1993 76 2.3 29 0.9 40 1.2 13 0.4 51 1.55 
1994 135 4.1 118 3.6 76 2.3 12 0.4 33 1 
1995 90 2.7 172 5.2 108 3.3 20 0.6 20 0.6 
1996 74 2.2 149 4.5 75 2.3 5 0.15 32 1 
1997 75 2.3 155 4.7 83 2.5 5 0.15 10 0.3 
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3. The research objectives 
The purpose of this thesis is to introduce (or to improve) the surveillance system of 
infectious diseases in Albania through a comprehensive survey of the current system and 
a comparative analysis of data from the data base system (14/Sh monthly reporting 
system for the period 1998 -2009) and individual data (personal information for the 
period 2007-2009). This results from the discrepancies and the gaps in the presentation of 
the monthly reporting data from 1998-2009 and of the individual forms mainly for the 
period 2007-2009. There forms were introduced around 1995. 
The goal of this study is to compare the data reported by monthly reporting form with the 
notified data by individual form of notification. The trend of the analysis of infectious 
diseases following proposes: 
1. Evaluation of epidemiological situation of these diseases by focusing attention on: 
a. Description of the trend of infectious diseases in Albania during the period of 
study (data from the monthly reporting forms) and the evaluation of the 
information by the individual form of infectious diseases notification; 
b. Distribution of the infectious diseases by sex and age; 
c.  Distribution by the regions and the areas (urban and rural); 
d.  Assessment of the vaccine coverage for vaccine preventable diseases in Albania;  
e.  Comparing of the levels of infectious diseases and our surveillance system with 
those of other European countries. 
2. Analysis of the characteristics of the surveillance system (the way of completing 
the individual forms) in terms of sensitivity of recording the cases of infection, 
emphasizing the importance of the system and making a balance between the 
strengths and weaknesses of the system, in order to implement of the measures to 
improve the monitoring of infectious diseases and the introduction of surveillance 
systems for specific diseases. 
The analysed parameters are as follows: 
a. sensitivity - the ability of the system for registration of actual cases of illness; 
b. simplicity - the structure and functioning of the system; 
c. flexibility - which has to do with the system's ability to add new data if necessary 
and to supplement existing ones; 
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d. timeliness - timeline about the possibility of rapid detection of outbreaks; 
3. Assessment of the organizational structure of the monitoring system, trying to 
find out any restrictions on the development and management of data from local 
levels of health; 
4. Providing a comparison of surveillance system on infectious diseases through the 
intersection of monthly and individual data to assess and calculate the percentage of 
cases reported by the monthly reporting forms and individual form, to assess whether 
there were any challenge in reporting of them and to understand the inadequacy of 
data from both forms, with the ultimate goal of improving the current system of 
surveillance on infectious diseases. 
 
4. The material and method 
4.1  Proceedings of the system analysis of data (monthly reporting system and the 
system of individual notification) 
Comparative analysis between the data of infectious diseases surveillance is based on the 
data by monthly reporting and by individual notification form. Monthly information 
system of infectious diseases surveillance (14/Sh monthly reporting) is based on 
aggregated data obtained from individual patient forms. 
In the study  there are included all the reported infectious diseases from the monthly 
reporting system for the period 1998-2009 and there are assessed individual notification 
forms  of infectious diseases which constitute the key point of the system of surveillance 
of these diseases from which depends and quality and reliability of monthly reporting 
data. 
The statistical analysis and the elaboration are presented by graphs and tables (through 
the use of Excel and the Epi-2002 software). The analysis was based on general 
information related to the total number of cases from monthly reporting system, in order 
to describe the trends and key variables of infectious diseases under the study, and the 
data reported by the individual notification forms, so that makes an assessment of the 
system through cross-analysis of data. 
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The procedure followed can be summarized as follows: 
1. detailed analysis of each of the databases in order: 
• description of the epidemiological trend of infectious diseases, the 
distribution by sex and age groups, geographical distribution (regional, urban and 
rural), exposure mode, hospitalization and risk factors for acquisition of infection; 
• describe the characteristics of the monthly reporting system to analyze and 
evaluate individual notification form on quality indicators such as simplicity, 
flexibility, and completeness / quality of data; 
2.  Subsequent comparison of the previously estimated parameters to compare 
information provided by each system, their characteristics and the recognition of 
the strengths parts and limitations of each; 
3. Nominal analysis (patient to patient), individual cases of illness and laboratory 
confirmation derived by individual notification form, to search for cases that may 
have been lost by monthly reporting form in order to assess the surveillance 
activities conducted from the monthly and individual notification system 
regarding infectious diseases, with the ultimate goal of identifying appropriate 
strategies for improving the current system. 
 
We note that the system is not electronic. 
Study of the functioning of surveillance system of infectious diseases was based on 
assessment of individual characteristics and comparing of them in accordance with the 
following steps: 
1. Calculation of simplicity and flexibility of the system 
The simplicity of this system was investigated by analyzing the following parameters 
assessed by operators who usually use 14/Sh system: 
• use the database 
• access to information 
The flexibility of the system was determined by assessing the possibility of upgrading the 
database to get information about speed and ease with which we can make changes and 
additions to existing data and new data. 
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2. Calculation the completion system 
We have estimated the percentage of the total number of cases included in the 
surveillance system and the number of cases diagnosed and reported in the database and 
the individual form of system. 
3. Calculation of data quality 
We have estimated by calculating the percentage of the "familiar" and "unknown" in the 
context of the questions within the modules that perform monitoring, calculation of 
sensitivity and positive predictive value in data collection. 
 
4.2  Structure and organization of the database system based on monthly reporting 
After 1997 is invested about the system of surveillance of infectious diseases (including 
the monthly reporting form to a considerable number of infectious diseases, the 
implementation of the ALERT system, and the introduction of individual files to the 
notification) in order to have an Information System quality of epidemiological data and 
programming and verification of results. Monthly reporting system and the individual 
notification cards are not electronic, and the data which are collected from this form are 
aggregated data which allow statistical analysis by providing the opportunity to study and 
monitor the trend of disease in the various territories of the country. 
Data recorded in the monthly reporting system are present in the form of general data, not 
specific to the patient, although the data are based on individual size. Monthly reporting 
variables are:  
• region 
• district 
• diagnosis 
• residence (urban & rural) 
• gender 
• confirmed or suspected 
• age group 
• hospitalized 
• dead 
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Statistical processing of the monthly data is based on: 
1. Analysis of general data describes trends and epidemiological characteristics of  
 infectious diseases for the period 1998-2009, according to these parameters: 
 general cases of infectious diseases estimated for each year; 
 the distribution by sex and age (second division 0-4 years, 5-14 years, 15-44  
years, 45-59 years and more than 60 years), to assess who are most at risk for 
getting infection; 
 geographic distribution by region and residence (urban & rural) 
 situation of the disease (confirmed or suspected); 
 analysis of collected data and organize the database in order to analyze the 
characteristics of the surveillance system, in particular: simplicity flexibility, 
timeliness and completeness / quality of data. 
2. Analysis of individual forms, is based on cross-comparisons of monthly data for the 
period 2007-2009, this to determine the loss of data in the system. Individual forms 
are different for various diseases as described above.   
So and analysis of various data contained in these forms is shared by groups of diseases: 
a. Analyzed variables of the individual forms for group B / 1 (14-2/Sh): 
 details of the first part - general information: name, surname, father's name, 
age, sex, occupation and address; 
 details of the second part - history of case: the place of onset of symptoms, 
date of onset of symptoms, date of hospitalization, the situation of the disease, 
vaccination status; 
 details of the third section - laboratory diagnosis: direct examination (date and 
place of examination, the outcome), culture examination (date and place of 
examination, the outcome), serological examination (date and place of 
examination, the outcome). 
 details of the fourth part - the epidemiological investigation: endemic or 
sporadic cases, the origin of the disease and the number of persons infected 
family members or not; 
 details of fifth part – conclusion (confirmed or suspected case). 
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b. Analyzed variables of the individual form for group B / 2 (14-3/Sh) 
 
 details of the first part - the vital records on the case and the onset of the 
diseases: name, surname, father's name, age, sex, profession and address, 
place of onset of symptoms, date of onset of symptoms, date of 
hospitalization date of commencement of therapy and vaccination status; 
 details of the second part - clinical and epidemiological Investigation: risk 
factors (exposure to TB, alcohol or drug user), the classification of past 
history (if new or recurrent), previous therapy, the last therapy, X-ray 
examination, intradermo reaction, epidemiological investigation (sporadic 
or endemic), the number of infected persons; 
 data of the third section - laboratory diagnosis: direct examination (date 
and place of examination, the outcome), culture examination (date and 
place of examination, the outcome), serological examination (date and 
place of examination, the outcome), the conclusion (pulmonary TB 
positive - BK +, negative pulmonary TB - BK - and the case 
unclassifiable. 
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5 RESULTS 
5.1 Epidemiological characteristics of diarrheal diseases 
Reporting of infectious diseases in central level is based on monthly reporting of cases through 14/Sh form. Monthly data are 
aggregated data distributed by gender, age group, residence (urban & rural). Monthly reporting is the amount of infectious disease 
cases for each collected data by individual notification forms. 
Table 5.1.1 shows that the number of cases of these diseases reported by monthly reporting form is greater in year‘s 2007 for diseases: 
Typhoid fever, salmonellosis and shigellosis, while, the poising cases represent the greater number of cases in year‘s 2009. Number of 
cases of these diseases is decreased from year to year, except the number of cases with poising which are increasing. Discordance 
between the data (monthly reporting and individual) expresses a major gap in the system of surveillance of infectious diseases in 
Albania. 
 
Table.5.1.1 Number of cases of diarrheal diseases in Albania [repoted by monthly form and by individual schedule ( )] 
Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Typhoid fever  41 13 15 21 30 29 13 19 22 29 (16) 8 (4) 11 (7) 
Salmonellosis (non-
typhoid) 
757 395 380 407 401 242 270 294 352 584 (133) 257 (69) 241 (61) 
Shigellosis (bacillary 
dysentery) 
848 817 728 885 694 795 764 607 614 652 (170) 390 (87) 300 (60) 
Poising 1176 1186 1826 1987 2601 2665 2536 2200 2415 3067 (58) 2764 (57) 3370 (70) 
Amoebiasis 45 49 20 4 24 4 5 7 6 0 (4)  6 (6) 0 
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Figure.5.1.1 The incidence rate (cases/100,000 inhabitants) of diarrheal diseases over the study period (1998-2009) 
 
The annual incidence rate of diarrheal diseases during the period 1998 - 2009, shows the 
decreased trend for each disease presented in figure 5.1.1 except the incidence rate of poising 
which is higher than the other diarrheal diseases and is increased from 40.0 to 120.0 
cases/100.000 population. The incidence rate of typhoid fever and amoebiasis is very low, the 
annual incidence rate of shigellosis and salmonellosis obtained oscillate around 24.7 to 9.3 
cases/100.000 population and also showing a decreasing trend.   
 
Table.5.1.2 Number of cases of diarrheal diseases reported by monthly and individual form ( ) by regions during the years 2007-2009  
Regions Typhoid 
fever 
Salmonellosis 
(non-typhoid) 
Shigellosis 
(bacillary 
dysentery 
Poisoning Amoebiasis 
Berat 1 (2) 54 (39) 157 (107) 1514 1 (4) 
Diber 2 5 (4) 5 (5) 1003 0 
Durres 3 (5) 3 (1) 48 (3) 84 0 
Elbasan 9 (9) 107 (2) 100 (5) 84 (80) 0 (6) 
Fier 1 6 (5) 16 (2) 138 (4) 0 
Gjirokaster 0 0 4 (3) 10 (7) 0 
Korce 2 13 (7) 90 (78) 144 6 (0) 
Lezhe 1 68 (58) 28 (30) 0 0 
Tirane 23 (11) 231 (132) 170 (42) 105 (87) 0 
Shkoder 0 523 618 0 0 
Kukes 4 60 76 6111 0 
Vlore 2 10 30 8 5 
Total  48 (27) 1080 (248) 1342 (275) 9201 (178) 12 (10) 
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The table 5.1.2 presents number of cases of diarrheal diseases by regions reported by monthly 
and individual form over the period 2007-2009. It‘s evident a discordance between the number 
of notified cases with the total number of cases reported by monthly form.  
50 % of regions have reported only the number of cases by monthly reporting form (14/Sh); 33% 
of them have presented monthly and individual data. As shown in the table above, some of 
regions represent more data by individual notification form than monthly data such as: Berat and 
Durres region for typhoid fever; Lezhe region for shigellosis; and Berat and Elbasan region for 
amoebiasis. 
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Distribution of diarrheal diseases over the period 1998 – 2009 by region 
Country Mean Incidence (cases/100,000 population) and range 
          Typhoid fever                                                                         Salmonellosis (non-typhoid) 
           0.6 (0.1 – 1.4)                                                                                  13.6 (1.3 – 42.0) 
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      Poisoning                                                                          Shigellosis 
          168.3 (2.7 – 1568.4)                                                                         24.2 (2.9 – 65.8)
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Table 5.1.3 Distribution of cases number of diarrheal diseases over the period 1998-2009 by age - group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
    no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
T
y
p
h
o
id
 f
ev
er
 
0-4 0 1 1 1 3 1 2 0 8 3 0 1 
5-14 10 6 3 7 10 18 5 8 4 10 0 5 
15-44 21 8 6 2 17 2 0 2 0 0 3 0 
45-59 5 1 3 1 2 2 0 0 2 0 1 17 
60 + 0 0 0 1 1 1 0 0 4 4 1 0 
                            
S
a
lm
o
n
el
lo
si
s 
(n
o
n
-t
y
p
h
o
id
) 0-4 429 206 125 162 207 94 127 120 196 222 90 74 
5-14 106 62 54 58 57 43 61 59 56 113 69 39 
15-44 145 75 137 137 78 64 48 72 48 158 50 70 
45-59 53 34 56 40 39 29 26 28 41 68 25 43 
60 + 24 18 24 10 20 12 8 15 11 23 23 15 
                            
S
h
ig
el
lo
si
s 
(b
a
ci
ll
a
ry
 
d
y
se
n
te
ry
) 
0-4 386 343 301 437 347 349 339 301 317 313 158 127 
5-14 132 150 145 162 138 158 206 120 108 114 87 63 
15-44 207 198 154 155 117 169 120 96 93 104 74 46 
45-59 90 92 83 91 63 80 63 52 59 91 38 46 
60 + 33 34 45 40 29 39 36 38 37 30 33 18 
                            
P
o
is
o
n
in
g
 0-4 264 176 209 164 296 269 282 197 220 399 342 325 
5-14 264 283 317 392 592 437 528 402 471 611 593 599 
15-44 472 583 957 1091 1217 1418 1264 877 1208 1391 1240 1657 
45-59 143 109 282 283 373 447 388 500 408 528 466 611 
60 + 33 35 61 57 123 94 74 224 108 138 123 178 
                            
A
m
o
eb
ia
si
s 0-4 11 28 11 1 2 0 3 3 4 0 1 0 
5-14 5 12 0 0 1 0 2 1 0 0 0 0 
15-44 21 8 6 2 17 2 0 2 0 0 3 0 
45-59 5 1 3 1 2 2 0 0 2 0 1 0 
60 + 3 0 0 0 2   0 1 0 0 1 0 
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Figure 5.1.2The incidence rate of diarrheal diseases during the years 1998-2009 by age groups 
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The epidemiological surveillance data on diarrhea diseases (typhoid fever, salmonellosis, 
shigellosis, and food-borne intoxication aomebiasis) during the period from 1998 to 2009 by age 
group are presented in Table 5.1.3 (cases number) and Figure 5.1.2 (incidence rate – case 
number/100.000 population). Their occurrence (typhoid fever, salmonellosis and shigellosis) 
over the time demonstrates a consistently decreasing trend from year to year. The pediatric age 
groups (0-4 and 05-14 years) are more affected by these diarrhea diseases. 
The annual frequency and incidence rate of poisoning is higher for all age-groups compared with 
others diseases of this diseases group, showing increased trend. 
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Table 5.1.4 Distribution of cases number of diarrheal diseases during the years 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
    no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
T
y
p
h
o
id
 
fe
v
er
 
Total 41 13 15 21 30 29 13 19 22 29 8 11 
Male 23 6 6 15 16 17 7 11 8 14 4 6 
Female 18 7 9 6 14 12 6 8 14 15 4 5 
  
                          
S
a
lm
o
n
el
lo
si
s 
(n
o
n
-t
y
p
h
o
id
) Total 757 395 380 407 401 242 270 294 352 584 257 241 
Male 431 216 165 228 211 125 155 165 194 278 138 127 
Female 326 179 215 179 190 117 115 129 158 306 119 114 
                            
S
h
ig
el
lo
si
s 
(b
a
ci
ll
a
ry
 
d
y
se
n
te
ry
) Total 848 817 728 885 694 795 764 607 614 652 390 300 
Male 458 412 370 490 384 410 402 297 320 338 198 161 
Female 390 405 358 395 310 385 362 310 294 314 192 139 
                            
P
o
is
o
n
in
g
 Total 1176 1186 1826 1987 2601 2665 2536 2200 2415 3067 2764 3370 
Male 617 591 902 976 1353 1452 1434 1101 1376 1661 1538 1880 
Female 559 595 924 1011 1248 1213 1102 1099 1039 1406 1226 1490 
                            
A
m
o
eb
ia
si
s Total 45 49 20 4 24 4 5 7 6 0 6 0 
Male 29 25 9 3 17 2 3 4 4 0 1 0 
Female 16 24 11 1 7 2 2 3 2 0 5 0 
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Figure 5.1.3The incidence rates of diarrheal diseases during the years 1998-2009 by gender  
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Epidemiological surveillance data for diarrheal diseases by gender are presented in detail in 
Table 5.1.4 (number of cases), and in Figure 5.1.3 is presented the incidence rate (cases/100.000 
inhabitants). During the study period the incidence rate of typhoid fever, salmonellosis and 
shigellosis show a decreased trend although there is no difference between the incidence rate by 
gender (male and female). The incidence rate of poising is presented with an increased trend 
from year to year; also, there is no difference between gender incidence rate (males and females). 
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Table 5.1.5 Distribution of cases number of diarrheal diseases over the period 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
    no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
T
y
p
h
o
id
 
fe
v
er
 Total 41 13 15 21 30 29 13 19 22 29 8 11 
Urban 19 5 3 14 23 24 6 6 11 9 3 6 
Rural 22 8 12 7 7 5 7 13 11 20 5 5 
  
                          
S
a
lm
o
n
el
lo
si
s 
(n
o
n
-t
y
p
h
o
id
) 
Total 757 395 380 407 401 242 270 294 352 584 257 241 
Urban 370 208 236 254 249 136 167 144 195 379 155 155 
Rural 387 187 144 153 152 106 103 150 157 205 102 86 
                            
S
h
ig
el
lo
si
s 
(b
a
ci
ll
a
ry
 
d
y
se
n
te
ry
) 
Total 848 817 728 885 694 795 764 607 614 652 390 300 
Urban 441 471 399 509 336 373 442 320 325 388 210 234 
Rural 407 346 329 376 358 422 322 287 289 264 180 66 
                            
P
o
is
o
n
in
g
 Total 1176 1186 1826 1987 2601 2665 2536 2200 2415 3067 2764 3370 
Urban 398 507 814 811 1117 1194 1309 979 1271 1706 1496 1639 
Rural 778 679 1012 1176 1484 1471 1227 1221 1144 1361 1268 1731 
                            
A
m
o
eb
ia
si
s Total 45 49 20 4 24 4 5 7 6 0 6 0 
Urban 27 16 5 2 8   3 4 1 0 0 0 
Rural 18 33 15 2 16 4 2 3 5 0 6 0 
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Figure 5.1.4 The incidence rate of diarrheal diseases during the years 1998-2009 by residence 
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In the table 5.1.5 and figure 5.1.4 are showed number of cases and incidence rate about the 
distribution of diarrheal diseases by residence.  
Our data show that in urban areas the occurrence of these diseases (typhoid fever, salmonellosis, 
shigellosis, poising and Amoebiasis) is about 1.5 times more than rural areas. Expressed in 
percentage urban areas are 55.7% more than rural areas for typhoid fever, salmonellosis, 
shigellosis and aomebiasis. The poising cases show the increasing trend and there is no 
difference between areas (urban and rural areas). 
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Individual notification schedul for diarrheal diseases  
As explained in section (2.4), the monthly reporting system of infectious diseases is based on data for each patient (individual 
notification form). The individual notification form contains 5 parts with corresponding questions on the generalities of the patient, 
history of disease, laboratory diagnosis, epidemiological investigation of the case and the conclusions on the disease. 
Statistical analysis is based on the quality and reliability of the information of the system (individual and monthly data). 
Indicators of general information about the patient are shown in Table 5.1.6. 
Results obtained show that the generalities of the patient are compiled at the highest percentage of forms, except for "name of the 
father" which is almost the same values for the "yes" and "missing". 
The average age groups affected by diarrhea diseases presented by individual form are: for typhoid fever is 22 old years in range (0-
73); for salmonellosis (non typhoid) is 20.2 years old in range (0-88); for shigellosis is 14.1 years old in range (0-88) and for 
poisoining is 29.6 years old in range (1-78).  
 
 Part I – “ General information”  
 Table 5.1.6 the general information data from the individual form   
 Typhoid fever Salmonellosis (non-
typhoid) 
Shigellosis (bacillary 
dysentery) 
Poisoning Amoebiasis 
Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing 
No.   (%) No.    (%) No.    (%) No.    (%) No.    (%) No.    (%) No. (%) No. (%) No.   (%) n   (%) 
Father's name 16 (59.3) 11(40.7) 132 (50.2) 131(49.8) 251(79.2) 66 (20.8) 57 (30.8) 128 (69.2) 6 (60) 4 (40) 
Gender 27 (100) 0 263 (100) 0 317 (100) 0 185 (100) 0 10 (100) 0 
Age 25(92.6) 2 (7.4) 261(99.2) 2 (0.8) 309 (97.5) 8 (2.5) 185(100) 0 10 (100) 0 
Profession 27 (100) 0 263 (10) 0 317 (100) 0 185(100) 0 10 (100) 0 
Address 26 (96.3) 1(3.7) 203(77.2) 60 (22.8) 288 (90.8) 29 (9.2) 154(83.2) 31(16.8) 10 (100) 0 
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 Part II – “ History of disease” 
The second part of the notification form contains indicators of "date of onset", data of patient hospitalization and the disease prognosis 
(see table 5.1.7 and 5.1.8). The obtained results show that in the highest percentages of these indicators are completed. 
 
Table 5.1.7The data of the disease history by individual form of notification 
 Typhoid fever Salmonellosis (non-
typhoid) 
Shigellosis (bacillary 
dysentery) 
Poisoning Amoebiasis 
Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing 
No   (%) No.   (%) No.   (%) No.  (%) No. (%) No.   (%) No. (%) No. (%) No. (%) No. (%) 
Date of onset 26 (96.3) 1 (3.7) 229 (87.1) 34 (12.9) 303 (95.6) 14 (4.4) 181 (97.8) 4 (2.2) 10 (100) 0 
Hospitalized 27 (100) 0 255 (96.9) 8 (3.1) 312  (98.4) 5 (1.6) 185 (100) 0 10 (100) 0 
 
 
Table 5.1.8 the disease prognosis for each disease 
  
  
Typhoid fever 
  
Salmonellosis (non-typhoid) 
  
Shigellosis (bacillary dysentery) 
  
Poisoning 
  
Aomebiasis 
  
No. % No. % No. % No. % No. % 
Cured 25 92.6 225 85.6 260 82 164 88.6 10 100 
Deceased 0 0 0 0 0 0 0 0 0 0 
Missing 2 7.4 38 14.4 57 18 21 11.4 0 0 
Total 27  100.0 263 100.0  317  100.0 185  100.00 10  100.0 
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 Part III- “Laboratory diagnosis” 
 
Case definition is based on case confirmed by specific laboratory tests 
Different diseases have different criteria for its confirmation. 
Basic criteria are: 
1. Clinic: the presence of the symptoms (clinical manifestations perceived by the doctor)  
and the symptoms (clinical manifestations perceived by patients) of pathology in the 
review. 
2. Direct examinations: Identification of the etiological agent by microscopic examination.  
3. Culture: Isolation and cultivation of the etiological agent in proper conditions and its  
identification through serotype. Positivity in culture is sufficient criterion of laboratory 
confirmation in the absence of direct examination or serology     
4. Serology: Identification of specific antibodies against etiological agents in significant  
titre when a single sample of blood serum of the patient or identification of sero- positive 
between the two serums samples of blood (growth 4 times the titre of specific antibodies 
between acute and convalescent phase of the disease.   
Criteria for confirmation of poisoning and typhoid fever are: clinics, culture and serology, but 
the results presented in the table 5.1.9 show that although the low percentage of positivity by 
directs examination which is not applicable for confirmation of these diseases. 
Salmonellosis and shigellosis unlike typhoid fever are confirmed by clinical and culture 
examination. 
In the individual form of notification is not included clinical diagnosis criteria, so these 
two diagnoses in over 80% were confirmed by culture. 
Aoebiasis confirmation is performed by clinical and direct examinations.   
Our results show that in 10 cases 3 of them are confirmed by cultur examination (not applicable) 
and in 7 other cases of aomebiasis we have ―missing‖ of laboratory confirmation.  
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Table 5.1.9 laboratory examinations for each disease 
Disease  Direct Culture Serology 
No.   (%) No.   (%) No.   (%) 
Typhoid fever             
No. = 27 
Positive 2 (7.4) not applicable 15 (55.6) 12 (44.5) 
negative 0 2 (7.4) 0 
Missing 25 (92.6) 10 (37) 15 (55.5) 
     
Salmonellosis 
(non-typhoid)       
No. =263 
Positive 5 (1.9) not applicable 237 (90.1) 1(0.4) not applicable 
negative 0 0 0 
Missing 258 (98.1) 26 (9.9) 262 (99.6) 
     
Shigellosis  
(bacillary 
dysentery)  
No. =317 
Positive 10 (3.2) not aplicable 280 (88.3) 1 (0.3) not applicable 
negative 0 3(0.9) 0 
Missing 307 (96.8) 34 (10.7) 316 (99.7) 
     
Poisoning 
No. =185 
Positive 22 (11.9) not applicable 65 (35.1) 1(0.5) 
negative 0 0 0 
Missing 163 (88.1) 120 (64.9) 184(99.5) 
     
Amoebiasis     
No. =10 
Positive 0 3(30) not applicable 0 not applicable 
negative 0 0 0 
Missing 10 (100) 7(70) 10 (100) 
*Not applicable – means wrong laboratory examination 
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 Part IV – “Epidemiological investigation” 
The fourth section contains indicators of the nature of outbreaks and origin of infection (see Tables 5.1.10 and 1.5.11). 
In over 40% of individual forms, the indicator of nature of outbreaks of infection is "missing". 
Results on the origin of infection indicate that the largest number of cases is "missing" and "unknown". 
 
Table 5.1.10 Outbreak nature of disease  
 Typhoid fever Salmonellosis (non-
typhoid 
Shigellosis(bacillary 
dysentery) 
Poisoning Amoebiasis  
Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing 
 No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No. (%) No.   (%) 
Sporadic 14 (51.9) 12 (44.4) 114 (43.3) 129 (49.1) 233 (73.5) 71(22.4) 60 (32.4) 107(57.9) 10 (100) 0 
Endemic 1(3.7) 20 (7.6) 13 (4.1) 18 (9.7) 0 
 
Table 5.1.11 Origine of infectious for each disease 
  typhoid  fever salmonellosis shigellosis poisoning  amoebic 
dysentery 
Total 
Known 
1 23 35 5 0 
64 
Unknown 13 82 156 55 6 312 
Missing 13 158 126 125 0 422 
Total 27 263 317 185 6 798 
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 Part V – “ Conclusion” 
The fifth part is the last part of the individual notification form; it contains the conclusions of the 
diagnosis (classification of the case) as a suspected or confirmed case.  
The ―confirmed cases‖ are over 60% of cases with diarrhea diseases, except the poisoning cases 
which in 57% of them are ―suspected‖.  The data of table 5.1.9 compared with the case 
classification data (table 5.1.12) represent a difference between the positivity of the case by 
appropriate laboratory tests and confirmation of diagnosis. 
 
Figure 5.1.12 Case classification for each disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Disease 
Confirmed Suspected Missing 
Total 
No. % No. % No. % 
Typhoid fever 18 66.7 3 11.1 6 22.2 27 
Salmonellosis (non-typhoid) 230 87.5 18 6.8 15 5.7 263 
Shigellosis (bacillary dysentery) 272 85.8 12 3.8 33 10.4 317 
Food borne intoxication 73 39.5 107 57.8 5 2.7 185 
Amoebiasis 10 100.0 0 0 0 0 10 
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5.2 Epidemiological characteristics of Viral hepatitis 
 
The 14/Sh Form of the statutory MDBSS (Major Diseases Based Epidemiological Surveillance 
System) contains along with the ―Unspecified viral hepatitis‖ and three basic types of viral 
hepatitis (Viral hepatitis A, Viral hepatitis B, Viral hepatitis nAnB) as well.   
Nevertheless, the following data belong to the ―Unspecified viral hepatitis‖, because of the 
impossibility (lack of diagnostic tests kits) of routine type identification by district 
microbiological laboratories. 
The table 5.2.1 shows of viral hepatitis cases (unspecified viral hepatitis, viral hepatitis A, Viral 
hepatitis B and Viral hepatitis nAnB) by monthly surveillance over the period 1998-2009 and by 
individual form from 2007 untill 2009.  
We have lack of information regarding to the basic types of viral hepatitis reported by monthly 
surveillance from 2002 and in continuous.  
During the years 2007-2009 are presented in the table only the number of cases reported by 
individual forms of hepatitis A, hepatitis B and hepatitis nAnB while we have lack of data by 
monthly reporting. 
The results obtained show significant differences in reporting of cases for each type of hepatitis versus the 
number of cases of unspecified hepatitis. 
As result of lack on viral hepatitis B data can not explain if the level of vaccination coverage 
have influenced on the reduction or increasing trend for this disease. 
  
5.2.1 Number of cases of viral hepatitis in Albania [reported by monthly reporting and by individual schedules ( )] 
Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Unspecified hepatitis 3489 4489 2489 1589 1734 1920 1430 1388 1699 1357(162) 1298 (145) 791(93) 
Viral hepatitis A 274 758 248 54 0 0 0 0 0 0 (41) 0 (97) 0 (76) 
Viral hepatitis B 54 40 63 62 0 0 0 0 0 0 (20) 0 (28) 0 (21) 
Viral hepatitis nAnB 262 411 168 55 0 0 0 0 0 0 (150) 0 (130) 0 (55) 
Vaccine coverage 
viral Hep.B (%) 
94.4 91.8 97.8 98.2 95.9 94.4 98.3 98.5 97.6 97.5 98.9 98.7 
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Figure 5.2.1The incidence rate of viral hepatitis over the study period (monthly surveillance) 
 
 
The available epidemiological surveillance data on viral hepatitis (especially unspecified 
hepatitis) present a detailed picture on disease occurrence as incidence rate (figure 5.2.1). In this 
period the annual incidence rate is characterized by decreasing trend. 
 
Table 5.2.2 Number of cases of viral hepatitis reported by monthly reporting form and individual schedules ( ) by region 
2007-2009 
Regions Unspecified 
hepatitis 
Viral hepatitis 
A 
Viral hepatitis 
B 
Viral hepatitis nANB 
Berat 140 (16) 0 (62) 0 (23) 0 (1) 
Diber 334 0 0 0 (53) 
Durres 346 0 0 0 
Elbasan 411 (1) 0 0 (10) 0 (270) 
Fier 281 0 0 0 
Gjirokaster 59 0 (26) 0 (5) 0 (6) 
Korce 377 0 0 0 
Lezhe 152 (104) 0 (1) 0 0 
Tirane 930 (232) 0 (108) 0 (14) 0 (1) 
Shkoder 174 0 0 0 
Kukes 112 0 0 0 
Vlore 130 (49) 0 (17) 0 (20) 0 (6) 
Total 3446 (403) 0 (213) 0 (72) 0 (237)* 
Just as in diarrhea disease and for viral hepatitis, the distribution by regions express great 
differences between the data reported by monthly reporting and individual notification (table 
5.2.2). In 53.3% of the regions is presented lack of information on the number of individual cases 
according to the notification form and in 46.7% of them the present cases number by individual 
notification and monthly reporting forms.
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Distribution of Unspecified Viral Hepatitis over the period 1998 – 2009 by region 
Country Mean Incidence (cases/100,000 population) and range 
 
Unspecified Viral Hepatitis 
 
65.4 (24.5 – 99.6) 
 
 
 
 
 
Dissertation 2011 
 
93 Elida MATA 
 
5.2.3 Number of cases of viral hepatitis over the period 1998-2009 by age - group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
    no .cases no .cases no .cases no .cases no .cases no .cases no .cases no .cases no .cases no .cases no .cases no .cases 
U
n
sp
ec
if
ie
d
 
h
ep
a
ti
ti
s 
0-4 810 1062 480 236 296 337 234 270 234 243 181 80 
5-14 1909 2686 1499 912 852 1086 754 679 752 649 678 348 
15-44 565 575 378 351 415 363 317 284 583 333 322 253 
45-59 151 120 101 66 136 98 86 109 106 98 93 99 
60 + 54 46 31 24 35 36 39 46 24 34 24 21 
                            
V
ir
a
l 
h
ep
a
ti
ti
s 
A
 0-4 89 192 55 9 0 0 0 0 0 0 0 0 
5-14 145 473 144 28 0 0 0 0 0 0 0 0 
15-44 28 73 37 11 0 0 0 0 0 0 0 0 
45-59 10 16 10 3 0 0 0 0 0 0 0 0 
60 + 2 4 2 3 0 0 0 0 0 0 0 0 
                            
V
ir
a
l 
h
ep
a
ti
ti
s 
B
 0-4 8 4 1 6 0 0 0 0 0 0 0 0 
5-14 11 22 24 24 0 0 0 0 0 0 0 0 
15-44 28 13 31 23 0 0 0 0 0 0 0 0 
45-59 7 1 4 7 0 0 0 0 0 0 0 0 
60 + 0 0 3 2 0 0 0 0 0 0 0 0 
                            
V
ir
a
l 
h
ep
a
ti
ti
s 
n
A
N
B
 
0-4 63 106 41 3 0 0 0 0 0 0 0 0 
5-14 144 252 92 27 0 0 0 0 0 0 0 0 
15-44 49 43 22 17 0 0 0 0 0 0 0 0 
45-59 4 4 10 7 0 0 0 0 0 0 0 0 
60 + 2 6 3 1 0 0 0 0 0 0 0 0 
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Figure 5.2.2The incidence rate of viral hepatitis over the period 1998-2009 by age-group 
 
Unspecified hepatitis 
 
Viral Hepatitis A 
 
Viral Hepatitis B 
 
Viral Hepatitis nA nB 
 
 
Pediatric age group (0-14 years) occupies the major burden of the disease, representing 45-54% 
of total annual cases (Table 5.2.3), followed by age group 15-44 years with 27 - 30% of total 
during the period 1998-2009 (in particular, viral hepatitis unspecified). The trend of unspecified 
viral hepatitis shows a decreased trend over this period. 
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Table 5.2.4 Number of cases of viral hepatitis over the period 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
    no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
U
n
sp
ec
if
ie
d
 
h
ep
a
ti
ti
s Total 3489 4489 2489 1589 1734 1920 1430 1388 1699 1357 1298 791 
Urban 1840 2350 1150 731 809 933 591 711 1003 636 602 325 
Rural 1649 2139 1339 858 925 987 839 677 696 721 696 466 
  
                          
V
ir
a
l 
h
ep
a
ti
ti
s 
A
 
Total 274 758 248 54 0 0 0 0 0 0 0 0 
Urban 95 391 131 32 0 0 0 0 0 0 0 0 
Rural 179 367 117 22 0 0 0 0 0 0 0 0 
                            
V
ir
a
l 
H
ep
a
ti
ti
s 
B
 
Total 54 40 63 62 0 0 0 0 0 0 0 0 
Urban 1 2 2 2 0 0 0 0 0 0 0 0 
Rural 36 21 35 32 0 0 0 0 0 0 0 0 
                            
V
ir
a
l 
h
ep
a
ti
ti
s 
n
A
n
B
 Total 262 411 168 55 0 0 0 0 0 0 0 0 
Urban 59 98 69 20 0 0 0 0 0 0 0 0 
Rural 203 313 99 35 0 0 0 0 0 0 0 0 
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Figure 5.2.3The incidence rates of viral hepatitis over the period 1998-2009 by residence 
Unspecified hepatitis 
Viral Hepatitis A 
Viral Hepatitis B 
 
Viral Hepatitis nAnB 
 
 
 
Urban areas show a disease occurrence of around 1.3 times higher than rural areas for 
unspecified viral hepatitis during our study period.The incidence rates of viral hepatitis shows a 
decreasing trend from year to year.
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Table 5.2.5 Number of cases of viral hepatitis over the period 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
U
n
sp
ec
if
ie
d
 
h
ep
a
ti
ti
s Total 3489 4489 2489 1589 1734 1920 1430 1388 1699 1357 1298 791 
Male 1872 2404 1333 863 956 1060 764 733 950 718 697 428 
Female 1617 2085 1156 726 778 860 666 655 749 639 601 363 
  
                          
V
ir
a
l 
h
ep
a
ti
ti
s 
A
 
Total 274 758 248 54 0 0 0 0 0 0 0 0 
Male 144 401 147 32 0 0 0 0 0 0 0 0 
Female 130 357 101 22 0 0 0 0 0 0 0 0 
                            
V
ir
a
l 
h
ep
a
ti
ti
s 
B
 
Total 54 40 63 62 0 0 0 0 0 0 0 0 
Male 39 21 34 33 0 0 0 0 0 0 0 0 
Female 15 19 29 29 0 0 0 0 0 0 0 0 
                            
V
ir
a
l 
h
ep
a
ti
ti
s 
n
A
n
B
 Total 262 411 168 55 0 0 0 0 0 0 0 0 
Male 145 226 84 34 0 0 0 0 0 0 0 0 
Female 117 185 84 21 0 0 0 0 0 0 0 0 
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Figure 5.2.4 the incidence rates of viral hepatitis over the period 1998-2009 by gender 
Unspecified hepatitis 
Viral Hepatitis A 
Viral Hepatitis B 
 
Viral Hepatitis nAnB 
 
The incidence rate of unspecified viral hepatitis by gender presented in figure 5.2.4 show a 
decreasing trend and also, was no differences between male and female incidence rate over study 
period. Regarding the viral hepatitis A, viral hepatitis B and viral hepatitis nAnB (or viral 
hepatitis C) tregohet decreasing trend over the period 1998-2001, but distribution by gender of 
the incidence rate for viral hepatitis C is higher in female. 
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Individual notification schedul for viral hepatitis  
 Part I – “General information”     
The patient's general information mainly "father's name" is "missing‖ in 23, 6 % for viral hepatitis B, 19.5% for viral hepatitis A and 
unspecified hepatitis and 16% for viral hetatits nAnB, (see 5.2.6). The average age groups most vulnerable to viral hepatitis reported 
by individual forms are: 18.5 years old in range (0-78) for unspecified viral hepatitis; 14.1 years old in range (0-87) for viral hepatitis 
A; 33.1 years old in range (50-70) for viral hepatitis B and 15.8 years old in range (0-78) for viral hepatitis C (nAnB). 
Table 5.2.6 Percentage of the general information data from the individual form 
 Unspecified hepatitis Viral hepatitis A Viral hepatitis B Viral hepatitis nA nB 
Yes Missing Yes Missing Yes Missing Yes Missing 
No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) 
Father's name 324 (80.6) 78 (19.4) 172 (80.4) 42 (19.6) 55 (76.4) 17 (23.6) 283 (84) 154 (16) 
Gender 402 (100) 0 214 (100) 0 72 (100) 0 337 (100) 0 
Age 338 (84.1) 64 (15.9) 198 (92.5) 16 (7.5) 70 (97.2) 2 (2.8) 328 (97.3) 9 (2.7) 
Profession 402 (100) 0 214 (100) 0 72 (100) 0 337 (100) 0 
Address 349 (86.8) 53 (13.2) 200 (93.5) 14 (6.5) 71 (98.6) 1(1.4) 324 (96.1) 13 (5.9) 
 
 Part II – “History of disease” 
Table 5.2.7The data of disease history 
 Unspecified hepatitis Viral hepatitis A Viral hepatitis B Viral hepatitis nA nB 
Yes Missing Yes Missing Yes Missing Yes Missing 
No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) 
Date of onset 402 (100) 0 214 (100) 0 72 (100) 0 337 (100) 0 
Hospitalized 391 (97.3) 11 (2.7) 213 (99.5) 1 (0.5) 72 (100) 0 337 (100) 0 
Vaccination 141 (35.1) 261 (64.9) 0 0 23 (31.9) 49 (68.1) 0 0 
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Table 5.2.8 Percentage of the disease prognosis for each disease 
Disease Cured Deceased Missing Total 
No. % No. % No. % 
Unspecified hepatitis 292 72.6 1 0.2 109 27.1 402 
Viral hepatitis A 144 67.3 0 0 70 32.7 214 
Viral hepatitis B 34 47.2 2 2.8 36 50.0 72 
Viral hepatitis nA  nB 298 88.4 0 0 39 11.6 337 
 
Table 5.2.7 and 5.2.8 present the second part of the individual form of notification as: history and 
prognosis of the disease. In 35.1% of individual forms is completed on vaccination against 
hepatitis unspecified instead of viral hepatitis B; in 61.8% of the individual forms is lack of 
information on vaccination against hep.B and lack of information on disease prognosis ranging 
from11.6% for viral hepatitis nAnB to 50% for hepatitis B (see table 5.2.8). 
 
 Part III – “Laboratory diagnosis” 
 
Based on the criteria for confirming the diagnosis of viral hepatitis are outlined clinical and 
serological examinations. The obtained results by statistical analysis of individual notification 
forms show that the highest percentage of positivity confirmation is performed by direct 
examination and some of cases present postivity confirmation by culture examination. These 
examinations are not applicable for viral hepatitis.  
Table 5.2.9 the laboratory examinations for each disease 
Disease  Direct Culture Serology 
No.   (%) No.   (%) No.   (%) 
Unspecified 
hepatitis   no = 402 
Positive 252 (62.7) not applicable 0  -  93 (23.1) 
negative 18 (4.5) 0 92 (22.9) 
Missing 132 (32.8) 402 (100) 217 (54) 
     
Viral hepatitis A                
no = 214 
Positive 84 (39.3) not applicable 3 (1.4) - not applicable 93 (43.5) 
negative 15 (7) 0 25 (11.7) 
Missing 115 (55.7) 210 (98.6) 98 (45.8) 
     
Viral hepatitis B  
no = 72 
Positive 19 (26.4) not applicable 0 -  45 (62.5) 
negative 1(1.4) 0 3 (4.2) 
Missing 52 (72.2) 72 (100) 24 (33.3) 
     
Viral hepatitis  
nA nB no = 337 
Positive 272 (80.7) not aplicable 2 (0.6) - not applicable 4 (1.2) 
negative 13 (3.9) 0 3 (0.9) 
Missing 52 (15.4) 335 (99.4) 330 (97.9) 
*Not applicable – means wrong laboratory examination 
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 Part IV – “Epidemiological investigation” 
 
The data tables 5.2.10 and 5.2.11 show the nature of the outbreak of infection during the period 2007-2009 which is "missing" in: 
55.3% for unspecified hepatitis, 28.9% for viral hepatitis A,  23.6% for viral hepatitis B and for viral hepatitis nAnB is in 31. % . 
While on the origin of the infection in 62.2% of unspecified hepatitis is "unknown" and in 35.6% of them is "missing"; for viral 
hepatitis A is about 67.8% "unknown" and in 13.1% of cases is "missing‖; origin of hepatitis B viral infection is "unknown" about 
73.6% of cases and is “missiing” in 23.6% of them and for viral hepatitis nAnB is "unknown" about 82.2% of cases and "missing" 
in 17.2%. 
 
Table 5.2.10 the outbreak nature of disease   
 Unspecified hepatitis Viral hepatitis A Viral hepatitis B Viral hepatitis nA nB 
 Yes Missing Yes Missing Yes Missing Yes Missing 
 No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) No.   (%) 
Sporadic 187 (46.5) 182 (55.3) 117 (54.7) 62 (28.9) 53 (73.6) 17 (23.6) 108 (32) 106 (31.5) 
Endemic 33 (8.2) 35 (16.4) 2 (2.8) 123 (36.5) 
 
Table 5.2.11 Origine of infectious for each disease 
  unspecified 
hepatitis 
viral hepatitis A viral hepatitis B viral hepatitis nA nB 
Known 9 41 2 2 
Unknown 250 145 53 277 
Missing 143 28 17 58 
Total 402 214 72 337 
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 Part V – “Conclusion” 
Individual form of notification for viral hepatitis contains the same elements (parts) as individual 
form of notification for diarrhea diseases. 
Although, the positivity and negativity are not confirmed by relevant laboratoritical tests (see 
table 5.2.9), our results show that the highest percentage of viral hepatitis diagnosis in general is 
"confirmed‖. 
 
Table 5.2.12 Case classification for each disease 
 
Disease 
Confirmed Suspected Missing Total 
No. % No. % No. % 
Unspecified hepatitis 
320 79.6 35 8.7 47 11.7 402 
Viral hepatitis A 
176 82.2 19 8.9 19 8.9 214 
Viral hepatitis B 
61 84.7 4 5.6 7 9.7 72 
Viral hepatitis nA  nB 
295 87.5 19 5.6 23 6.8 337 
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5.3 Epidemiological characteristics of zoonoses 
Zoonotic diseases are another infectious diseases group included in infectious diseases surveillance system.  Monthly reporting data 
are based on notified cases by individual form of notification. Zoonotic diseases are included in the individual form  of notification 
called 14-2/Sh. Table 5.3.1 shows the number of cases of zoonotic diseases through monthly reporting for the period 1998-2009 and 
the notified cases number  for the years 2007-2009 which are expressed by ( ). 
Numbers of cases reported by both of forms (monthly and individual forms) show the difference between them. Also, important is that 
during 2007-2009 the cases number of visceral leishmanies by individual form is higher than the cases number reported by the 
monthly form. 
 
Table 5.3.1 Number of cases of zoonosis in Albania [by monthly reporting and individual schedules ( )] 
Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Anthrax 95 64 62 56 52 47 36 47 32 32 (16) 40 (11) 28 (2) 
Brucellosis 523 458 519 695 937 970 1139 1015 879 846 (451) 620 (244) 479 (168) 
Coetaneous 
leishmaniasis 
149 88 91 142 129 118 95 67 58 64 30 (1) 40  
Visceral leishmaniasis 9 18 12 20 11 11 16 3 3 7 (44) 2 (16) 1(16) 
Leptospirosis 7 9 6 4 16 16 13 7 12 12(4) 6 (3) 21(6) 
Extra-pulmonary 
tuberculosis 
56 50 34 53 52 71 90 49 30 32 (7) 30 (10) 32 (6) 
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Figure 5.3.1The incidence rate of zoonosis over the period 1998 – 2009 in Albania 
 
 
 
The occurrence of zoonoses such as anthrax, leishmaniasis, leptospirozis and extra-pulmonary 
tuberculosis during the period 1998-2009 was characterized by a tendency more or less stable in 
decreasing trend. The highest level of incidence rate is shown for brucellosis, with a high peak in 
year‘s 2004.
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Table 5.3.2 Number of zoonoses cases reported by monthly and individual forms ( ) by region during the years 2007-2009 
 Regions Anthrax Brucellosis Coetaneous 
leishmaniasis 
Visceral 
leishmaniasis 
Leptospirosis Extra-pulmonary 
tuberculosis 
Berat 0 91 (27) 0 18 (17) 4 1 
Diber 1 71 (49) 0 13 0 22 (23) 
Durres 0 20 (11) 0 1 4 4 
Elbasan 3 (4) 170 (57) 0 11 (8) 3 (2) 7 
Fier 6 255 (127) 3 3 (2) 8 (1) 27 
Gjirokaster 26 (9) 274 (127) 1 (1) 8 (4) 0 1 
Korce 9 467 (233) 10 134 39 9 
Kukes 2 38 (42) 0 2 (3) 0 2 
Lezhe 0 3 (1) 0 16 (10) 2 (1) 2 
Tirane 5 (4) 42 (16) 6 28 (29) 16 (9) 0 
Vlore 48 (12) 499 (235) 0 7 (4) 0 5 
Shkoder 0 15 0 27 2 14 
Total  99 (29) 1945 (869) 20 (1) 268 (77) 78 (13) 94 (23) 
 
 
Distributions of zoonoses by region express inconsistency of data between monthly reporting and individual notification (which must 
be equal). Some of regions present number of notified cases more than the monthly reported data as: the region of Tirana for visceral 
leishmaniasis; Elbasan region for anthrax; Kukes region for brucellosis and visceral leishmaniasis and Diber region for extra-
pulmonary tuberculosis. Also, the table presents the lack of notified cases reported by the individual forms of notification 
(table 5.3.2).  
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Country Mean Incidence (cases/100,000 population) and range 
              Anthrax                                                                                  Brucellosis                                                                               
        2.7 (6.5 – 18.3)                                                                             32.8 (0.7 – 123.7)                                                                  
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     Coetaneous leishmaniasis                                                              Visceral leishmaniasis 
        0.3 (0.2 – 0.6)                                                                                  3.4 (0.2 – 7.7) 
                           
 
 
                                                                                    
 
 
 
 
 
 
         Leptospirosis  
        0.3  (0 – 0.6)                                    
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         Leptospirosis                                                                                TBC extra pulmonary 
            0.3 (0 – 0.6)                                                                                              1.5 (0.1 – 6.5)    
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Table 5.3.3 the number of zoonoses cases over the period 1998-2009 by age-group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
n
th
ra
x
 0-4 0 0 0 0 0 0 0 0 0 0 0 0 
5-14 13 3 5 3 3 3 3 3 1 1 3 1 
15-44 47 36 27 30 18 21 18 17 11 14 16 15 
45-59 30 21 23 21 23 22 13 23 18 13 18 9 
60 + 5 4 7 2 8 1 2 4 2 4 3 3 
                            
B
ru
ce
ll
o
si
s 0-4 6 2 2 4 3 8 7 8 5 7 8 6 
5-14 26 30 37 52 69 61 104 87 68 68 48 40 
15-44 339 287 313 367 486 520 588 454 425 394 283 226 
45-59 131 123 145 224 286 308 342 361 310 294 217 164 
60 + 21 16 22 48 93 73 98 105 71 83 64 43 
                            
C
o
et
a
n
eo
u
s 
le
is
h
m
a
n
ia
si
s 
0-4 5 7 5 7 6 4 13   2 1   1 
5-14 0 5 5 7 4 3 0 0 0 3 1 0 
15-44 3 5 1 4 1 4 3 3 0 3 0 0 
45-59 1 0 0 2 0 0 0 0 1 0 0 0 
60 + 0 1 1 0 0 0 0 0 0 0 1 0 
                            
V
is
ce
ra
l 
le
is
h
m
a
n
ia
si
s 
0-4 114 69 63 92 81 75 64 43 9 41 18 21 
5-14 13 13 16 40 37 20 22 16 42 13 7 8 
15-44 14 6 7 8 9 15 4 5 5 4 4 9 
45-59 7   4 1 2 4 1 1 2 3 1 1 
60 + 1 0 1 1 0 4 4 2 0 3 0 1 
                            
L
ep
to
sp
ir
o
si
s 
0-4 1 0 0 0 0 0 0 0 0 0 0 0 
5-14 0 0 0 0 2 1 0 1 0 0 0 0 
15-44 6 3 4 3 2 7 4 4 6 8 2 8 
45-59 6 2 1 10 6 7 2 6 4 3 11   
60 + 0 0 0 0 2 2 2 0 0 0 1 2 
                            
E
x
tr
a
-
p
u
lm
o
n
a
ry
 
tu
b
er
cu
lo
si
s 0-4 3 1 1 3 1 3 2 0 1 1 0 1 
5-14 5 6 7 3 7 6 13 2 0 1 1 2 
15-44 20 23 14 27 18 33 27 13 9 13 13 10 
45-59 19 12 8 11 15 20 30 18 16 13 11 8 
60 + 9 8 4 9 11 9 18 16 4 4 5 11 
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Figure 5.3.2The incidence rates of zoonoses over the period 1998-2009 by age - group 
Anthrax
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Visceral leishmaniasis
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Leptospirosis 
 
Extra-pulmonary tuberculosis 
 
Most affected by anthrax, brucellosis, leptospirosis and extra-pulmonary tuberculosis are age 
groups over 15 years. Regarding of visceral and coetaneous leishmaniasis, most affected is the 
pediatric age group 0-4 years (table 5.3.3 & figure 5.3.2), which occupies the major burden for 
visceral and coutaneous leishmaniasis whith around 60-65% of reported cases. 
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Table 5.3.4 the number of zoonosis cases over the period 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
n
th
ra
x
 Total 95 64 62 56 52 47 36 47 32 32 40 28 
Male 70 44 38 36 37 37 23 29 22 25 29 20 
Female 25 20 24 20 15 10 13 18 10 7 11 8 
  
                          
B
ru
ce
ll
o
si
s Total 523 458 519 695 937 970 1139 1015 879 846 620 479 
Male 404 349 352 446 606 652 784 705 643 580 425 342 
Female 119 109 167 249 331 318 355 310 236 266 195 137 
                            
C
o
et
a
n
eo
u
s 
le
is
h
m
a
n
ia
si
s Total 9 18 12 20 11 11 16 3 3 7 2 1 
Male 6 12 7 9 6 2 10 3 1 4 1 1 
Female 3 6 5 11 5 9 6 0 2 3 1 0 
                            
V
is
ce
ra
l 
le
is
h
m
a
n
ia
si
s 
Total 149 88 91 142 129 118 95 67 58 64 30 40 
Male 90 46 61 93 76 70 52 40 31 30 19 24 
Female 59 42 30 49 53 48 43 27 27 34 11 16 
                            
L
ep
to
sp
ir
o
si
s 
Total 7 9 6 4 16 16 13 7 12 12 6 21 
Male 6 9 6 4 12 13 11 4 11 11 5 19 
Female 1 0 0 0 4 3 2 3 1 1 1 2 
                            
E
x
tr
a
-
p
u
lm
o
n
a
ry
 
tu
b
er
cu
lo
si
s Total 56 50 34 53 52 71 90 49 30 32 30 32 
Male 19 23 11 25 26 38 49 28 13 12 12 15 
Female 37 27 23 28 26 33 41 21 17 20 18 17 
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Figure 5.3.3The incidence rate of zoonoses over the period 1998-2009 by gender 
Anthrax 
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Coetaneous leishmaniasis 
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Leptospirosis 
Extra-pulmonary tuberculosis 
 
 
One factor in the development of zoonotic diseases is a professional nature. 
Table 5.3.4 and Figure 5.3.3 show the frequencies (number of cases) and incidence 
(case/100.000 population) for this group of diseases. Although, the trend is decreased, the major 
burden occupy by male in 66.3% of cases, as well as the brucellosis disease show higher 
incidence rate than others diseases of this group. 
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 Table 5.3.5 Number of zoonotic diseases cases over the period 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
n
th
ra
x
 Total 95 64 62 56 52 47 36 47 32 32 40 28 
Urban 8 1 14 11 4 5 4 4 6 5 8 8 
Rural 87 63 48 45 48 42 32 43 26 27 32 20 
  
                          
B
ru
ce
ll
o
si
s Total 523 458 519 695 937 970 1139 1015 879 846 620 479 
Urban 78 53 96 142 123 176 176 125 123 358 91 247 
Rural 445 405 423 553 814 794 963 890 756 488 529 232 
                            
C
o
et
a
n
eo
u
s 
le
is
h
m
a
n
ia
si
s Total 9 18 12 20 11 11 16 3 3 7 2 1 
Urban 2 11 6 8 7 6 10 3 1 4 2 1 
Rural 7 7 6 12 4 5 6 0 2 3 0 0 
                            
V
is
ce
ra
l 
le
is
h
m
a
n
ia
si
s 
Total 146 88 91 142 129 118 95 67 58 64 30 40 
Urban 54 33 32 53 59 49 35 21 21 35 13 14 
Rural 92 55 59 89 70 69 60 46 37 29 17 26 
                            
L
ep
to
sp
ir
o
si
s 
Total 7 9 6 4 16 16 13 7 12 12 6 21 
Urban 4 5 0 3 10 6 7 2 4 7 2 9 
Rural 3 4 6 1 6 10 6 5 8 5 4 12 
                            
E
x
tr
a
-
p
u
lm
o
n
a
ry
 
tu
b
er
cu
lo
si
s Total 56 50 34 53 52 71 90 49 30 32 30 32 
Urban 30 21 13 27 33 32 37 19 12 15 11 12 
Rural 26 29 21 26 19 39 53 30 18 17 19 20 
 
 
Dissertation 2011 
 
116 Elida MATA 
 
Figure 5.3.4The incidence rate of zoonotic diseases over the period 1998-2009 by residence 
Anthrax 
Brucellosis 
Coetaneous leishmaniasis 
Visceral leishmaniasis 
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Leptospirosis 
 
Extra-pulmonary tuberculosis 
 
 
The zoonotic diseases cases have been recorded not only in rural areas, but also in urban ones.  
Still, the vast majority of reported cases (> 90%) pertain to rural areas and recently to suburban 
ones as well. 
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Individual notification schedul for zoonotic diseases  
In general, individual forms of notification of zoonotic disease present the general information indicators about the patients (patient‘s 
generalities). From these forms result that the average age group affected by each zoonotic disease is: 43.5 years old in range (10-87) 
for anthrax; 39.1 years old in range (1-81) for brucellosis; 8.1 years old in range (0-77) for visceral leishmaniasis; 39 years old in 
range (16-64) for leptospirosis and 48.5 years old in range (18-79) for extra-pulmonary tuberculosis. 
 
 Part I – “General information”   
Table 5.3.6 Percentage of the general information data from the individual form 
  
  
  
Anthrax Brucellosis Coetaneous 
leishmaniasis 
Visceral leishmaniasis Leptospirosis Extrapulmonary   
TBC 
Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing 
No.   (%) No.   (%) No.   (%) No.   (%) No.(%) No. (%) No.(%) No.  (%) No.  (%) No.  (%) No. (%) No. (%) 
Father's name  24 (82.8)  5 (17.2)  713(82)  156 (18)  0  1(100)  73 (94.8)  4 (5.2)  7 (53.8)  6 (46.2)  22 (95.7)  1(4.3%) 
Gender  29 (100)  0  869 (100)  0  1(100)  0  77 (100)  0 13 (100)  0  23 (100)  0 
Age  29 (100)  0  862 (99.2) 7 (0.8)  1(100) 0   75 (97.4) 2 (2.6) 13 (100)  0  23 (100)  0 
Profession  29 (100)  0  869 (100)  0  1(100)  0  77 (100)  0 13 (100)  0  23 (100)  0 
Address  28 (96.6)  1(3.4)  838 (96.4)  31(3.6)  1(100) 0   66 (85.7)  11 (14.3)  9 (69.2)  4 (30.8)  18 (78.3)  5 (21.7%) 
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 Part II – “ History of disease” 
 
Tables 5.3.7 and 5.3.8 represent indicators of part II of the notification form of case. 
Onset of illness and hospitalization in the highest percentage are completed, while on the prognosis of the disease in each of them 
result ―missing‖ in 51.7% of anthrax forms; in 43.3% of brucellosis forms and in 34.8% of extra-pulmorary tuberculosis forms (not 
known if the patients were cured or died). 
 
Table 5.3.7 The data of the disease history  
  
  
  
Anthrax Brucellosis Coetaneous 
leishmaniasis 
Visceral leishmaniasis Leptospirosis Extrapulmonary 
tuberculosis 
Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing 
No.  (%) No.  (%) No.  (%) No.  (%) No.  (%) No. (%) No.  (%) No. (%) No. (%) No. (%) No. (%) No.   (%) 
Date of onset  28 (96.6)  1(3.4)  832 (95.7)  37 (4.3)  1 (100)  0  74 (96.1)  3 (3.9)  13 (100)  0  22 (95.7)  1 (4.3) 
Hospitalized  29 (100)  0  834 (96)  35 (4)  1 (100)  0  76 (98.7)  1(1.3)  13 (100)  0  23 (100)  0 
 
Table 5.3.8 Percentage of the disease prognosis for each disease 
Disease Cured Deceased Missing Total 
No. % No. % No. % 
Anthrax 14 48.3 0 0 15 51.7 29 
Brucellosis 493 56.7 0 0 376 43.3 869 
Coetaneous leishmaniasis 0 0.0 0 0 1 100.0 1 
Visceral leishmaniasis 65 84.4 0 0 12 15.6 77 
Leptospirosis 12 92.3 1 7.7 0 0.0 13 
Extra pulmonary tuberculosis 15 65.2 0 0 8 34.8 23 
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 Part III – “Laboratory diagnosis” 
For each zoonotic diseases have different laboratory examination. The table 5.3.9 show how are 
confirmed these diagnosis.  
Anthrax is confirmed by clinic, direct and cultura examination. In individual notification 
schedule there is not the rubric of clinical examination. In 51.7% of cases the laboratory 
confirmation (direct examination) for anthrax ―missing‖, and 79.3% of them ―missing‖ with 
cultur examination. 
Brucellosis – laboratory confirmation of brucellosis is carried out by clinical and serological 
examination. Results obtained show that 3% of confirmed cases is directly and 0.5% is cultur 
examination. In 25.2% of cases of brucellosis we have "missing" for serology examination. 
Viscral and coetaneous leishmaniasis is confirmed by clinical and direct examination.  
66.2% of cases of visceral Leishmania show "missing" on the laboratory examination 
(direct examination), even to the case of leishmaniasis coutaneous laboratory examination is 
not performed (100% "missing"). 
In 10.4% (positive and negative) of cases indicates that confirmation is done with serology 
(wrong). 
Inadequate confirmation is and for leptospirosis which is confirmed by clinical and serology 
examination. Our data presented in table 5.3.9 show that in 69.2% of cases we have ―missing‖ 
for serology examination and in 23.1% of them the leptospirosis is confirmed by direct 
examination (wrong). 
Laboratory confirmation for extra-pulmonary tuberculosis presents "missing" for all given 
cases. 
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Table 5.3.9 Percentage of the laboratory examinations for each disease 
Disease  Direct Culture Serology 
No.   (%) No.   (%) No.   (%) 
Anthrax           
N = 29 
Positive 12 (41.4) 4 (13.8) 0 - not applicable 
negative 2 (6.9) 2 (6.9) 2 (6.9) 
Missing 15 (51.7) 23 (79.3) 27 (93.1) 
     
Brucellosis 
 N = 869 
Positive 26 (3) - not applicable 4 (0.5) - not applicable 644 (74.1) 
negative 0 0 6 (0.7) 
Missing 843 (97)  865 (99.5) 219 (25.2) 
     
Coetaneous leishmaniasis  
N = 1 
Positive 0 0 - not applicable 0 - not applicable 
negative 0 0 0 
Missing 1 (100) 1 (100) 1(100) 
     
Visceral leishmaniasis  
N = 77 
Positive 25 (32.5) 0 - not applicable 6 (7.8) - not applicable 
negative 1 (1.3) 0 2 (2.6) 
Missing 51 (66.2) 77 (100) 69 (89.6) 
     
Leptospirosis  
N = 13 
Positive 3 (23.1) - not applicable 0 - not applicable 4 (30.8) 
negative 0 0 0 
Missing 10 (76.9)  13 (100) 9 (69.2) 
     
Extrapulmonary 
tuberculosis  
N = 23 
Positive 0 0 1 (4.3) 
negative 7 (39.4) 0 0 
Missing 16 (60.6) 23 (100) 22 (95.7) 
*Not applicable – means wrong laboratory examination
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 Part IV – “Epidemiological investigation” 
In general the indicators of epidemiological investigation are completed except leptospirosis which in 30.8% of forms is ―missing‖ 
followed by anthrax (17.2% of them) and brucellosis (12.2 %of them). Regarding the origin of the infection which has caused it 
represents "unknown" and"missing for each disease (see table 5.3.11). 
 
Table 5.3.10 Percentage of outbreak nature for each disease 
  
  
  
Antrax Brucellosis Coetaneous 
leishmaniasis 
Visceral leishmaniasis Leptospirosis Extrapulmonary 
tuberculosis 
Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing Yes Missing 
No.  (%) No. (%) No. (%) No. (%) No. (%) No. %) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
Sporadic  18 (62.1%) 5 (17.2)  529 (60.9)  193 (12.2) 
  
 1(100) 0   59 (76.6) 15 (19.5) 
 
 9 (69.2) 4 (30.8) 
 
 16 (69.6) 1 (4.3) 
Endemic  6 (20.7%)  147 (16.9)  0  3 (3.9)  0  6 (26.1) 
 
 
Table 5.3.11 Origine of infectious for each disease 
  Anthrax Brucellosis Coetaneous 
leishmaniasis 
Visceral 
leishmaniasis 
Leptospirosis Extra - pulmonary 
tuberculosis 
Total 
Known 16 467 0 10 0 0 493 
unknown 2 169 0 43 8 0 222 
missing 11 233 1 24 5 23 297 
Total 29 869 1 77 13 23  
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 Part V – “Final Diagnosis” 
In total, the diagnosis was confirmed in 754 patients compared to 655 positive results by 
serology examinations (see table 5.3.9); in 18.1% of cases the case classification is ―missing‖. 
 
Table 5.3.12 Percentage of case classification for each disease 
Disease Confirmed Suspected Missing Total 
No. % No. % No. % 
anthrax 16 55.2 7 24.1 6 20.7 29 
brucellosis 659 75.8 44 5.1 166 19.1 869 
coetaneous leishmaniasis 0 0.0 1 100.0 0 0.0 1 
visceral leishmaniasis 57 74.0 14 18.2 6 7.8 77 
leptospirosis 8 61.5 4 30.8 1 7.7 13 
extra pulmonary tuberculosis 14 60.9 5 21.7 4 17.4 23 
 
Occupation is the most important factors in zoonotic infections. Table 5.3.13 shows that 61.4% of 
patients were farmers more likely to be sick than officials, 84.4% more than workers, and 60.3% 
more than the unemployed. 
Also, in 61.3% of cases (1267 cases out of 2068) is completed in the individual forms the answer 
"no" for profession. 
 
Table.5.3.13 Occupational indicator 
  Yes No OR  95%CI p 
Official 204 810 1 <0.01 
Worker 60 108   2.2  (1.5 - 3.1) <0.01 
Unemployed 213 330    2.6   (2.0 - 3.2) <0.01 
Farmer 324 19       67.7   (41.6 - 110.2) <0.01 
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5.4 Epidemiological characteristics of the pulmonary tuberculosis (TB) 
Chapter 2.4 has dealt the qualitative and quantitative deficiencies of the existing monthly reporting form (14/Sh). 
Tubercular diseases in this form are reported only as tuberculous (010). Reporting is done each year, only under this label, 
creating gaps in the knowledge of frequency of other tuberculosis forms of tuberculosis. 
It is known that extrapulmonary form of tuberculosis is zoonotic nature (mainly human infection from bovine tuberculosis). 
Individual form of notification for tuberculosis is different with other infectious diseases forms (14-3/Sh). The table 5.4.1 shows gaps 
between the number of reported cases by individual form and reported cases by monthly reporting during the periof 2007-2009, also 
the number of cases is almost a same in all study period. 
 
Table 5.4.1 Number of pulmonary tuberculosis cases in Albania [by monthly reporting and by individual schedules ( )] 
Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Pulmonary   
TBC 
281 271 212 236 223 263 208 239 230 220 (149) 252 (150) 234(117) 
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Figure 5.4.1 The incidence rate of pulmonary tuberculosis over the period 1998-2009 in Albania 
 
 
 
The above data are based on mandatory reporting by the monthly form of (14/Sh), 
summary of infectious diseases which is sent rhythmically from each epidemiological service of 
the district to IPH.  Compared with the data sent to the hospital rateve number 
of pulmonary diseases reported in the institute of public health are lower. The occurrence levels 
of tuberculosis in Albania have remained nearly constant over the study period. The annual 
incident cases vary in a range from 208 to 281 ones, with an incidence rate that vary from 6.67 to 
9.2 cases/100.000 population. As seen, the figure 5.4.1 shows  little oscillations of trend. 
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Table 5.4.2 Number of cases of pylmonary tuberculosis by monthly and individual form ( ) by regions during the 
years 2007-2009 
Regions Number cases reported by monthly form and individual 
form ( ) for Pulmonary tuberculosis  
Berat 6 
Diber 54 (32) 
Durres 50 (54) 
Elbasan 51 
Fier 66 (1) 
Gjirokaster 3 
Korce 22 
Lezhe 45 (42) 
Tirane 291 (249) 
Shkoder 70 
Kukes 13 
Vlore 35 (39) 
 
 
The table 5.4.2 shows that 5 out of 12 regions of the country have not completed the 
individual notification form for pulmonary tuberculosis. Also, the regions of 
Durres and Vlora have more notified cases to those reported at the Institute of Public Health by 
monthly reporting form.   
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Distribution of Pulmonary TBC over the period 1998 – 2009 by region 
Country Mean Incidence (cases/100,000 population) and range 
Pulmonary TBC 
7.0 (1.0 – 15.8) 
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Table 5.4.3 Number of  pulmonary tuberculosis cases over the period 1998-2009 by age - group 
Disease 
  
  1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
P
u
lm
o
n
a
ry
 
tu
b
er
cu
lo
si
s 0-4 5 3 2 5 2 9 9 5 8 3 1 2 
5-14 18 15 26 13 22 14 10 19 7 11 13 4 
15-44 146 141 93 110 108 129 85 79 101 89 124 109 
45-59 72 68 55 67 48 60 67 73 61 65 64 67 
60 + 40 44 36 41 43 51 37 63 53 52 50 52 
 
 
Figure 5.4.2 The incidence rate of pulmonary tuberculosis over the period 1998-2009 by age - group 
 
 
 
 
The major burden is occupied from the adult age group (25 and older). Specifically, age 15-44 years represent 45.8% of cases, 45-59 
years about 26.7 % of them and  60+ years old represent 19.6 % of cases with pylmonary tuberculosis over the our study period (see 
table 5.4.3). The incidence rate shows oscillations of trend for all age groups. The higher incidence rate is for age 60+ followed by 45 -
59 years and 15 – 44 years old.
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Table 5.4.4 Number of pulmonary tuberculosis cases over the period 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
P
u
lm
o
n
a
ry
 
tu
b
er
cu
lo
si
s Total 281 271 212 236 223 263 208 239 230 220 252 234 
Urban 153 137 111 165 100 130 107 132 152 134 147 214 
Rural 128 134 101 71 123 133 101 107 78 86 105 20 
 
 
Figure 5.4.3 The incidence rate of pulmonary tuberculosis over the period 1998-2009 by residence 
 
 
 
 
Regarding the distribution by areas of the pulmonary tuberculosis (cases number and the incidence rate) in 58.6% of cases are of urban 
areas (see figure 5.4.4), and the figure 5.4.3 represent increasing trend for urban cases and decreasing trend for rural cases.   
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Table 5.4.5 Number of pulmonary tuberculosis cases over the period 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
P
u
lm
o
n
a
ry
 
tu
b
er
cu
lo
si
s Total 281 271 212 236 223 263 208 239 230 220 252 234 
Male 174 179 130 139 136 169 131 172 153 146 154 146 
Female 107 92 82 97 87 94 77 67 77 74 98 88 
 
 
Figure 5.4.4 The incidence rate of pulmonary tuberculosis over the period 1998-2009 by gender 
 
 
 
Distribution by gender shows that the highest incidence rate and the number of cases are males; expressed in percentage they 
constitute 63.2% of cases of pulmonary tuberculosis. The ratio male / female is 1.7/1.5 respectively see table 5.4.5 and figure 5.4.4. 
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Individual notification schedul of pulmonary diseases.  
Individual form of pulmonary tuberculosis notification contains three parts. 
Part I - Vital records on the case and the onset of the diseases 
Part II - Clinical and epidemiological investigation 
Part III - Microbiological laboratory diagnosis data 
 
Part I – “Vital records on the case and the onset of the diseases”  
The difference between the date of onset of symptoms and hospital admission date and date 
of hospitalization and date of starting of therapy was calculated as follows: 
Time lag (days):   median & range 
 Date of onset    to   Date of hospital admission     12  (0 – 160) 
             Kolmogorov-Smirnov test for Normal distribution P<0001- Normality rejected 
 Date of hospital admission to Date of starting therapy    0  (0   – 66) 
             Kolmogorov-Smirnov test for Normal distribution P<0001- Normality rejected 
This calculation is based on the median as a result of abnormal distribution of data 
Other indicators of the first part of the individual notification form also included information on 
vaccination, the patient is exposed to TB or not and case classification. 
From the obtained results show that in 247 (59.2% of cases) have a lack of information on 
vaccination. The frequency of ―missing‖ is higher than others as: vaccinated, unvaccinated and 
unknown. 
 
Table 5.4.6 the vital records and onset of diseases 
 
Yes Missing 
No. % No. % 
Father’s name 227 54.4 190 45.6 
Address 417 100 0 0 
Profession 347 83.2 70 16.8 
Date of onset     334 80.1 83 19.9 
Date of hospital admission 309 74.1 108 25.9 
Date of starting therapy 327 78.4 90 21.6 
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Part II – “Clinical and Epidemiological Investigation” 
The second part of the form contains risk factors (alcohol and intravenous drug users), 
classification of the case, radiological and intra dermo reaction examinations and spread of the 
disease (sporadic or endemic). Table 5.4.7 shows that in 417 patients, 11 of them (2.6%) are 
users of intravenous drugs and alcohol. 
 Table 5.4.7 frequency of patients, users of alcohol and intravenous drugs 
 Intravenous drugs 
(narcotic) 
Alcoholism  Total 
Missing No Unknown Yes 
Missing 43 21 1 10 75  
Unknown 0 0 6 0 6  
No 0 228 7 85 320  
Yes 0 4 1 11 16  
 Total 43 253 15 106 417 
   
 
Regarding to exposure in 298 (71.5%) patients there was no exposure to TB cases. 
The vast majority of cases are new ones with 85.6% 0f cases (357 cases to 417 in total). 
 
Table 5.4.8 frequency of radiography and intradermoreaction examinations 
 Intradermo reaction Radiography examination  Total 
Missing Not done Negative Positive 
Missing 71 3 17 52 143  
Not done 0 3 0 10 13  
Negative 4 9 35 29 77  
Positive 9 8 50 117 184  
 Total 84 23 
 
102 208 
 
          417 
   
 
The table 5.4.8 shows that 117 (28.1%) of patients with positive results have also conducted two 
examinations (radiological and intradermoreaction) and in 12% of cases we have ―missing‖ of 
examination type. 
Also, Epidemiological investigation of cases of pulmonary tuberculosis according to individual 
forms included in the study shows that in 240 (57.6%) cases the extent of infection is ―missing‖ 
(if the cases are sporadic or endemic). 
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Part III – “Microbiological laboratory diagnosis data” 
Case definition and confirmation of pulmonary tuberculosis was determined and laboratory 
examinations such as direct examination, culture and serology. 
The following tables present the number of cases which have committed directly, culture 
examinations and serology.  
Table 5.4.9 frequency of laboratory results (direct and cultura examination) 
  
Result Culture 
Result Direct Total  
  
MISSING NEGATIVE POSITIVE 
MISSING 92 48 49 189  
NEGATIVE 8 5 1 1 
POSITIVE 195 1 18 214  
 Total 295 
 
54 
 
68 
 
417 
 
In 18 cases (expressed in 4.3% of them) positivity was confirmed by direct and culture 
examination (see table 5.4.9).  22.1% of cases represent ―missing‖ for direct and culture 
examination. 
Table 5.4.10 frequency of laboratory results (direct and serology examination) 
  
Result Serology 
Result Direct Total  
  
MISSING NEGATIVE POSITIVE 
MISSING 294 53 66 413  
POSITIVE 1 1 2 4  
 Total 295 
 
54 
 
68 
 
417 
 
In 2 cases (expressed in 0.5% of them) positivity was confirmed by direct and serology 
Examination (see table 5.4.10). 70.5% of them are ―missing‖ for direct and serology 
examination. 
Table 5.4.11 frequency of laboratory results (serology and cultura examination) 
  
Result Serology 
Result Culture Total  
  
MISSING NEGATIVE POSITIVE 
MISSING 186 14 213 413  
POSITIVE 3 0 1 4  
 Total 189 
 
14 
 
214 
 
417 
 
In one case (0.2%) positivity was confirmed by three examinations (see table 5.4.11). 
44.6% of cases have ―missing‖ for cultura and serology examination. 
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5.5 Epidemiological characteristics of vaccine preventable deseases – Diphtheria-Tetanus-Pertussis (DTP) 
Most of infectious diseases preventable by vaccination, (diseases of the Albanian Programme on Immunization according to WHO 
Expanded Programme on Immunization – EPI), are of an airborne nature transmission, namely diphtheria, pertussis, measles, rubella.  
Therefore, their epidemiological surveillance data are presented in tables of the respective subchapter (see subchapter 2.6.7). 
The following table 5.5.1 presents data on preventable infectious diseases, the absolute number of cases reported monthly for the 
period 1998-2009 and the number of individual cases according to the notification form for the period 2007-2009. 
Table shows the total absence of notified cases compared with the monthly data reported at the Institute of Public Health. 
The level of vaccination is satisfactory in explaining the decreasing trend of these diseases, especially pertussis cases. 
 
Table 5.5.1 Number of DTP cases in Albania [reported by monthly and individual form ( )] 
Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Diphtheria 0 2 4 0 0 0 0 2 0 0 0 1 
Tetanus 3 3 0 2 1 0 1 4 2 2 0 0 
Pertussis 24 29 86 36 20 11 72 15 36 10 (1) 10 (1) 10 (1) 
DTP vaccination 98.1 97.5 96.6 97.6 97.5 97.7 97.8 97.3 98.2 98.4 97.2 98.4 
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Figure 5.5.1 the incidence rate of DTP over the study period  
 
 
Actually, the annual diphtheria cases are zero to at 3 reported as suspected (not laboratory 
confirmed) cases. Very low levels of tetanus characterize over the period 1998-2009 with an 
annual frequency from 2 to 3 reported cases. 
The incidence rate for pertussis shows a decreasing trend with big oscillations.  
Table 5.5.2 shows a lack of data from individual notification form for the period 2007-2009 by 
region. The total number of cases for pertussis is 30 and only three were reported by individual 
notification form. 
Table 5.5.2 Number of DTP cases reported by monthly and individual form ( ) in region during the years 2007-2009 
Regions Diphtheria Tetanus Pertussis 
Berat 0 0 2 
Diber 0 0 0 
Durres 0 0 9 (1) 
Elbasan 0 0 0 
Fier 0 0 9 
Gjirokaster 0 0 0 
Korce 0 0 3 
Lezhe 0 0 0 
Tirane 0 1 2 (2) 
Shkoder 1 0 5 
Kukes 0 0 0 
Vlore 0 0 0 
Total 1 1 30 (3) 
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Table 5.5.3 Number of DTP cases during the years 1998-2009 by age group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
D
ip
h
th
er
ia
 
0-4 0 1 1 0 0 0 0 1 0 0 0 0 
5-14 0 1 2 0 0 0 0 0 0 0 0 0 
15-44 0 0 1 0 0 0 0 1 0 0 0 1 
45-59 0 0 0 0 0 0 0 0 0 0 0 0 
60 + 0 0 0 0 0 0 0 0 0 0 0 0 
                            
T
et
a
n
u
s 
0-4 0 0 0 0 0 0 0 0 0 0 0 0 
5-14 2 0 1 1 0 0 0 1 0 0 0 0 
15-44 0 2 0 0 0 0 0 2 0 0 4 0 
45-59 0 1 1 1 1 0 1 1 2 1 0 0 
60 + 1 0 0 0 0 0 0 0 0 1 0 0 
                            
P
er
tu
ss
is
 
0-4 22 18 72 26 8 7 44 9 21 5 9 6 
5-14 2 11 14 8 12 4 27 6 14 5 1 4 
15-44 0 0 0 2 0 0 1 0 1 0 0 0 
45-59 0 0 0 0 0 0 0 0 0 0 0 0 
60 + 0 0 0 0 0 0 0 0 0 0 0 0 
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Figure 5.5.2 The incidence rate for DTP over the period 1998-2009 by age – group 
Diphtheria  
Tetanus 
Pertussis 
 
Distribution by age group of diphtheria cases shows that most vulnerable age groups are 0-4 and 
5-14 years. After 2000 number of cases for these age groups becomes zero while the age group 
15-44 years old in 2000, 2005 and 2009 represents only 1 case. 
Tetanus incidence rate by age-group presents oscillations, which are expressed in the age group 
45-59 and 5-14 years old, while incidence rate for the 0-4 age group and ≥ 60 years shows peaks 
at 2007 and 2008 (see figure 5.5.2). 
Regarding the pertussis incidence rate, the highest frequency of pediatric age groups are 0-4 and 
5-14 years. 
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Table 5.5.4 Number of cases of DTP during the years 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
D
ip
h
th
er
ia
 
Total 0 2 4 0 0 0 0 2 0 0 0 1 
Urban 0 0 2 0 0 0 0 2 0 0 0 0 
Rural 0 2 2 0 0 0 0 0 0 0 0 1 
  
                          
T
et
a
n
u
s Total 3 3 0 2 1 0 1 3 2 2 0 0 
Urban 0 1 0 2 0 0 0 1   0 0 0 
Rural 3 2 0 0 1 0 1 2 2 2 0 0 
                            
P
er
tu
ss
is
 Total 24 29 86 36 20 11 72 15 36 10 10 10 
Urban 14 12 40 15 7 3 50 5 15 7 6 6 
Rural 10 17 46 21 13 8 22 10 21 3 4 4 
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Figure 5.5.3 The incidence rate of DTP during the years 1998-2009 by residence  
Diphtheria 
Tetanus 
Pertussis 
 
There was no difference between areas (urban and rural areas) incidence rates for diphtheria and 
pertussis, while cases of tetanus are present in 76.5% of them in rural areas. The figure shows for 
diphtheria an increased tred in year 2008 for rural areas with 1/100.000 population. 
After year 2008 tetanus shows a decresed trend for urban and rural areas to zero cases.  
Regarding the pertussis in 2004 the incidence rate for urban areas was reached in 3.5 /100.000 
inhabitants and after this year represent the significant reduction of trend. 
0
0,05
0,1
0,15
0,2
0,25
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
C
as
e
s/
1
0
0
,0
0
0
Total
Urban
Rural
0,0
0,1
0,1
0,2
0,2
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
C
as
e
s/
1
0
0
.0
0
0
Total
Urban
Rural
0
1
2
3
4
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
C
as
e
s/
1
0
0
.0
0
0
 
Total
Urban
Rural
Dissertation 2011 
 
140 Elida MATA 
 
Table 5.5.5 The number  of DTP case during the years 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
D
ip
h
th
er
ia
 
Total 0 2 4 0 0 0 0 2 0 0 0 1 
Male 0 2 3 0 0 0 0 1 0 0 0 0 
Female 0 0 1 0 0 0 0 1 0 0 0 1 
  
                          
T
et
a
n
u
s Total 3 3 0 2 1 0 1 3 2 2 0 0 
Male 3 3 0 2 1 0 0 2 2 2 0 0 
Female 0 0 0 0 0 0 1 2 0 0 0 0 
                            
P
er
tu
ss
is
 
Total 24 29 86 36 20 11 72 15 36 10 10 10 
Male 15 12 48 15 14 8 31 10 17 4 4 8 
Female 9 17 38 21 6 3 41 5 19 6 6 2 
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Figure 5.5.4 The incidence of DTP during the years 1998-2009 by gender 
Diphtheria
Tetanus 
Pertussis 
 
The distribution by gender for diphtheria and tetanus show low incidence rate for both of gender. 
The pertussis trend show big oscillations for both of gender with decreasing trend.   
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Epidemiological characteristics of vaccine preventable deseases – Measles-Mumps-Rubella 
The year 2000 denotes the beginning of the implementation of the national strategy on measles 
elimination untill 2007 in Albania, set up according to WHO respective target for the European 
Region. In the year 2001 is introduced the bivalente vaccine (Measles Rubella) and in 2005 is 
introduced trivalent vaccine (Measles Mumps and Rubella). 
Table 5.5.6 Number of cases of MMR in Albania over the period 1998-2009 
Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Measles 1900 798 662 18 12 1 3 1 68 28 0 0 
Rubella 721 15 1752 10 12 2 1 0 3 0 0 0 
Mumps 1375 1011 1648 1414 3124 2236 896 1992 2102 706 50 22 
Vaccination 
coverage  
91.7 91.0 89.9 83.9 91.6 95.2 96.1 95.5 96.5 97.2 92.9 95.8 
              MR                                       MMR 
Figure.5.5.5 The incidence rate of MMR over the period 1990-2009 
 
 
 
The general trend of measles in Albania shows dramatically decrease over the study period. It 
vary from 1900 cases (62.1/100.000) to zero cases in 2009, due to the increased use of the two 
doses – vaccination policy and based on WHO strategy objectives, in order to eliminate measles 
and rubella in 2010.  
In 2000 began the application of bivalent vaccine for measles and rubella. The main aim of 
rubella vaccination is the prevention of congenital rubella infectious (CRI). The vaccination, in 
the first phase includes the age group 5-14 years old and at the second phase included the 
vaccination of the female in productive ages.  
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Obtained results show that after the introduction of this vaccine, the general trend of rubella has 
a significant decrease to zero cases for 2007, 2008 and 2009. 
The epidemiological data as cases number and  incidence rates (cases/100.000 inhabitants) 
present a detailed picture of measles, mumps and rubella epidemiology in Albania over the 
period 1998-2009 (tables 5.5.6 and figure 5.5.5). This period is characterized by decreasing trend 
for MMR diseases. Incidence rates of measles and rubella after 2001 has decreased significantly 
from 2 to 0 cases/100.000 inhabitants and for mumps up to 1-2cases/100.000 over the study 
period. 
 
Like the above diseases and for measles, mumps and rubella exists discordance and the absence 
between reported cases by individual form and cases reported by monthly form. The discordance 
of data between both of surveillance system is expressed for measles disease in country level.In 
33.3% of regions (4 out of 12 regions) number of cases reported by individual form is more than 
number of cases reported by monthly form. 
We have lack of data reported by individual form in 100% of cases for mumps and rubella 
diseases (table 5.5.7) 
Table.5.5.7 Number of MMR cases reported by monthly and individual form ( ) at the regions level during the years 
2007-2009 
Regions Measles Mumps Rubella 
Berat 0 (3) 52 0 
Diber 0 6 0 
Durres 6 (3) 6 0 
Elbasan 0 12 0 
Fier 0 (1) 92 0 
Gjirokaster 0 (3) 6 0 
Korce 0 105 0 
Lezhe 0 (1) 58 0 
Tirane 19 (8) 153 0 
Shkoder 3 (1) 60 0 
Kukes 0 11 0 
Vlore 6 (4) 217 0 
Total 34 (24) 778 0 
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Table 5.5.8 Number of MMR cases over the period 1998-2009 by age group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
M
ea
sl
es
 
0-4 529 236 112 11 3 1 1 1 41 17 0 0 
5-14 1182 456 487 6 5 0 2 0 24 10 0 0 
15-44 172 96 57 1 4 0 0 0 3 1 0 0 
45-59 16 9 6 0 0 0 0 0 0 0 0 0 
60 + 1 1 0 0 0 0 0 0 0 0 0 0 
                            
M
u
m
p
s 
0-4 326 253 314 284 601 533 179 441 408 193 11 5 
5-14 807 639 1055 927 2042 1285 539 1255 1407 396 32 14 
15-44 229 116 264 195 458 404 171 282 271 113 7 2 
45-59 13 3 14 7 20 12 7 12 15 4 0 0 
60 + 0 0 1 1 3 2 0 2 1 0 0 1 
                            
R
u
b
el
la
 
0-4 219 4 423 5 7 2 1 0 0 0 0 0 
5-14 422 6 1240 4 5 0 0 0 1 0 0 0 
15-44 73 5 88 1 0 0 0 0 2 0 0 0 
45-59 7 0 1 0 0 0 0 0 0 0 0 0 
60 + 0 0 0 0 0 0 0 0 0 0 0 0 
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Figure 5.5.6 The incidence rate of MMR over the period 1998-2009 by age group  
Measles 
Mumps 
Rubella 
 
Although, the trend of measles, mumps and rubella has decreased year by year, the highest 
incidence rate (cases/100.000 population) is for the pediatric age group (0-14 years old) (see 
table 5.5.8 and figure 5.5.6).  
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Table.5.5.9 Number of cases of MMR during the years 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
M
ea
sl
es
 Total 1900 798 662 18 12 1 3 1 68 28 0 0 
Urban 937 362 428 13 8 0 2 0 45 18 0 0 
Rural 963 436 234 5 4 1 1 1 23 10 0 0 
  
                          
M
u
m
p
s Total 1375 1011 1648 1414 3124 2236 896 1992 2102 706 50 22 
Urban 703 574 786 790 1941 1011 369 1083 1081 360 33 17 
Rural 672 437 862 624 1183 1225 527 909 1021 346 17 5 
                            
R
u
b
el
la
 Total                         
Urban 281 8 1302 7 12 1 1 0 0 0 0 0 
Rural 440 7 450 3 0 1 0 0 3 0 0 0 
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Figure.5.5.7 The incidence rate of MMR over the period 1998-2009 by residence 
Measles 
Mumps 
Rubella 
 
For two respective nosologies: the higher incidence rate for measles dhe rubella is expressed in 
year  1998-2001 mainly for urban areas and after year 2001 represent significant decreased trend 
up to zero cases. Regarding mumps the figure presents oscillations with increasing incidence rate 
during the years 2002-2003 and 2005-2006. After the 2006, the data represent a significant 
decreasing trend for mumps. Reducing of the incidence rate for mumps is due to well function of 
the vaccine system (MMR vaccine) introduced in 2005.
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Table 5.5.10 the number of MMR cases during the years 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
M
ea
sl
es
 Total 1900 798 662 18 12 1 3 1 68 28  0 0 
Male 968 431 345 12 7 1  0 1 47 16  0 0 
Female 932 367 317 6 5  0 3  0 21 12 0  0 
  
                          
M
u
m
p
s Total 1375 1011 1648 1414 3124 2236 896 1992 2102 806 50 22 
Male 887 688 1055 893 1997 1466 567 1276 1333 497 35 13 
Female 488 323 593 521 1127 770 329 716 769 309 15 9 
                            
R
u
b
el
la
 Total 721 15 1752 10 12 2 1  0 3  0  0 0 
Male 356 7 922 4 9 1    0 2  0  0 0 
Female 365 8 830 6 3 1 1  0 1  0  0 0 
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Figure 5.5.8 the incidence rate of MMR over the period 1998-2009 by gender  
Measles 
Mumps 
Rubella 
 
Distribution of the number of cases and incidence rate (cases/100.000 inhabitants) for measles 
and rubella is at same values in both sexes, expressing a significant reduction trend after 2002. 
Mumps presents big oscillations with the highest incidence rates in males but after 2006 the 
decreasing trend is expressed in both genders.
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AFP- Unspecified (Unspecified Paralyses) 
Poliomyelitis is eliminated as indigenous infection in Albania from 1997. 
From 1997 onwards Albania is a Polio-free country, thus achieving the WHO target on poliomyelitis elimination by year 2000 in the 
European Reagion. 
Table 5.5.11 Number of AFP-unspecified paralysis cases in Albania [reported by monthly and individual form ( )] 
AFP 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Cases 2 2 2 5 0 3 3 2 2 4 (1) 3 (2) 5 (4) 
 
Nevertheless it is value to consider the main features of poliomyelitis epidemiology in Albania on basis of epidemiological 
surveillance data, available from 1998-2009 (see table 5.5.11 and figure 5.5.9). 
Regarding to the individual and general surveillance of infectious diseases even in cases with polio, the table 5.5.11 shows the 
difference between recorded data in the individual form versus general data reported every month. Results obtained show fluctuacion 
of the AFP (unspecified paralyses) cases after year 2001 (decrease and increase of trend). 
Figure 5.5.9The incidence rate of AFP-unspecified paralysis during the years 1998-2009 
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Reporting of AFP-Unspecified paralyses cases presents the difference between the individual 
and monthly reporting; the individual  reporting is carried out only in 4 regions (33.3% of the 
country). 
In individual forms for the group of preventable vaccine diseases we have lacks of information 
about the generalities of the patient, the onset of disease, vaccination (if is applied the respective 
vaccines for the respective disease), laboratory confirmation and conclusion on the disease. 
 
Table 5.5.12 Number of AFP-unspecified paralysis cases reported by monthly and individual form ( ) by regions 
during the years 2007-2009 
Regions AFP-unspecified paralysis 
Berat 8 (2) 
Diber 0 
Durres 1 (1) 
Elbasan 0 
Fier 0 
Gjirokaster 0 
Korce 0 
Lezhe 0 
Tirane 12 (3) 
Shkoder 0 
Kukes 3 (1) 
Vlore 0 
Total 24 (7) 
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Table 5.5.12 Number of AFP unspecified paralysis cases during the years 1998-2009 by age group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
F
P
 -
 u
n
sp
ec
if
ie
d
 
p
a
ra
ly
si
s 
0-4 0 2 1 1   2 1 1   2 3 5 
5-14 1 0 1 4   1 2 1 2 2 0 0 
15-44 1 0 0 0 0 0 0 0 0 0 0 0 
45-59 0 0 0 0 0 0 0 0 0 0 0 0 
60 + 0 0 0 0 0 0 0 0 0 0 0 0 
 
Figure 5.5.10The incidence rate of AFP unspecified paralysis over the period 1998-2009 by age group 
 
AFP-unspecified paralysis is expressed in the pediatric age group (0-4 years old) with an increasing trend after 2006, and the age 
group (05-14 years old) with a decreasing trend after 2007. 
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Table 5.5.13 Number of AFP unspecified paralysis cases during the period 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
F
P
 -
 
u
n
sp
ec
if
ie
d
 
p
a
ra
ly
si
s 
Total 2 2 2 5 0 3 3 2 2 4 3 5 
Urban 0 1 1 3 0 0 2 0 0 1 1 3 
Rural 2 1 1 2 0 3 1 2 2 3 2 2 
 
Figure 5.5.11The incidence rate of AFP – unspecified paralysis over the period 1998-2009 by residence 
 
Regarding the distribution by area, the figure represents the peak of the incidence rates as in urban and rural areas. 
The peaks of the highest incidences of AFP-Unspecified paralyses for the urban area were in the years 2000, 2003, 2007 and 2008. 
For rural areas the high peaks of incidence are presented in the years 2003, 2007. The years 2008 and 2009 are characterized by a 
constant incidence rate. 
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Table 5.5.14 Number of cases of AFP unspecified paralysis during the years 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
F
P
 -
 
u
n
sp
ec
if
ie
d
 
p
a
ra
ly
si
s Total 2 2 2 5 0 3 3 2 2 4 3 5 
Male 2 2 1 4 0 1 3 2 1 0 1 4 
Female 0 0 1 1 0 2 0 0 1 4 2 1 
 
Figure 5.5.12 the incidence rate of AFP unspecified paralysis over the period 1998-2009 by gender 
 
The data in Table 5.5.14 and Figure 5.5.12 show that the most affected by unspecified paralyses are males.  
Increasing trend is presented in male after 2007, while in female is presented a constant trend during the years 2008-2009.    
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5.6 Epidemiological characteristics of “Other infectious diseases” group 
In the group of other infectious diseases are included meningococcal meningitis, other meningitet (aseptic viral meningitis and non 
meningococcal bacteric meningitis), and varicella, erysipelas, scarlatina and other rickettsiosis. 
Reporting of cases is carried out by monthly form and individual form. Individual form of notification is the same as the above 
mentioned infectious diseases. Comparison of data between them (monthly and individual forms) shows discrepancies in the number 
of cases. 
 
Table 5.6.1Number of “other infectious diseases” group cases [reported by monthly and individual form ( )] 
 Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Aseptic viral meningitis 118 91 105 152 162 74 65 77 132 97 (30) 19 (17) 23 (10) 
Meningococcal meningitis 38 28 15 10 15 6 7 10 9 3 (4) 8 (3) 7 (4) 
Non.mening.bact.meningitis 57 35 29 44 53 41 28 29 33 35(24) 43 (24) 20 (12) 
Tuberculosis meningitis 3 7 1 4 3 3 4 0 2 5  2 2 
Varicella 748 696 1018 837 998 1594 1414 1239 1228 1663( 55) 849 (5) 699 (15) 
Erysipelas 76 67 68 99 83 153 106 97 94 115 (16) 99 (13) 76 (7) 
Scarlatina 59 79 134 73 54 80 67 57 58 29 (1) 23 (2) 22 (3) 
Other rickettsiosis 11 23 16 45 67 44 42 26 37 15 (8) 18 (13) 12 (4) 
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Figure 5.6.1 The incidence rate of “other infectious diseases” group over the period 1998-2009 
 
 
 
The annual frequency (number of reported cases) and incidence rate (cases/100.000 population) 
of meningococcal meningitis include aseptic viral meningitis and non-meningococcal bacteric 
meningitis and tubercular meningitis over the our study period presented in table 5.6.1 and figure 
5.6.1 show a decreased trend. Also, is a same situation and for erisipelas, scarlatina and other 
rickettsiosis. Varicella is presented by big oscillations with a decreased trend after 2007.  
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Table 5.6.2 Number of cases of “other infectious diseases” group reported by monthly and individual form ( ) by regions during the years 2007-2009 
 Regions Aseptic 
viral 
meningitis 
Meningococcal 
meningitis 
Non 
meningococcal 
bacteric 
meningitis 
Varicella Erysipelas Scarlatina Other 
rickettsiosis 
Berat 7 5 (1) 1 (5) 192 8 32 0 
Diber 0 0 7 37 1 0 0 
Durres 20 (16) 1 (1) 17 (21) 139 3 4 0 
Elbasan 15 (9) 3 5 (7) 190 (87) 41 (21) 6 (4) 3 (3) 
Fier 16 (6) 2 (1) 9 (5) 507 71 12 0 
Gjirokaster 11 (2) 0 0 67 5 2 (2) 9 (6) 
Korce 2 2 6 189 5 2 45 
Kukes 2 0 0 31 6 0 0 
Lezhe 2 (1) 0 (2) 4 274 26 (8) 3 0 
Tirane 17 (23) 4 (6) 41 (22) 340 115 10 19 (19) 
Vlore 41 1 2 651 7 (7) 0 0 
Shkoder 6 0 6 594 2 4 14 
Total 139 (57) 18 (5) 98 (60) 3211 (87) 290 (36) 75 (6) 90 (28) 
 
Discordonce in the number of cases reported by the monthly surveillance system and the individual form for the group of 
 "other diseases" is presented in 41.7% of the regions for meningococcal meningitis, meningococcal bacteric non-
viral meningitis and aseptic viral meningitis), and in over 50%  of regions for varicella, erysipelas,  scarlatine and other  rickettsiosis. 
50% of the regions do not represent individual data for this group of diseases, while 91.7% of the regions have not used individual 
forms for varicelle cases. 
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Distribution of Other Diseases over the period 1998 – 2009 by region 
Country Mean Incidence (cases/100,000 population) and range 
 
Aseptic viral meningitis                                                             Meningococcal meningitis 
    3.7 (0.2 – 12.5)                                                                               0.4 (0.1 – 1.2) 
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Non meningococcal bacterial                                                                      Varicella 
            Meningitis 
       1.3 (0.3 – 3.0)                                                                                         36 (4 – 83) 
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       Erysipelas                                                                                           Scarlatina 
  2.5 (0.4 – 5.3)                                                                                        1.9 (0 – 5.8) 
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Other Rickettsiosis 
1.7 (0 – 9.9) 
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Table 5.6.3 Number of cases of “other infectious diseases” group over the period 1998-2009 by age groups 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
se
p
ti
c
 v
ir
a
l 
m
e
n
in
g
it
is
 0-4 22 25 15 25 44 12 19 19 24 16 3 9 
5-14 69 49 76 103 101 45 26 45 97 66 7 6 
15-44 23 13 13 19 13 15 12 12 10 12 5 5 
45-59 2 2 1 5 4 1 6 1 1 2 3 1 
60 + 2 2 0 0 1 1 2 0 0 1 1 2 
                            
M
e
n
in
g
o
c
o
c
c
a
l 
m
e
n
in
g
it
is
 
0-4 17 12 2 6 9 0 4 4 4 0 0 6 
5-14 18 8 6 2 4 4 1 3 1 1 4 0 
15-44 3 7 6 1 1 0 1 0 2 1 4 26 
45-59 0 1 1 1 1 1 1 1 1 1 0 1 
60 + 0 0 0 0 0 1   2 1 0 0 0 
                            
N
o
n
 
m
e
n
in
g
o
co
c
c
a
l 
b
a
c
te
ri
a
 
m
e
n
in
g
it
is
 0-4 22 9 9 17 15 7 9 9 12 6 15 6 
5-14 17 17 16 17 23 23 8 5 14 19 16 7 
15-44 15 7 3 9 10 8 7 10 7 7 7 3 
45-59 3 1 1 0 3 1 3 4 0 1 4 2 
60 +                         
                            
V
a
r
ic
el
la
 0-4 247 206 360 282 287 532 426 326 429 565 280 222 
5-14 417 468 609 530 676 989 942 829 715 1006 527 390 
15-44 83 22 46 22 33 71 43 81 82 91 38 79 
45-59 1 0 0 3 1 2 3 3 2 1 2 4 
60 + 0 0 3 0 1 0 0 0 0 0 2 4 
                            
E
ry
si
p
el
a
s 0-4 2 2 4 1 4 8 2 0 9 3 2 2 
5-14 4 9 1 10 6 33 6 5 5 18 7 3 
15-44 39 23 23 36 27 39 31 28 17 29 21 18 
45-59 22 23 29 36 29 50 45 40 45 42 49 33 
60 + 9 10 11 16 17 23 22 24 18 23 20 20 
                            
S
c
a
rl
a
ti
n
a
 0-4 26 33 27 27 21 29 27 25 28 16 8 11 
5-14 33 35 104 43 31 49 37 29 26 12 14 10 
15-44 0 8 3 3 1   3 3 2 1 1 1 
45-59 0 3 0 0 1 2 0 0 2   0 8 
60 + 0 0 0 0 0 0 0 0 0 0 0 0 
                            
O
th
e
r
 
r
ic
k
e
tt
si
o
si
s 0-4 2 5 1 4 7 5 7 2 8 4 0 1 
5-14 0 4 3 11 26 14 8 6 10 4 4 3 
15-44 6 6 3 21 19 14 11 8 12 5 6 6 
45-59 4 5 4 9 13 6 12 9 4 1 6 2 
60 + 0 3 5 0 2 5 4 1 3 1 2 0 
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Figure 5.6.2The incidence rate of “other infectious diseases” group over the period 1998-2009 by age group 
Aseptic viral meningitis 
Meningococcal meningitis 
Non meningococcal bacteria meningitis 
 
 
Age group with the highest incidence for meningococcal diseases (meningococcal 
meningitis, aseptic viral meningitis and non- meningococcal bacteric  meningitis) are 0-4 years 
old with the increasing trend for meningococcal meningitis during 2008-2009 and 5-14 years 
old with decreasing trend for all meningococcal diseases (see the table 5.6.3 and figure 5.6.2). 
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Figure 5.6.3The incidence rate of “other infectious diseases” group over the period 1998-2009 by age group 
Varicella 
Erysipelas
 
Scarlatina
Other rickettsiosis
 
The erysipelas, scarlatina and other rickettsiosis occurrence show an oscillating trend over the 
period 1998-2009 for all age-grops, with peaks every 2-3 years, except varicelle 
which shows oscillation with decreasing trend in the pediatric age groups 0-4 and 5-14 years old. 
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Table 5.6.4 Number of cases of “other infectious diseases” group by residence during the years 1998-2009 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
se
p
ti
c 
v
ir
a
l 
m
en
in
g
it
is
 
Total 118 91 105 152 162 74 65 77 132 97 19 23 
Urban 46 40 45 51 81 28 30 36 65 42 8 15 
Rural 72 51 60 101 81 46 35 41 67 55 11 8 
  
                          
M
en
in
g
o
co
cc
a
l 
m
en
in
g
it
is
 
Total 38 28 15 10 15 6 7 10 9 3 8 7 
Urban 15 12 6 3 9 1 2 5 5   4 2 
Rural 23 16 9 7 6 5 5 5 4 3 4 5 
                            
N
o
n
 
m
en
in
g
o
co
cc
a
l 
b
a
ct
er
ia
 
m
en
in
g
it
is
 
Total 57 35 29 44 53 41 28 29 33 35 43 20 
Urban 19 12 15 19 21 16 12 13 20 18 19 11 
Rural 38 23 14 25 32 25 16 16 13 17 24 9 
                            
V
a
ri
ce
ll
a
 Total 748 696 1018 837 998 1594 1414 1239 1228 1663 849 699 
Urban 525 490 718 570 700 1017 812 753 889 1047 583 268 
Rural 223 206 300 267 298 577 602 486 339 616 266 431 
                            
E
ry
si
p
el
a
s Total 76 67 68 99 83 153 106 97 94 115 99 76 
Urban 39 37 42 62 56 98 52 60 56 71 62 21 
Rural 37 30 26 37 27 55 54 37 38 44 37 55 
                            
S
ca
rl
a
ti
n
a
 
Total 59 79 134 73 54 80 67 57 58 29 23 22 
Urban 46 27 100 54 40 55 39 49 39 23 16 9 
Rural 13 52 34 19 14 25 28 8 19 6 7 13 
                            
O
th
er
 
ri
ck
et
ts
io
si
s 
Total 11 23 16 45 67 44 42 26 37 15 18 12 
Urban 4 16 15 28 39 18 21 13 22 7 9 4 
Rural 7 7 1 17 28 26 21 13 15 8 9 8 
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Figure 5.6.4The incidence rate of “other infectious diseases” group over the period 1998-2009 by residence 
Aseptic viral meningitis 
Meningococcal meningitis 
Non meningococcal bacteria meningitis 
 
 
The urban and rural areas have a same situation regarding with the meningococcal meningitis 
diseases group. The numer cases and incidence rate (cases/100.000 population) show oscillations 
and decreasing trend.  
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Figure 5.6.5The incidence rate of “other infectious diseases” group over the period 1998-2009 by residence 
Varicella
Erysipelas 
Scarlatina
Other rickettsiosis 
 
 
Varicella, erysipelas, scarlatina and other rickettsiosi represent higher incidence in urban areas 
and decreasing trend in both of areas (urban and rural areas).
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Table 5.6.5 Number of cases of “other infectious diseases” group over the period 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
  no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases no. cases 
A
se
p
ti
c 
v
ir
a
l 
m
en
in
g
it
is
 
Total 118 91 105 152 162 74 65 77 132 97 19 23 
Male 80 62 71 121 107 53 47 52 93 61 12 16 
Female 38 29 34 31 55 21 18 25 39 36 7 7 
  
                          
M
en
in
g
o
co
cc
a
l 
m
en
in
g
it
is
 
Total 38 28 15 10 15 6 7 10 9 3 8 7 
Male 24 17 8 5 11 4 6 6 4 2 4 7 
Female 14 11 7 5 4 2 1 4 5 1 4 0 
                            
N
o
n
 
m
en
in
g
o
co
cc
a
l 
b
a
ct
er
ia
 
m
en
in
g
it
is
 
Total 57 35 29 44 53 41 28 29 33 35 43 20 
Urban 30 21 20 33 32 29 23 17 23 23 25 14 
Rural 27 14 9 11 21 12 5 12 10 12 18 6 
                            
V
a
ri
ce
ll
a
 Total 748 696 1018 837 998 1594 1414 1239 1228 1663 849 699 
Male 404 356 533 455 540 873 757 670 681 783 411 369 
Female 344 340 485 382 458 721 657 569 547 880 438 330 
                            
E
ry
si
p
el
a
s Total 76 67 68 99 83 153 106 97 94 115 99 76 
Male 34 31 27 45 38 64 53 35 40 45 47 39 
Female 42 36 41 54 45 89 53 62 54 70 52 37 
                            
S
ca
rl
a
ti
n
a
 
Total 59 79 134 73 54 80 67 57 58 29 23 22 
Male 27 47 58 47 30 44 28 27 36 17 15 14 
Female 32 32 76 26 24 36 39 30 22 12 8 8 
                            
O
th
er
 
ri
ck
et
ts
io
si
s 
Total 11 23 16 45 67 44 42 26 37 15 18 12 
Male 8 12 9 22 38 22 22 17 19 10 8 5 
Female 3 11 7 23 29 22 20 9 18 5 10 7 
Dissertation 2011 
 
169 Elida MATA 
 
Figure 5.6.6 The incidence rate of “other infectious diseases” group over the period 1998-2009 by gender 
Aseptic viral meningitis
Meningococcal meningitis 
Non meningococcal bacteria meningitis 
 
 
Table 5.6.5 and Figure 5.6.6 represent the annual frequency (number of reported 
cases) and incidence rate (cases/100.000 population) for meningococcal group distributed by 
gender for the period 1998-2009. Males constitute 69.5% of meningitis cases. 
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Figure 5.6.7 The incidence rate of “other infectious diseases” group over the period 1998-2009 by gender 
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Figure 5.6.7 shows the incidence rate (cases/100.000) for each of the above diseases by gender.  
Varicella, scarlatina and other rickettsiosi show higher incidence in males, expressed as a 
percentage the males represent: varicella in 52.6% of cases, scarlatina in 53.1% of them and 
other rickettsiosis in 53.9% of cases. Regarding to erysipelas, the major number of cases (56.1% 
of cases) and higher incidence rate is presented to women.This group of diseases represents a 
decreasing trend. 
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Individual notification schedul of other diseases.  
 Part I – “General information”   
Table 5.6.6 represent presence or missing of data on general information of patients for each 
disease defined as ―other infectious diseases‖. Indicator "father's name" for the group of viral 
diseases meningiteve is completed in about 80.0% of cases, while for diseases: varicella, 
erysipelas, scarlatina and other rickettsiosis is presented by‖missing" at about 30-60% of cases. 
Gender, age and profession are completed almost 100% of individual forms, while the address is 
not compiled in 8.0% to 26.3% of them, except the scarlatine cases in which was completed in 
100% of forms (see table 5.6.6). 
 
Table 5.6.6 the general information data on patient’s form 
Disease  Father's name Gender Age Profession Address 
No. (%) No.   (%) No.   (%) No.   (%) No.   (%) 
Aseptic viral meningitis         
n = 57 
Yes  47 (82.5) 57 (100.0) 57 (100.0) 57 (100.0) 42 (73.7) 
missing 10 (17.5) 0 0 0 15 (26.3) 
Meningococcal meningitis    
n =11 
Yes 9 (81.8) 11 (100.0) 11 (100.0) 11 (100.0) 9 (81.8) 
missing 2 (18.2) 0 0 0 2 (18.2) 
Non meningococcal 
bacteria meningitis  n = 60 
Yes 49 (81.7) 60 (100.0) 59 (96.7) 60 (100.0) 53 (88.3) 
missing 11 (18.3) 0 1 (3.3) 0 7 (11.7) 
Varicella                                    
n = 87 
Yes 18 (20.7) 87 (100.0) 85 (97.7) 87 (100.0) 80 (92) 
missing 69 (79.3) 0 2 (2.3) 0 7 (8.0) 
Erysipelas                                 
n = 36 
Yes 16 (44.4) 36 (100.0) 35 (97.2) 36 (100.0) 29 (80.6) 
missing 20 (54.6) 0 1 (2.8)  7 (19.4) 
Scarlatina                                    
n = 6 
Yes 3 (50) 6 (100.0) 5 (83.3) 6 (100.0) 6 (100.0) 
missing 3 (50) 0 1 (16.7) 0 0 
Other rickettsiosis                  
n = 28 
Yes 17 (60.7) 28 (100.0) 28 (100.0) 28 (100.0) 25 (89.3) 
missing 11 (39.3) 0   3 (10.7) 
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 Part II –“ History of disease” 
Table 5.6.7 and 5.6.8 contain the indicators of the second half of patient information related to 
the history of disease (date of onset of illness and hospitalization) and the prognose of disease 
(cured or deceased). In individual form for viral meningiti group is completed date of onset and 
hospitalization in the highest percentage, while in individual forms of diseases as: varicela, 
erisipelas, scarlatina and other rickettsiosis there is ―missing‖ for "date of onset" in about 45% of 
forms. 
Table 5.6.7 The data of the disease history 
Disease  Date of onset Hospitalized 
No.   (%) No.   (%) 
Aseptic viral meningitis         n=57 Yes 47 (82.5) 57 (100.0) 
missing 10 (17.5) 0 
Meningococcal meningitis    n=11 Yes 9 (81.8) 11 (100.0) 
missing 2 (18.2) 0 
Non meningococcal bacteria 
meningitis    n=60 
Yes 49 (81.7) 60 (100.0) 
missing 11 (18.3) 0 
Varicella                                    n=87 Yes 18 (20.7) 87 (100.0) 
missing 69 (79.3) 0 
Erysipelas                                 n=36 Yes 16 (44.4) 36 (100.0) 
missing 20 (55.6) 0 
Scarlatina                                    n=6 Yes 3 (50) 6 (100.0) 
missing 3 (50) 0 
Other rickettsiosis                  n=28 Yes 17 (60.7) 28 (100.0) 
missing 11 (39.3) 0 
 
Indicators cured and deceased are completed almost in all forms of study (see table 5.6.8) 
Table 5.6.8 the disease prognosis for each disease 
Disease Cured Deceased Missing Total 
No.  % No. % No. % 
Aseptic viral meningitis 
52 91.2 1 1.8 4 7.0 
57 
Meningococcal meningitis 
9 81.8 1 9.1 1 9.1 
11 
Non mening. bact. meningitis 
53 88.3 4 6.7 3 5.0 
60 
Varicella 
80 92.0 0 0.0 7 8.0 
87 
Erysipelas 
30 83.3 0 0.0 6 16.7 
36 
Scarlatina 
6 100.0 0 0.0 0 0.0 
6 
Other rickettsiosis 
23 82.1 0 0.0 5 17.9 
28 
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 Part III- “ Laboratory diagnosis”  
Confirmation of the final diagnosis based on laboratory examinations is needed for each disease. 
Viral Aseptic meningitis is confirmed by clinic, culture and serology; meningococcal 
meningitis is confirmed by direct examination and culture, and serology; varicela by clinic and 
serology; erysipelas and scarlatina by clinic, cultur and serology; other rickettsiosi by clinic and 
serology. 
Based on the criteria for laboratory confirmation of the obtained results show that the highest 
percentage of individual forms for the listed diseases in table 5.6.9 is‖missing" for 
information about laboratory examination. 
 
Table 5.6.9 the laboratory examinations for each disease 
Disease  Direct Culture Serology 
No.   (%) No.   (%) No.   (%) 
Aseptic viral 
meningitis  
n= 57 
Positive 1(1.8) not applicable 21 (36.8) 1(1.8) 
negative 0 0 0 
Missing 56 (98.2) 36 (63.2) 56 (98.2) 
     
Meningococcal 
meningitis  
n = 11 
Positive 2 (18.2) 4 (36.4) 0 
negative 0 0 0 
Missing 9 (81.8) 7 (63.6) 11 (100) 
     
Non mening. 
bacterial 
meningitis  
n = 60 
Positive 4 (6.7) 18 (30) 1 (1.7) 
negative 1(1.7) 2 (3.3) 0 
Missing 55 (91.6) 40 (66.7) 59 (98.3) 
     
Varicella  
N = 87 
Positive 0 not applicable 0 not applicable 0 
negative 0 0 0 
Missing 87 (100) 87 (100) 87 (100) 
     
Erysipelas  
n = 36 
Positive 4 (11.1) not applicable 0 0 
negative 0 0 0 
Missing 32 (88.9) 36 (100) 36 (100) 
     
Scarlatina  
n = 6 
Positive 0 not applicable 0 0 
negative 0 0 0 
Missing 6 (100) 6 (100) 6 (100) 
     
Other 
rickettsiosis  
n = 28 
Positive 7 (25) not applicable 0 not applicable 9 (32.1) 
negative 0 0 1 (3.6) 
Missing 21 (75) 28 (100) 18 (64.3) 
*Not applicable – means wrong laboratory examination
Dissertation 2011 
 
174 Elida MATA 
 
 Part IV – “Epidemiological investigation” 
Part of the epidemiological investigation includes appropriate indicators of the spread and 
origin of the infection presented in table 5.6.10 and 5.6.11. 
Epidemiological investigation in about half of cases for each disease has not identified the spread 
of disease. 
Table 5.6.10 the outbreak nature of disease 
 Disease Sporadic Endemic 
No. (%) No. (%) 
Aseptic viral meningitis N=57 yes 34 (59.6) 0 
missing 23 (40.4) 
Meningococcal meningitis N=11 yes 7 (63.6) 0 
missing 4 (36.4) 
Non meningococcal bacteria meningitis N=60 yes 28 (46.7) 2 (3.3) 
missing 30 (53.3) 
Varicella N=87 yes 63 (72.4) 0 
missing 24 (27.6) 
Erysipelas N=36 yes 20 (55.6) 1(2.8) 
missing 15 (41.6) 
Scarlatina N=6 yes 5 (83.3) 0 
missing 1(16.7) 
Other rickettsiosis N=28 yes 17 (60.7) 0 
missing 11(39.3) 
 
Also, regarding the information on the disease origin is ―missing‖ and ―unknown‖ in highest 
percentage. 
 
Table 5.6.11 Origine of infectious for each disease 
Disease unknown % missing % Total 
Aseptic viral meningitis 21 36.8% 36 63.2% 57 
Meningococcal meningitis 5 45.5% 6 54.5% 11 
Non meningococcal bact. Meningitis 22 36.7% 38 63.3% 60 
Varicella 61 70.1% 26 29.9% 87 
Erysipelas 18 50% 18 50% 36 
Scarlatina 5 83.3% 1 16.7% 6 
Other rickettsiosis 18 64.3% 10 35.7% 28 
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 Part V – “Conclusion” 
 
Regarding the fifth part of the individual notification form "conclusion part" which is based on 
clinical data, laboratory and epidemiological investigation is indicated an inconsistency of the 
data with the appropriate classification (confirmed or suspected case). Table 5.6.12 show that 
over 50% of cases is completed the conclusion part as ―confirmed‖, while for the necessary 
laboratory examinations is ―missing‖ in highest percentage of cases. 
Table 5.6.12 Case classification for each disease 
Disease Confirmed Suspected Missing Total 
No. % No. % No. % 
Aseptic viral meningitis 
29 50.9 11 19.3 17 29.8 
57 
Meningococcal meningitis 
8 72.7 1 9.1 2 18.2 
11 
Non mening. bact. meningitis 
32 53.3 8 13.3 20 33.3 
60 
Varicella 
73 83.9 13 14.9 1 1.1 
87 
Erysipelas 
29 80.6 6 16.7 1 2.8 
36 
Scarlatina 
3 50.0 1 16.7 2 33.3 
6 
Other rickettsiosis 
20 71.4 8 28.6 0 0.0 
28 
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5.7 Epidemiological characteristics of infectious diseases without individual schedule  
In this group are included the infectious diseases whose evaluation is not based on the assessment of the cases through individual 
notification form, but only by clinical symptoms and reporting of cases from monthly reporting form. 
This group includes: unspecified gastroenteritis, influenza, common cold, scabies and pediculossis. 
Obtained and presented results in table and figure 5.7.1 show increasing trend for unspecified gastroenteritis, influenza, common cold 
and the decreasing trend for scabies and pediculossis. 
Table 5.7.1 Number of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis cases over the period 1998-2009 in Albania 
 Disease 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Unspecified 
gastroenteritis 47149 51073 49410 49820 53575 53221 45811 48514 49868 68740 65440 65810 
Influenza 63764 65845 67879 70100 44695 61960 45355 48986 39200 65575 50370 58819 
Common cold 27127 19361 18150 20910 26972 37388 33929 39026 43785 56103 50730 58983 
Scabies 6238 4481 4665 4147 5905 4819 4899 4052 4502 3567 2244 1596 
Pediculosis 735 1003 862 354 961 939 889 628 622 658 494 724 
 
Figure 5.7.1The incidence ratefor unspecified gastroenteritis, influenza, common cold, scabies and pediculosis over the period 1998-2009 in Albania 
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Distribution of Diseases without schedule over the period 1998 – 2009 by region 
Country Mean Incidence (cases/100,000 population) and range 
 
          Unspecified gastroenteritis                                                             Influenza 
                 1838.6 (860 – 3820)                                                            1866 (495 – 5676) 
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                 Common cold                                                                          Scabies 
              972.2 (23 – 4707)                                                                170.2 (48 – 464) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Dissertation 2011 
 
179 Elida MATA 
 
Pediculosis 
46.7 (0 – 393) 
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Table 5.7.2 Number of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis cases over the period 1998-2009 by age-group 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
U
n
sp
ec
if
ie
d
 
g
a
st
ro
en
te
r
it
is
 
0-4 27192 25821 22651 23578 24778 24486 19104 19769 22120 26153 23174 25160 
5-14 8287 10693 9710 9957 10996 11517 10528 11219 10650 15732 15365 16621 
15-44 8675 10218 11111 11163 11672 10846 10175 10471 9695 15631 15765 14184 
45-59 2322 3536 4684 4094 4865 4808 4516 5190 5532 8326 8512 7625 
60 + 673 805 1254 1028 1264 1564 1488 1865 1871 2898 2624 2220 
                            
In
fl
u
en
za
 0-4 17923 17428 16912 18019 12761 16016 12872 12902 10609 17968 13566 17415 
5-14 16628 16642 15929 24101 12607 19704 14434 16203 11834 21627 15736 11392 
15-44 21928 23171 23454 21234 14259 18287 12602 13749 11591 16922 13696 18025 
45-59 6217 7353 9669 5791 4339 6599 4405 5118 4365 7280 5919 8371 
60 + 1068 1251 1915 955 729 1354 1042 1014 801 1778 1453 3616 
                            
C
o
m
m
o
n
 c
o
ld
 
0-4 11054 7386 6906 7861 10315 14942 14119 14645 17399 20275 18987 20293 
5-14 7035 4668 3991 5897 7822 10690 9682 11910 13595 18607 16022 20621 
15-44 7067 5526 4966 5213 6192 7539 5839 7023 7475 9825 8827 10372 
45-59 1663 1543 1904 1588 2091 3239 3071 3825 3977 5044 4788 5387 
60 + 308 238 383 351 552 978 1218 1623 1339 2352 2106 2310 
                            
S
ca
b
ie
s 
0-4 847 559 521 487 661 629 821 672 666 685 369 235 
5-14 1896 1710 1909 1472 2474 1833 2018 1540 1811 1268 842 542 
15-44 2587 1713 1660 1697 2203 1973 1618 1412 1594 1231 740 605 
45-59 773 435 500 422 499 305 345 335 353 295 203 144 
60 + 135 64 75 69 68 79 97 93 78 88 90 70 
                            
P
ed
ic
u
lo
si
s 0-4 91 234 192 46 392 597 548 338 408 342 380 545 
5-14 562 644 609 288 482 323 317 246 203 260 114 100 
15-44 78 100 42 19 80 19 17 43 11 56 0 15 
45-59 3 18 15 1 7 0 7 1 0 0 0 52 
60 + 1 7 4 0 0 0 0 0 0 0 0 0 
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Figure 5.7.2 the incidence rates of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis 
over the period 1998-2009 by age group 
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Scabies 
Pediculosis 
 
 
Distribution by age group for each disease shows that more sensitive age group is the pediatric 
age group (0-4 and 5-14 years old). Number of cases with this infective disease is present in all 
age groups, but the highest incidence rate is for pediatric age groups (0-4 and 5-14 years). 
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Table 5.7.3 Number of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis cases over the period 1998-2009 by residence 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
U
n
sp
ec
if
ie
d
 
g
a
st
ro
en
te
ri
ti
s Total 47149 51073 49410 49820 53575 53221 45811 48514 49868 68740 65440 65810 
Urban 22312 25750 23794 22932 29336 35344 21533 25851 27005 36467 35379 40034 
Rural 24837 25323 25616 26888 24239 17877 24278 22663 22863 32273 30061 25776 
  
                          
In
fl
u
en
za
 
Total 63764 65845 67879 70100 44695 61960 45355 48986 39200 65575 50370 58819 
Urban 40193 40919 38307 40714 24167 33886 22794 25816 21290 35342 28074 17695 
Rural 23571 24926 29572 29386 20528 28074 22561 23170 17910 30233 22296 41124 
                            
C
o
m
m
o
n
 
co
ld
 
Total 27127 19361 18150 20910 26972 37388 33929 39026 43785 56103 50730 58983 
Urban 16265 11907 8996 9233 11385 17339 14443 17172 18575 25261 23579 21530 
Rural 10862 7454 9154 11677 15587 20049 19486 21854 25210 30842 27151 37453 
                            
S
ca
b
ie
s Total 6238 4581 4665 4147 5905 4819 4899 4052 4502 3567 2244 1596 
Urban 2650 1773 1633 1481 1641 1701 1326 1322 1572 1387 901 667 
Rural 3588 2808 3032 2666 4264 3118 3573 2730 2930 2180 1343 929 
                            
P
ed
ic
u
lo
si
s Total 735 1003 862 454 961 939 889 628 622 658 494 660 
Urban 55 315 148 13 203 300 252 189 222 291 207 367 
Rural 680 688 714 441 758 639 637 439 400 367 287 293 
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Figure 5.7.3The incidence rates of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis 
over the period 1998-2009 by residence 
Unspecified gastroenteritis 
Influenza 
Common cold 
 
0
500
1000
1500
2000
2500
3000
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
C
as
e
s/
1
0
0
,0
0
0
Total
Urban
Rural
0
500
1000
1500
2000
2500
3000
3500
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
C
as
e
s/
1
0
0
,0
0
0
Total
Urban
Rural
0
500
1000
1500
2000
2500
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
C
as
e
s/
1
0
0
,0
0
0
Total
Urban
Rural
Dissertation 2011 
 
185 Elida MATA 
 
Scabies 
 
Pediculosis 
 
The cases distribution of according areas, Figure 5.7.3 shows that the biggest predominance for 
unspecified gastroenteritis and influenza (in 53.3% of cases) is in urban areas and an increasing 
trend in rural area after the year 2008, while common cold, scabies and pediculosis are most 
frequent in rural areas. 
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Table 5.7.4 Number of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis cases over the period 1998-2009 by gender 
 Disease   1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
U
n
sp
ec
if
ie
d
 
g
a
st
ro
en
te
ri
ti
s 
Total 47149 51073 49410 49820 53575 53221 45811 48514 49868 68740 65440 65810 
Male 25876 26871 25872 26219 27773 28323 23247 25961 26415 36720 34135 35341 
Female 21273 24202 23538 23601 25802 24898 22564 22553 23453 32020 31305 30469 
  
                          
In
fl
u
en
za
 
Total 63764 65845 67879 70100 44695 61960 45355 48986 39200 65575 50370 58819 
Male 33951 34490 34811 36161 23707 32449 23290 25680 20727 34433 26519 30952 
Female 29813 31355 33068 33939 20988 29511 22065 23306 18473 31142 23851 27867 
                            
C
o
m
m
o
n
 
co
ld
 Total 27127 19361 18150 20910 26972 37388 33929 39026 43785 56103 50730 58983 
Male 14431 10117 8375 10986 14123 19849 17890 20816 23742 29564 26265 31280 
Female 12696 9244 8775 9924 12849 17539 16039 18210 20043 26539 24465 27703 
                            
S
ca
b
ie
s Total 6238 4581 4665 4147 5905 4819 4899 4052 4502 3567 2244 1596 
Male 3294 2364 2433 2084 2951 2641 2509 2175 2463 1899 1102 793 
Female 2944 2117 2232 2063 2954 2178 2390 1879 2039 1668 1142 803 
                            
P
ed
ic
u
lo
si
s Total 735 1003 862 454 961 939 889 628 622 658 494 660 
Male 261 377 353 110 423 406 414 236 287 316 259 371 
Female 474 626 509 244 538 533 475 392 335 342 235 353 
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Figure 5.7.4The incidence rates of unspecified gastroenteritis, influenza, common cold, scabies and pediculosis 
over the period 1998-2009 by gender 
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Scabies 
 
Pediculosis 
 
Distribution by gender shows that the highest incidence is persent among males except 
pediculosis where until 2007 were women and after 2007 with a parallel increasing trend for 
both gender. However, there was no difference between male and female. 
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6. DISCUSSION 
6.1 Epidemiological characteristics of infectious diseases 
Since the years 1950s Albania has undertaken a lot of efforts towards infectious diseases because 
of their great on public health. The permanent application of measures for their control and 
prevention, regulated by a proper legal framework (numerous legislative laws and governmental 
decisions, regulations and directives mentioned above in the section 2.2). Albania actually 
although the total morbidity rates (diarrhea diseases, viral hepatitis, zoonoses, pulmonary 
tuberculosis morbidity etc.) are decreased over the time is higher then European developed 
countries. The incidence of vaccine-preventable infectious diseases results to be quite 
insignificant, some of them being already eliminated (poliomyelitis since 1997) or in the phase 
of elimination (measles and rubella). Nevertheless, infectious diseases still represent the major 
burden of the total morbidity in Albania, thus remaining a permanent threat for the health of the 
country population.  
Such a context requires an enhanced epidemiological surveillance of infectious diseases and 
enhanced monitoring of environmental hazards (water, air and soil pollutants). Such a context 
requires on the other hand a careful and scrutinized preparedness planning for any eventual 
disaster, in order to promptly respond with proper control and preventive measures. Because, a 
disaster event, despite of its form and infectious diseases involved represents a vicious circle: the 
former is always accompanied with a considerable increase of infectious diseases occurrence 
(threat of epidemics), whereas the latter aggravates the disaster disastrous consequences on 
public health. Then, it is an indispensable requirement to know the actual epidemiological 
situation of infectious diseases in Albania, always into the respective framework, because such a 
modus operandi helps to a better preparation for any eventual disaster in the future. 
In this thesis we analyzed the epidemiological characteristics regarding to the trend of infectious 
disease (incidence in total, by region, by age group, by gender and areas) in Albania for the 
period 1998-2009 based on the aggregated data and compared their incidence rate with the 
European countries.  
In table 6.1 are shown the incidence of common infectious diseases encountered and analyzed 
for Albania compared with the incidence of these diseases in developed countries of Europe, 
especially Greece as the nearest border and the greatest immigration of Albanians in this country 
(38). 
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1. Diarrhea Diseases 
The incidences of diarrhea diseases in Albania even though presenting a decreasing trend during 
the study period were higher than the incidence of these diseases in the countries of Europe and 
the neighboring country Greece. 
Diarrhea diseases, mainly resulting from unsolved problems in Albania regarding to drinking 
water that uses population in urban and rural areas which is due to infective diseases as a result: 
 Drinking water supply non quality safety in both of areas (urban and rural areas).  
 Temporary supply of tap-water (1-3 hours/day) at the urban areas. Drinking water supply  
 Disinfected drinking water for urban areas and non disinfected drinking water for rural  
 areas.   
 Diarrhea diseases persist with a considerable high incidence rate due, first of all, to a still  
inadequate of problems to potable water and food safety. The drinking water supply 
infrastructure both in rural and urban areas of Albania still suffers from the inadequacy of 
the system both by qualitative and quantitative point of view (cross-contamination 
between sewerage and pipes of drinking water outside technical – sanitary regulations 
especially, during the interruption time of drinking water). The food safety remains a 
common problem of a country in transition from the former centralized and limited 
economy to the current free-market one. The sanitation of human and animal excrements 
represent another urgent problem in both urban and rural settlements because the 
development of communal feeding, catering, tourism etc, for which there is not 
sufficiently strict sanitary inspection. Therefore, there is a permanent threat of outbreaks 
and epidemics of diarrhea diseases of all kinds of transmission (water-borne like 
salmoneloses, food-borne like alimentary toxic-infection, person to person like 
shigelloses) (39). A terrible example of the potential risk posed by water infrastructure 
was the outbreak of cholera in 1994. 
 Another cause of infective diseases is the use of drinking water from individual or  
 collective deposits and do not care to them (cleaning and chlorination). 
 Salmonellosis (non typhoid) which is expressed at lower levels of the EU countries but  
higher than in Greece is due to lack of identification, diagnosis, registration and 
declaration from all health system (primary and hospital). 
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2. Viral hepatitis 
In this report on viral hepatitis group identified only Albania has the form of unspecified 
hepatitis (including in this group and viral hepatitis A, B and C), as a result of lack of 
identification of the virus (see section 2.7). Also, the lack of reporting of cases of viral hepatitis 
B does not allow us to arrive at the conclusion that as a result of vaccination coverage levels are 
increased or decreased the cases of this disease (vaccination coverage rate for hepatitis B virus 
reaches 98.7 %.). Comparison of the incidence for all forms together with the EU countries and 
Greece shows that our country has the highest incidence.  The high incidence of unspecified viral 
hepatitis is the result of some factors such as: 
 Unsafe drinking water which is the cause of viral hepatitis A outbreaks in many urban 
areas (confirmed by laboratory and not identified in the reports of cases).  
 Poorly hygienic-sanitary conditions in both urban and rural areas. 
 Lack of knowledge to people regarding the prevention of viral hepatitis B (addition of 
syringe drug users) who do not achieve to identify as specific forms of viral hepatitis A, 
B and C. 
3. Zoonosis diseases 
Regarding the incidence zoonoses values for Anthrax and Brucellosis disease although 
decreasing are higher than those of European countries, especially Greece (see table 6.1), this for 
the following reasons: 
 major development of livestock sector after 90 years; 
 migration and emigration of animals in an uncontrolled manner; 
 adequate legitimacy but very poor implementation of animal health control and their 
immunizations; 
 poor conditions in the manipulation of livestock on farms and in slaughterhouses 
 the current inadequate level of veterinary preventive medicine activity regarding primary  
prevention (vaccination against anthrax), secondary prevention (brucellinisation) and 
tertiary prevention (diagnosis and control of leishmaniasis) 
 veterinary control structures are not well organized (differentiated structure of central  
 and local governments, who do not cooperate with each other).  
Besides the anthrax and brucellosis in my country continues to be present leishmaniasis infection 
(visceral and coetaneous) in some areas as ingle due to: 
Dissertation 2011 
 
192 Elida MATA 
 
 poor sanitary conditions, 
  no effective veterinary service 
 lack of control of this infection in animals. 
The incidence rate for leptospirosis remains at higher values compared to those of EU countries 
and Greece, this is due to: 
  lack of hygiene to the people, 
 poor condition of the environmental hygiene, 
 the total absence of war against rats. 
4. Pulmonary tuberculosis 
The incidence rate of pulmonary tuberculosis in Albania is presented in smaller value than that 
of the EU countries and slightly higher than that of Greece (40), this is because the organization 
and implementation of all obligations by the WHO for the fight against pulmonary tuberculosis 
as implementing the program DOTS. 
5. Vaccine preventable diseases (DTP, MMR) 
Diphtheria, tetanus, pertussis, measles, mumps and rubella in our country show a lower 
incidence rate than the EU countries and Greece (41), this is due to the correctly implementation 
and control of EPI program by the entire health system (from primary to public health 
institutions) . 
 
 
 
 
 
 
 
 
 
 
Dissertation 2011 
 
193 Elida MATA 
 
Table 6.1 Incidence rate of reported cases of infectious diseases in Albania, European Country especially Greece, (year 2009) 
Diseases 
  
Albania European Greece 
incidence rate/100.000 population incidence rate/100.000 population incidence rate/100.000 population 
Typhoid fever 0.3 0.16 0.16 
Salmonellosis (non-typhoid) 7.5 34.16 6.3 
Shigellosis (bacillary dysentery 9.4 2.08 0.44 
Unspecified hepatitis 24.7 not applicable not applicable 
Viral hepatitis A missing  2.81 2.6 
Viral hepatitis B missing  1.49 0.7 
Viral hepatitis nAnB missing  6.85 0.1 
Anthrax 0.9 0.03 < 0.1 
Brucellosis 15 0.13 0.9 
Coetaneous leishmaniasis 0.03 No data No data 
Visceral leishmaniasis 1.3 No data No data 
Leptospirosis 0.7 0.22 0.12 
Pulmonary tuberculosis 7.31 17.1 5.9 
Diphtheria 0.03 0.0042 0 
Tetanus (non neonatal) 0 0.03 < 0.01 
Pertusis 0.3 3.14 < 0.1 
Measles 0 0.57 0 
Rubella 0 1.17 0 
Mumps 0.7 4.33 < 0.1 
Meningococcal disease 1.6 1 0.95 
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6.2 Evaluation of infectious diseases surveillance system (individual notification forms) 
Financing of health, economic and policy development have created fluctuations at the 
prosecution of evaluation and monitoring of the infectious diseases.  As every where, even in 
Albania, infectious diseases have their flow necessarily related to other factors such as economic 
development, migration and emigration of population seeking their close supervision on a 
continuous effort to improve the existing system in order to exercise control over the spread of 
infectious diseases, to overcome the problems of underreporting, which underestimate the true 
impact of these diseases in the population health. In this thesis also, we are based in assessment 
of characteristics of our surveillance system of infectious diseases (monthly and individual) for 
the period 2007-2009 in order to obtain a general evaluation for the reporting system; the 
advantages and weaknesses of the current system if it has been able to exercise surveillance of 
these diseases in effectively and conveniently way. Our results obtained show that the data 
collected by the surveillance system of infectious diseases in Albania are not reliable as a result 
of incompatibility with the requirements relating to the attributes of a surveillance system, such 
as simplicity, flexibility, acceptability and quality of data as described in section 1.1.4 -
Characteristics of Surveillance System. Discussion of surveillance system characteristics will be 
performed based on the results presented in tables 6.2 and 6.3. Table 6.2 shows the monthly 
number of cases reported and individual cases notified during the period 2007-2009. The table 
clearly expresses a major discrepancy between the information and dissonance monthly and 
notified cases and also stated their respective individual form (where the number of cases should 
be equal). This discrepancy and discordance is because of: 
 Lack of qualified personnel in public health services 
 No estimation of the laws by public and private health structures 
 Lack of periodic analysis of epidemiological service activity (central level – IPH) related  
to discrepancy between notified and monthly reported data of infectious disease. The 
epidemiological service at the central level does not take correct measures in order to 
reduce or eliminate this gap. 
 Lack of communication between hospital institutions and public health structures 
 Populate migration that makes impossible the individual form compilation  
 Reforms in health, health insurance introduction (primary and secondary level) made  
 impossible the full declaration of infectious diseases cases. 
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Table 6.2 Number of infectious diseases cases reported by monthly and individual form over the period 2007-2009 
Diseases No of cases by monthly reporting 
(2007-2009) 
No of cases by individual 
form (2007-2009) 
Percentage (%) Range in % 
(maximum-minimum) 
Typhoid fever 48 27 56.3 64.0-50.0 
Salmonellosis (non typhoid) 1082 260 24.1 27.0-22.0 
Shigellosis (bacillary dysentery) 1342 317 23.6 26.1-20.0 
Poisoing 9201 182 2 2.0-1.9 
Unspecified hepatitis 3446 400 11.6 12.0-11.0 
Viral hepatitis A 0 214 0  
Viral hepatitis B 0 69 0  
Viral hepatitis nAnB 0 335 0  
Anthrax 100 29 29 50.0-7.0 
Brucellosis 1945 863 44.4 53.0-35.0 
Coetaneous leishmaniasis 134 1 0.8 0.0-3.0 
Visceral leishmaniasis 10 76 13.2 16.0-6.0 
Leptospirosis 39 13 33.3 50.0-29 
Extra-pulmonary tuberculosis 94 23 25.5 33.0-19.0 
Pulmonary tuberculosis 706 416 58.9 68.0-50.0 
Diphtheria 1 0 0   
Tetanus 2 0 0   
Pertusis 30 3 10 10.0-10.0 
Measles 96 0 0   
Rubella 0 0 0   
Mumps 2858 0 0   
Unspecified Paralyses (AFP) 12 7 58.3 80.0-25.0 
Aseptic viral meningitis 139 57 41.01 89.0-31.0 
Meningococcal meningitis 18 11 61.1 75.0-38.0 
Non.mening.bact.meningitis 98 60 61.2 69.0-56.0 
Tubercular meningitis 9 0 0  
Varicella 3211 75 2.4 3.0-1.0 
Erysipelas 290 36 12.4 14.0-9.0 
Scarlatina 74 6 8.11 14.0-3.0 
Other rickettsiosis 45 25 55.6 72.0-33.0 
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The table 6.3 shows the percentage of notified individual form application at the regional level. 
The results show that in major percentage, the regions do not perform notified individual case 
(*N/A) or notified cases are greater than monthly reported cases at the central level (**more than 
monthly). We guess that the reasons of this major gap are: 
1. Lack of medical staff (see table 2.3.1 – section 2.3 Infrastructure and operation of public 
health) 
2. Lack of qualification (carried out only the training during the epidemiological situations 
but no essential training for professionals is organized). 
3. There is an inappropriate level of laboratory confirmation of infectious diseases, because 
of the inadequate level of performance of districts microbiological (public health) 
laboratories.  
4. Lack of accountability from all levels of the health system 
5. Developing of an incorrect reform in health system (maninly on health information 
system and lack of fluid information at the epidemiological services by family doctor, 
hospital and microbiological laboratories). 
6. Political changes in regional and local level associated with frequent changes of 
leaderships at all health institutions levels (not professional but political leaders). 
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Table 6.3 Reporting of infectious diseases at the region level by individual form of notification 
Diseases Berat (%) Diber (%) Durres (%) Elbasan (%) Fier (%) Gjirokaster (%) Korce (%) Lezhe (%) Tirane (%) Shkoder (%) Kukes (%) Vlore (%) 
Typhoid fever more than 
monthly 
N/A more than 
monthly 
88.9 N/A N/A N/A N/A 39.1 N/A N/A N/A 
Salmonellosis (non-
typhoid) 
72.2 80 33.3 1.9 83.3 N/A 53.8 85.3 57.1 N/A N/A N/A 
Shigellosis (bacillary 
dysentery) 
68.2 100 6.25 5 12.5 75 86.7 more than 
monthly 
24.7 N/A N/A N/A 
Poisoing N/A N/A N/A 95.2 2.9 70 N/A N/A 82.9 N/A N/A N/A 
Unspecified hepatitis 11.4 N/A N/A 0.24 N/A N/A N/A 68.4 24.9 N/A N/A 37.7 
Viral hepatitis A more than 
monthly 
N/A N/A N/A N/A more than 
monthly 
N/A more than 
monthly 
more than 
monthly 
N/A N/A more than 
monthly 
Viral hepatitis B more than 
monthly 
N/A N/A more than 
monthly 
N/A more than 
monthly 
N/A N/A more than 
monthly 
N/A N/A more than 
monthly 
Viral hepatitis nAnB more than 
monthly 
more than 
monthly 
N/A more than 
monthly 
N/A more than 
monthly 
N/A N/A more than 
monthly 
N/A N/A more than 
monthly 
Anthrax N/A N/A N/A more than 
monthly 
N/A 34.6 N/A N/A 80 N/A N/A 25 
Brucellosis 29.7 69.1 55 33.5 49.8 46.4 49.9 33.3 38.1 N/A more than 
monthly 
47.1 
Coetaneous 
leishmaniasis 
N/A N/A N/A N/A N/A 100 N/A N/A N/A N/A N/A N/A 
Visceral leishmaniasis 94.4 N/A N/A 72.7 66.7 50 N/A 62.5 more than 
monthly 
N/A N/A 57.1 
Leptospirosis N/A N/A N/A 66.7 12.5 N/A N/A 50 56.3 N/A N/A N/A 
Pulmonary 
tuberculosis  
N/A 59.3 more than 
monthly 
N/A 1.5 N/A N/A 93.3 85.6 N/A N/A more than 
monthly 
Diphtheria N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Tetanus N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Pertussis N/A N/A 11.1 N/A N/A N/A N/A N/A 100 N/A N/A N/A 
Measles more than 
monthly 
N/A 50 N/A more than 
monthly 
more than 
monthly 
N/A more than 
monthly 
42.1 33.3 N/A 66.7 
Rubella N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Mumps N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Aseptic viral 
meningitis 
N/A N/A 80 60 37.5 18.2 N/A 50 more than 
monthly 
N/A N/A N/A 
Meningococcal 
meningitis 
20 N/A 100 N/A 50 N/A N/A more than 
monthly 
more than 
monthly 
N/A N/A N/A 
Non mening.bact. 
Meningitis 
more than 
monthly 
N/A more than 
monthly 
more than 
monthly 
55.6 N/A N/A N/A 53.7 N/A N/A N/A 
Varricella N/A N/A N/A 46.9 N/A N/A N/A N/A N/A N/A N/A N/A 
Erysipelas N/A N/A N/A 51.2 N/A N/A N/A 30.8 N/A N/A N/A 100 
Scarlatina N/A N/A N/A 66.7 N/A 100 N/A N/A N/A N/A N/A N/A 
Other rickettsiosis N/A N/A N/A 100 N/A 66.7 N/A N/A 100 N/A N/A N/A 
*N/A – the individual form of notification is not applicable by region 
**More than monthly - means that the number of reported cases for the respective infectious diseases is greater by the individual forms of notification. 
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6.3 Final comments and suggestions for the improvement of surveillance system 
Complementarity and integration of the surveillance system as monthly reporting and individual 
notification form will allow compatibility of the data, which is the only form required avoiding 
loss of information about infectious diseases. Compliance of the reporting in a short time and 
finally integration of information is a full description of the epidemiological characteristics of 
infectious diseases. To improve the system of surveillance of infective diseases is necessary to 
strengthen the connection between the monthly reporting system and the individual notification, 
this increasing sensitivity to the registration of disease cases, integration of laboratory and 
clinical data, enabling recognition of risk factors. Referring to the table 2.1 (Organization of 
Diagnostic and Curative Health Services in Albania- page 28) is necessary introduction of new 
organizational structures which will be able to respond to current needs and to help in improving 
the actual surveillance system through the: 
 reorganization of responsibilities at the regional level  
 strengthening of local structures, including the training of specialists and operators  
 better coordination between regional structures and reference center (IPH).  
All opinions above are measures which will be the best solution for the implementation and 
surveillance system efficiency at regional level (42). 
In the preliminary evaluation of surveillance system during 2007-2009 are noticed deficiencies in 
the information collection, not awareness of specialists related the compilation of the infectious 
diseases forms, failure of diagnostic laboratories, making the surveillance system not fully 
reliable. In this sense, it seems important to enable strengthening of the "culture of reporting", 
explaining the importance of health care professionals for a better completation of reporting 
forms and the possibly damages that can result from under-reporting at local, regional and 
national level. Related to the broader practices of notification (see table 2.8) versus three classes 
of infectious diseases, simplifying of the individual forms notification will allow us to facilitate 
the collection of significant data. 
Another frequently observed problem is the deficiency of feed-back information that should be 
communicated to the involved persons in surveillance activities. 
In fact, there are organizational problems, which generate difficulties in communication between 
family doctors and polyclinics and hospitals doctors. In general all these specialist doctors do not 
report in correct form and time to the epidemiologist. 
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Another weakness of surveillance system is reporting only through post mail. The introduction of 
electronic procedures of data will also improve communication between doctors and local 
regional and national health authorities, increasing the distribution of notification practice. 
Sensitivity of surveillance system reduction in terms of infectious diseases is associated with 
absence of the patient to medical care centers, or the refusal to conduct the further investigations. 
The sensitivity of the system is ultimately influenced by different factors such as living 
perception cultures and understanding of their health. (42). 
One of the concerns raised by experts in the surveillance system is a compilation of individual 
notification forms for specific groups of infectious diseases and their surveillance based on 
laboratory diagnosis in order to maintain data quality. The improvement of completion of the 
data, clarification of the way of infectious diseases transmission and understanding it in context, 
should orient the interventions for control and prevention of infectious diseases. (43). 
The achievement of these points is very helpful to strengthen surveillance system and inter-
institutional cooperation too. In terms of food borne diseases, strengthening the current system is 
very important in order to have a better cooperation between veterinary network and public 
health institutions. In this way we will have a better management / administration of food (from 
farms to consumers) and we will be able to control all zoonoses, which can be achieved through 
an integrated analysis of data, samples of human and animal, according to the interdisciplinary 
study of food-borne diseases (44). 
In cases of passive surveillance is necessary the epidemiological investigation which should be 
organized by polls and surveys. As is recommended by WHO and the ECDC, is very important 
the surveillance networks strengthening at local, regional and national levels, in order to 
consolidate the relationship and coordination between the responsible authorities. This 
organization will provide the exchange of epidemiological data, in addition to recognition of the 
epidemics level and the creation of action plans joint, in order to address the national importance 
events (43). 
Surveillance improvement is important to continue with the periodic system, to ensure that are 
appropriate and possible to carry out its activities in the context of new problems and the 
development of epidemiological scenarios. 
Effective surveillance of infectious diseases can eventually provide guidance for prevention 
implementation and control of these diseases (45). 
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7. Appendix 
Appendix .1 
 Monthly reporting  form  of the infectious diseases Region___________District_______  Months________/Year__________ 
Nr DIIAGNOSI Cases         SEX AGE                 HOSPITAL Deaths 
    TOTAL URBAN RURAL SUSPECTET CONFIRMED   0-1 1-
4 
5-
14 
15-
24 
25-
34 
35-
44 
45-
54 
55-
64 
65+     
                                      
1 Plague           M                       
              F                       
2 Cholera           M                       
              F                       
3 Yellow fever           M                       
              F                       
4 Hemorrhagic fever           M                       
  Afrikan (Ebola)           F                       
5 Exanthematous 
typhus 
          M                       
              F                       
6 Recurrant fever           M                       
  epidemic           F                       
7 Viral encephalitis           M                       
  epidemic           F                       
8 Viral encephalitis           M                       
  beat           F                       
9 Fever emorragicha           M                       
  viral           F                       
10 Fever dengue           M                       
              F                       
11 Malaria           M                       
              F                       
12 Rabies           M                       
              F                       
13 Botulism           M                       
              F                       
14 Leprosy lebbromatose           M                       
              F                       
15 Leprosy tubercoloide           M                       
              F                       
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16 Diphtheria           M                       
              F                       
17 Tetanus           M                       
  (nonneonatale)           F                       
18 Neonatal tetanus           M                       
              F                       
19 PFA-Polio           M                       
              F                       
20 PFA-Paralysis           M                       
  unspecified           F                       
21 Abdominal typhus           M                       
              F                       
22 Pre typhus           M                       
              F                       
23 Salmonellosis           M                       
  non-typhoid           F                       
24 Shigellosis           M                       
  (Dizenteri Bacila)           F                       
25 Alimentary toxicology           M                       
              F                       
26 Disenteria amoebic           M                       
              F                       
27 Anthrax           M                       
              F                       
28 Brucellosis           M                       
              F                       
29 Listeriosis           M                       
              F                       
30 Measles           M                       
              F                       
31 Rubella           M                       
              F                       
32 Mumps           M                       
              F                       
33 Pertussis           M                       
              F                       
34 Pulmonary TB           M                       
              F                       
35 Extra pulmonary TB           M                       
              F                       
36 Milliare tuberculosis           M                       
              F                       
37 Tuberculous meningitis            M                       
              F                       
38 Meningocoxic bacterial 
meningitis 
          M                       
              F                       
39 non-meningococcal           M                       
  bacterial meningitis           F                       
40 Viral meningitis           M                       
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  (aseptic)           F                       
41 Encephalitis           M                       
  unspecified           F                       
42 Encephalitis           M                       
  after vaccination           F                       
43 Hepatitis           M                       
  unspecified           F                       
44 Viral hepatitis A           M                       
              F                       
45 Viral hepatitis B           M                       
              F                       
46 Viral hepatitis           M                       
  nAnB           F                       
47 Scarlatina           M                       
              F                       
48 Erysipelas           M                       
              F                       
49 varicella           M                       
              F                       
 
50 Gray endemic typhus           M                       
              F                       
51 Butonose fever           M                       
              F                       
52 Fever Q           M                       
              F                       
53 Other Rickettsiosis           M                       
              F                       
54 Leishmaniasis           M                       
  visceral           F                       
55 Leishmaniasis            M                       
  coetaneous           F                       
56 Leptospirosis           M                       
              F                       
57 AIDS (SIDA)           M                       
              F                       
58 Primary syphilis           M                       
              F                       
59 Unspecified 
secondary  
          M                       
  syphilisis            F                       
60 Latent syphilis           M                       
              F                       
61 Gonorrhea           M                       
              F                       
62 Blenorrhagia           M                       
              F                       
63 Tularemia           M                       
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              F                       
64 Ankilostomiase           M                       
              F                       
65 Dermatophytosis           M                       
  endemic           F                       
66 Ecinococcus           M                       
              F                       
67 Trichinosis           M                       
              F                       
68 Legionellosis           M                       
              F                       
69 Gastroenteritis           M                       
  nonspecified           F                       
70 Influenza            M                       
              F                       
71 Common Cold           M                       
  (Sindrom flulike)           F                       
72 Scabies           M                       
              F                       
73 Pediculosiss+Infes-           M                       
   tim me Phthirus           F                       
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